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ABSTRACT 
Heroin use and dependency is a growing concern within South Africa, individuals face 
difficulty in remaining abstinent from the use of heroin due to constant relapse. The opioid 
antagonist known as the naltrexone pellet implant offers an alternative form of aid to relapse 
prevention in the recovery and abstinence from heroin dependency. This qualitative study 
explored the subjective experiences and perceptions of heroin dependent individuals, that 
made use of the naltrexone pellet implant. This study was rooted in the interpretive, 
qualitative paradigm where a phenomenological research design was used. Participants were 
selected using a purposive, snowball sampling technique and four individuals who had made 
use of the naltrexone pellet implant for the aid in heroin dependency for a minimum of three-
months were interviewed. Interpretative Phenomenological Analysis (IPA) was used to 
extract recurrent themes across participants. The findings suggested that the use of the 
naltrexone pellet implant was beneficial in the aid for relapse prevention from heroin use. 
Furthermore, the exploration of difficulties that were faced in remaining abstinent, the 
attempt to make use of the naltrexone pellet implant and the physical and psychological 
aspects regarding the use of this alternative method of remaining abstinent were explored in 
this study.  
KEY TERMS 
abstinence; antagonist; heroin; illicit substances; interpretative phenomenology; Marlatt’s 
relapse prevention model; naltrexone pellet implant; relapse prevention; South Africa; 
substance dependence. 
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CHAPTER 1: INTRODUCTION 
1.1 Background 
Heroin abuse and dependency has become a significant concern in South Africa. It 
has developed into a major problem, which is on the increase. Substance abuse and 
dependence, has broken out of well-defined localised dependent communities and evolved 
into a global problem, which infiltrates all strata of society.   
The changing nature of substance abuse has shifted from so called ‘soft’ to ‘hard’ 
drugs in the past thirteen years. Data presented by the South African Community 
Epidemiology Network on Drug Use (SACENDU) indicates that overall 26% of in-patients, 
those that receive treatment, reported heroin as a primary or secondary drug of use in the 
whole of Gauteng area, South Africa. It has been reported that in the Gauteng area 34% of 
heroin patients had previously been in rehabilitation for this substance without achieving 
abstinence from heroin abuse (Plüddemann et al., 2013).  
According to the South African Community Epidemiology Network on Drug Use 
(2013) heroin is still the most commonly abused illicit opioid in South Arica. South Africa is 
believed to be a major consumer market for heroin, deriving its supply from South-West Asia 
via East and West Africa and close to the Middle East, making it one of the major drug 
trafficking waypoints for heroin (Davis, Niaz, Pietschmann, Shelton, & Vella, 2014). It was 
also noted that Afghanistan had increased their production of heroin, which has led to 
increased availability of affordable heroin within South Africa.  
Various forms of heroin can be found within South Africa, the most pure form called 
‘Thai white’ is sold, in 2016, for between R30 and R50 per bag. Another form called ‘Sugars’ 
is a cheaper version of an illicit substance which consists out of a mixture of cheap heroin 
and cocaine, however, this substance is usually cut with a variety of other substances that 
may include rat poison or other household detergents. This is then usually sold for a price that 
ranges between R10 and R35 per bag. One of the most popular drugs found in the Gauteng 
area is called ‘Nyaope’ which is a mixture of heroin and other products that include rat 
poison and antiretroviral medication, this substance is usually smoked with cannabis (Weich, 
Perkel, van Zyl, Rataemane, & Naidoo, 2013). The accessibility of the drug has raised 
concerns of relapse rates within the Gauteng area and a necessary treatment strategy to aid 
heroin abstinence. 
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Numerous procedures and interventions have been integrated into the clinical practice 
of treating heroin use disorder within South Africa. Public healthcare policies designed to 
reduce the harmful consequences associated with heroin use and developing dependent 
behaviour, still needs to be implemented in the South African context. However, there are 
concerns regarding the difficult process that heroin dependent individuals face which 
involves the ‘coming off’ or ‘staying off’ of the substance known as abstinence. The recovery 
process of a heroin dependent individual is a complex issue due to individual differences and 
various pathways of recovery (Dos Santos & van Staden, 2008). Thus, for heroin dependent 
individuals to be able to cease the use of this particular illicit substance, it is vital to prevent 
relapse after the detoxification and rehabilitation procedure. 
One of the most fundamental features found in drug dependence is the tendency to 
relapse, this may occur in various periods of abstinence whether it is short or long term. 
Various factors that seem to have an effect on relapse are drug-associated environmental 
stimuli that tend to provoke drug-seeking behaviour and cravings which are known as 
triggers to the use of illicit substances (Giuliano, Robbins, Wille, Bullmore, & Everit, 2013). 
These so called ‘triggers’ could also be explained in a more theoretical concept developed by 
Marlatt and Gordon (1985a) in that individuals that attempt to remain abstinent from the use 
of an illicit substance would be faced with what he called high-risk situations during their 
attempt to remain abstinent. The opioid neurotransmitter system tends to play a significant 
role in the mediating conditioned incentive effects of stimuli associated with drugs of abuse 
(Zubieta et al., 2005).  
The recovery and abstinence process from heroin dependency remains a difficult task 
that may take several years to master, with occasional relapse and setbacks during the 
recovery process; therefore heroin dependency can be seen as a chronic, relapsing disease 
(McLellan, Lewis, O’Brien, & Kleber, 2000). Most of our present knowledge of opioid 
dependence comes from experience with illicit heroin users, all types of opioid agonists such 
as methadone and suboxone tend to share the same basic neurophysiological pathways and 
thus the risk of dependence, tolerance, withdrawal, intoxication and abuse increases (Kunøe, 
Lobmaier, Ngo, & Hulse, 2012).  
This may call for the consideration of alternative treatment methods, such as a 
maintenance or substitute substance, in the treatment process of heroin dependence. One of 
the most important factors in treating addictive behaviour is the use of 
psychopharmacological strategies. Naltrexone, as an opioid antagonist intervention in the 
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field of pharmacotherapy might be an alternative method of aid when it comes to the 
treatment process of heroin dependence and relapse prevention (Gorman, 2007). Naltrexone 
hinders the activity of opioids by blocking the μu opioid receptors, thus taking away the 
euphoric and analgesic effect of opioids such as heroin (Kirchmayer et al., 2002). According 
to Gorman (2007) the use of naltrexone would result in less discomfort, including a decrease 
in the trauma and agony being experienced by the dependent individual during the 
withdrawal phase and should therefore benefit the heroin dependent individual in the 
recovery process and sustaining abstinence. The use of naltrexone implants have been 
investigated for the use in treating opioid dependence under the motivation that the use of 
opioids will be reduced if an individual is unable to experience the pleasurable effects of 
opioid use known as the euphoric effect (Larney et al., 2014). 
The naltrexone pellet implant is not available for purchase within South Africa due to 
the reason that it has not yet been approved by the Medicines Control Council (MCC). The 
channel that various practitioners follow in the procedure of access to this implant is currently 
only available under Section 21 approval from the MCC. The patient would individually 
apply for the administration of the drug through the practitioner that will send their 
application for assessment and approval if deemed appropriate. This procedure would be 
followed only if the patient seeks to remain abstinent but has the inability to do so even after 
multiple inpatient rehabilitation admissions have been unsuccessful (Weich et al., 2013). 
It is recommended that only experienced physicians in the field of substance disorders 
treatment should prescribe naltrexone for their patients. Specifically, the naltrexone pellet 
implant is not registered in South Africa, therefore each patient needs MCC approval before 
it may be prescribed. There are a limited amount of professional practitioners that prescribe 
and conduct the medical procedure of insertion of the naltrexone pellet implant within South 
Africa due to the medication’s unavailability in the country. The naltrexone pellet implant 
can be obtained from other countries outside of South Africa via an online pharmacy. These 
countries include, but is not limited to Hong Kong, Russia and India (Weich et al., 2013). 
Naltrexone was initially approved as an oral medication for the management of opioid 
dependence in countries such as Russia, China, Israel and the USA. However the 
effectiveness of the use of oral naltrexone was limited due to poor adherence and low 
retention in treatment during the period that these studies were conducted. Due to these 
circumstances various other methods have been developed such as the sustained-release 
formulations of naltrexone that could be injected or implanted (Larney et al., 2014). 
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The current study focused on the use of the sustained-release formulation of 
naltrexone which would also be referred to as the naltrexone pellet implant. The study of the 
use of naltrexone pellet implant in the treatment of heroin dependence is fairly new within a 
South African context, where a lack of local evidence may lead to uncertainty about the use 
of this substance as an opiate antagonist in aiding with the recovery process. 
Interview data was gathered from heroin dependent individuals’ own perspective in 
an explorative manner, where the subjective experiences of these individuals were examined, 
transcribed and analysed. The aim was to provide a better understanding of the use of the 
naltrexone pellet implantation as an aid for heroin dependent individuals for relapse 
prevention from the use of heroin. This was done in order to answer the overall research 
question regarding the subjective experiences of individuals that made use of the naltrexone 
pellet implant as an aid for relapse prevention.  
1.2 Research Problem 
According to the SACENDU report (Plüddemann et al., 2013) the use of heroin in the 
South African context remains a growing problem across many treatment sites. Heroin is 
mostly smoked although there is a steady increase of patients reporting that they inject heroin 
in the past year. This poses is a major threat not only to the vast dependent properties 
associated with the use of heroin, but to the concern of the sharing of needles which is 
associated with health and social harms such as hepatitis and other infectious diseases such as 
HIV. Many infectious diseases may be transmitted to individuals that are non-heroin users, 
whereby it poses as a public health concern if not controlled, regulated or treated. 
There seems to be a lack of valid information when it comes to knowing about certain 
medications in aiding or assisting in treatment of heroin related disorders, specifically the use 
of the naltrexone pellet implant in the local context. Individuals that suffer from substance 
use disorders may go to many lengths to try and find a way to cope with their dependent 
lifestyle. For them to be able to deal with the psychological aspects of substance abuse, they 
need to find some way to deal with the physical factors that come with being dependent upon 
a substance such as heroin (Dos Santos, Fourie, Rataemane, & Trathen, 2010). 
Due to a high rate of relapse and poor social readjustment possibilities when it comes 
to the use of heroin, the combination of both psychological and pharmacological factors 
would contribute in a meaningful way to a better understanding and intervention of 
individuals affected by continuous heroin abuse (Gorman, 2007). Customary practices in the 
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treatment process of heroin dependency were limited to three main alternatives that include: 
detoxification followed by long-term residential treatment; opioid maintenance treatment; 
and oral naltrexone (Kunøe et al., 2012). The process of detoxification followed by a long-
term residential treatment has been found to be successful in some reduction in the use of 
illicit substances for some patients, however they tend to suffer from difficulties with 
maintenance in treatment and have a major risk for overdose upon discharge from the long-
term residential facility (Gossop, Stewart, Browne, & Marsden, 2002). Opioid maintenance 
treatment involves agonist medications that include methadone, buprenorphine, suboxone, or 
medically dispensed heroin that are administered under controlled supervision and is seen as 
substituting or maintaining dependence to heroin. The opioid maintenance treatment has been 
found successful in reducing mortality, morbidity and drug-related criminal activity, 
however, there remain concerns around the dropout rate during the initial months of treatment 
and that only a minority of these patients are able to achieve normal vocational and social 
functioning (Verthein et al., 2008). 
The focus of this study was to explore and understand the subjective experiences of 
heroin dependent individuals regarding the naltrexone maintenance therapy with pellet 
implants as specifically suited for withdrawal difficulties, cravings and obsessions in order to 
prevent relapse from occurring. This study has aimed to provide understandings of the use of 
naltrexone maintenance therapy with pellet implantation and to enhance the knowledge of 
medical healthcare professionals and the general public regarding this treatment method. It 
may offer an alternate form in future treatment where substance abuse problems and 
difficulties of abstinence to various substances will not interfere with the process of 
psychological as well as physical rehabilitation. The researcher set out to gain an in-depth 
understanding in the use of this aid from the perspective of dependent individuals and their 
experiences of the recovery process with the naltrexone maintenance therapy with pellet 
implantation as it was the participants’ personal journey that informed a rich description of 
their attempted recovery process. 
1.3 Grounds From Where the Topic Emerged (Experiences of the researcher) 
 During the researcher’s honours degree a six-month internship was required in order 
to be able to register with the Health Professions Council of South Africa (HPCSA) as a 
Registered Counsellor. During this period the researcher had gained some experience at 
SANCA in working with individuals that suffer from addictive behaviour. It was noted that 
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the group of individuals that tend to suffer the most from various drug-related problems, both 
during abstinence and use, was the opioid dependent individuals. In fact, the worst case noted 
was an male client that had extreme withdrawal symptom from the use of “Nyaope”, he was 
sick, confused and scared and wanted to leave as soon as possible in order to return to using. 
 During this period, at honours level, a fellow student was working on a paper 
regarding the use of naltrexone implants in the South African context that sparked the interest 
of the researcher. After a few readings on the use of naltrexone implant the researcher asked 
the opinion of the fellow colleagues at SANCA if they were aware of the “miracle drug” 
known as naltrexone. Their response was a form of disapproval and disappointment regarding 
the use of the naltrexone implant that led the researcher to believe that there is more to be 
explored regarding the use of this “miracle drug” known as naltrexone.  
When the researcher asked various heroin dependent individuals regarding their 
awareness of the substance known as naltrexone, it seemed that they were not aware of this 
specific aid to recovery. Some of these individuals mentioned that they have heard of a friend 
or a family member that had this “implant”. However, soon enough the researcher noted that 
individuals tended to confuse the naltrexone implant with a substance that is used for alcohol 
recovery know as Antabuse. This led to the believe that the people tend to become confused 
with a drug that was not yet registered or freely advertised in general public. 
 From these initial experiences, the researcher became interested in the experiences of 
individuals who have utilised naltrexone implants during their recovery process from heroin 
dependence, including the different processes that they went through in order to remain 
abstinent from heroin use.  
1.4 Research Questions 
 Maree (2014), advised that a good research question relates directly to the selected 
research topic at hand where it is linked logically and conceptually by using the same terms 
as used in the research topic. A research question should be easy to understand and be able to 
be implemented on its own. With this in mind, the research question for the purpose of this 
research project is: 
What are the subjective experiences and perceptions of individuals who made use of 
the naltrexone maintenance therapy with pellet implantations as an aid for relapse prevention 
from heroin use and dependency? 
7 
 
1.5 Research Aims 
 The aim of this proposed study was to explore the use of naltrexone maintenance 
therapy with pellet implantations as a suitable option in aiding individuals who suffer from 
attempting to remain abstinent from the use and dependency to heroin. Such an exploration 
was pursued to gain a better understanding of the subjective experiences of patients who 
receive naltrexone maintenance therapy with pellet implantation in preventing relapse and 
maintaining abstinence from the abuse of heroin. This would provide a description and form 
a platform of what it entails to be on the naltrexone pellet implant in aiding individuals with 
heroin abuse problems. 
1.6 Chapter Contents 
 This study consists of five chapters, each serving its own purpose for the totality of 
the research project. Chapter one provides an overview of the study that includes the aim, 
problem and purpose of the study. Chapter two reviews the literature of the topic and outlines 
the theoretical framework pertaining to the study. Chapter three describes methodology of the 
current study with the Interpretative Phenomenological Approach as the paradigmatic 
perspective. Chapter four discusses the findings that arose from the analysis process of the 
study regarding the participants’ subjective experiences and perceptions regarding the use of 
the naltrexone pellet implant as an aid to relapse prevention of heroin use. Lastly, Chapter 
Five concludes the study by means of an elaboration of the limitations of the current study 
and recommendations for the field of heroin dependence. 
  Chapter One forms the introduction to the study at hand, providing a summary of the 
relevant factors included in the study. It describes the problem statement regarding the use of 
naltrexone maintenance therapy with regards to relapse prevention of heroin addiction in a 
South African context. It includes a brief description of the need for alternative methods to 
deal with the problem of heroin use in South Africa and its emerging availability to the 
general public. The aim and purpose of this introduction is to provide an overview of what 
the study entailed and how the researcher decided to approach the research question. This 
chapter included the research question that forms the benchmark of this particular study in the 
collection of the relevant data in order to have answered it appropriately. 
Chapter Two forms the basis of the understanding of the relevant literature. This 
chapter serves the purpose of introducing and elucidating the reader to the relevant factors of 
heroin and the use of the naltrexone pellet implant in aiding individuals with heroin 
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dependency. The literature review chapter aimed to provide informative background on 
relevant topics that are related to the distribution, availability, use, concerns, 
psychopharmacology, dangers of the use, health implications and administration of heroin. 
This chapter focused on various aspects regarding the use of naltrexone maintenance therapy 
with pellet implantation, portraying various factors related to naltrexone which include 
different forms of naltrexone, the availability, the process of administering, previous studies, 
psychopharmacological factors and other relevant information pertaining to the use of 
naltrexone maintenance therapy with pellet implantation. Focus was given on a South African 
perspective regarding the relevant factors pertaining to the use of naltrexone pellet 
implantation therapy and heroin dependency. Furthermore, this chapter included the 
theoretical framework related to heroin dependency and relapse prevention that was used in 
various processes in conducting this study. Moreover, this theory is known as the relapse 
prevention theory which was integrated to the use of naltrexone as an aid to relapse 
prevention with the focus of exploring the subjective experiences of individuals that went 
through this type of therapy. 
 Chapter Three focuses on the methodological approach of the research study, in that a 
focus was given to the paradigmatic approach of Interpretative Phenomenological Analysis 
(IPA) as the lens through which this study was conducted. Furthermore, this chapter outlined 
the research design, the method of sampling, the data collection method and the process of 
how the data was analysed according to the IPA format. Moreover, this chapter stipulated the 
measures the researcher took in order to ensure the trustworthiness of this particular study at 
hand. The ethical considerations throughout the process of conducting this study were also 
included in this particular chapter, together with the significance of this particular study at 
hand. 
 In Chapter Four the researcher discussed the findings that arose during the analysis 
process of this particular study. This chapter included a brief narrative of each participant as 
to provide a wholistic picture of each participant. This chapter continues to discuss five 
superordinate themes together with twenty four subordinate themes regarding these 
participants’ subjective experiences and perceptions regarding the use of the naltrexone pellet 
implant as an aid to relapse prevention to heroin use and dependency. 
 Chapter Five concludes the current study by presenting the overall findings of this 
study. The final chapter aimed to sum up the research process of conducting this study 
together with a conclusion of the findings that arose from the gathering of information from 
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the participants in this study. Furthermore, this chapter outlines some of the limitations that 
the researcher became aware of and faced during the researcher process. This chapter ends of 
with future recommendations for studies in this particular field. 
1.7 Summary 
 This chapter provided an overview of the research problem to the current study 
together with a brief background in order to inform the reader of the use of the naltrexone 
pellet implant in the aid of relapse prevention from heroin use within the South African 
context. Furthermore, this chapter outlined the purpose, aim and outline of the study. 
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CHAPTER 2: LITERATURE REVIEW: AN OVERVIEW ON NALTREXONE 
MAINTENANCE THERAPY WITH PELLET IMPLANTAION, HEROIN 
DEPENDENCE AND PHARMACOLOGICAL INTERVENTIONS 
2.1 Introduction 
 A literature review involves the identification and analysis of information resources 
and literature related to one’s own research study at hand. The process of a literature review 
comprises of identifying potentially relevant sources, an initial assessment of these sources 
and the construction of an account that integrates and explains relevant sources. It tends to 
put the research study into context by showing how it fits into a particular field (Terre 
Blanche, Durrheim, & Painter, 2006).  
This study focused on the use of naltrexone maintenance therapy with pellet 
implantation with regards to relapse prevention to heroin dependence, with special focus on 
the subjective experiences of the individuals regarding the use of naltrexone pellet 
implantation as a method to aid the process of recovery from heroin dependency. It aimed to 
provide an indication to what these individuals experienced when making use of this 
treatment method.  
A holistic approach towards this study was adopted to ensure that a rich description of 
these individuals’ experiences could be explored in order to form a platform of information of 
what it is to be on this specific treatment method from the perspective of the recovering 
dependent individual. 
 The researcher was aware that it would be more appropriate to speak of the person 
with heroin use disorder, rather than of the ‘addict’. Furthermore, it is important to note that 
the researcher took a stance of curiosity in terms of the study of the subjective experiences of 
individuals who made use of the naltrexone pellet implant as an aid to relapse prevention. 
The research did not intend to sell or advertise this specific form of treatment, but rather the 
intention was to explore the use of this treatment modality which may benefit healthcare 
professionals and the general public by informing them regarding the use of this particular aid 
from the perspective of the individual who made use of this aid. 
 The particular literature review focused on the use of naltrexone maintenance therapy 
with pellet implantation, providing and in-depth description of the origins of this treatment 
method. Previous research regarding the use of naltrexone in various formats including the 
pellet implantation form was discussed in order to form an overview of the use of naltrexone. 
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A description of the procedure of accessing this form of treatment was included together with 
the procedure of administering (surgically) this form of treatment within the Gauteng 
province of the Republic of South Africa. Previous research regarding the use of naltrexone 
maintenance therapy with pellet implantation was included in this review. Epidemiological 
information regarding the use of heroin and its different formats was explored, including a 
more concrete discussion on the use, availability, and effects of heroin within the South 
African context, and why it is necessary to explore this alternative form of treatment in South 
Africa. Various treatment methods related to the recovery and maintaining abstinence from 
heroin abuse were explored as the use of naltrexone maintenance therapy with pellet 
implantation involves a psychological treatment procedure that needs to be followed when 
individuals with heroin dependence are making use of the naltrexone implant. 
2.2 Substance Abuse as a Worldwide Problem 
 It is estimated that globally 243 million individuals, which corresponds to 5.2 per cent 
of the world’s population, between the ages of 15 and 64 years of age had previously used an 
illicit drug. These illicit substances consist mainly of cannabis, opioids, cocaine or 
amphetamine-type stimulants (ATS) which were used at least once in the previous year of 
2012. Globally, cannabis users comprise the largest number of illicit drug users with an 
estimate of 177 million people. The amphetamine-type stimulants was ranked as the second 
most common type of substance with an estimate of 34 million users globally, followed by 
cocaine and opiates.  It has been reported that since 2009 there has been an increase in the use 
of opioids and cannabis (Davis et al., 2014).  
The one main focus of substance abuse is the ‘problem drug user’: who are 
individuals who engaged in the high-risk consumption of illicit substances. There is no 
standard definition of a ‘problem drug user’. However, a workable definition includes 
individuals that tend to inject illicit substances, people who use these substances on a daily 
basis, and who are diagnosed with substance-related disorders based on clinical criteria. With 
regards to the injecting of illicit substances, there still seems to be a gap in service provision 
when it comes to the treatment of ‘problem drug users’, it was found that only one in six 
‘problem drug users’ have had access to treatment services globally, these include the 
injection of cocaine and heroin (Davis et al., 2014). 
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2.3 Substance Abuse as a Problem in South Africa 
 Since the mid-1990s the price of illicit substances has demonstrated some change 
which contributed to an increase in demand and availability of the less customary drugs of 
choice. The South African Rand price remained stable, however, when expressed in US 
dollars, the price of illicit substances such as cocaine and heroin fell by more than 75% 
between 1992 and 2001. This allowed for a much wider consumer market of these particular 
substances. Drug users were more able to finance the use of these more dependent prone 
substances which could not previously be afforded. This price drop caused the likelihood of 
drug use among lower income and youth within South Africa (UNODC, 2006). 
 The massive increase of the role of illicit substances within South Africa is of 
significant concern. Findings from the South African Community Epidemiological Network 
on Drug Use (SACENDU) indicates that the use of cannabis still remains one of the most 
often used illicit substances among youth that attend specialist treatment centres. However, in 
the Western Cape the amount of adolescents admitted to in-patient clinics for the abuse of 
methamphetamine-related (known locally as ‘tik’) problems remain dominant when it comes 
to this province. The use of heroin remains a growing problem in most parts of South Africa, 
except for KwaZulu Natal (KZN) where it seems to have remained stable. Of concern is that 
though heroin is most commonly smoked and snorted, there is evidence that indicates the 
increase of the injection of this substance which poses various health related problems such 
as infectious diseases including the transmission of HIV/AIDS due to the sharing of needles 
(Dada et al., 2014). 
2.4 Heroin 
 Heroin can be referred as a narcotic, an opiate, or an opioid. The term ‘narcotic’ is 
derived from the Greek word for ‘narkõtiskos’ which means benumbing or stupor. It 
originated from the fourteenth century where the term was used to refer to certain substances 
that produced stupor or sleep that was associated with pain relief. The term referred mainly to 
opium and its derivatives such as the morphine like analgesics, or opium like compound 
(Korsmeyer & Kranzler, 2009). The term ‘narcotics’ is used to refer to a variety of illegal 
substances and is used mostly in legal context. There are government laws that prohibit the 
use, selling, buying and distribution of these substances, so contravening these laws is 
punishable by law. 
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  Opioids can be seen as biochemical synthetics that are usually prescribed by 
physicians to help patients with the alleviation of pain and can also be used to suppress 
coughing. Opioids have morphine-like action when it enters the body. Opioids are also used 
in postoperative situations where it acts as an analgesic for pain management. Furthermore, 
opioids are also used for the therapeutic purposes in cancer and terminal illnesses. They act 
by binding to receptors in the brain and limit the release of neuro-transmitters involved with 
pain (Gulmatico-Mullin & Cross, 2009). 
 The term ‘opiate’ can refer to as any psychoactive substance of either natural or 
synthetic origin that has an effect similar to morphine. Opium, however, is the raw efflux of 
the opium poppy (Papaver somniferum) that is scraped from the scored seed head of the 
poppy (a herbaceous plant). This sap that is collected contains a number of alkaloids, 
including morphine and codeine. Morphine and codeine are extracted from opium, and heroin 
is manufactured chemically from morphine. Morphine is used in variety of medical incidents 
in order to stop pain and is legal when prescribed by a medical practitioner (Rassool, 2010). 
Opiates are distinguished from opioids, in that opiates are known as narcotic alkaloids and 
are derived from opium. Such derivatives include morphine, codeine, and thebaine 
(Gulmatico-Mullin & Cross, 2009). 
Diacetylmorphine, better known as heroin, is an illegal and highly dependent 
substance that is synthesized from morphine, a naturally occurring substance that is extracted 
from the seed pod of the Asian opium poppy plant. Heroin is usually found in a white or 
brown powder, it can also take the form of a black sticky substance that is known as black tar 
heroin. This substance has various street names depending on the region that it would be 
found in, some of these names may include smack, horse, junk, tai white, shag etcetera 
(Kleiman & Hawdon, 2011). As an imitator of endorphins, heroin is well known for creating 
a sense of euphoria and well-being a short time after being introduced into the bloodstream of 
the individual that tend to use or abuse this substance. One of the notable dangers in the use 
of heroin is the fact that it tends to have an extremely high potential for addiction, as 
tolerance can occur rather quickly with constant use of heroin. Although heroin is illegal in 
various countries, heroin is a legal prescription in other countries under the name 
diamorphine and is used for various medical purposes (Wessel, Martino-McAllister, & 
Gallon, 2009). 
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2.4.1 The Distribution of Heroin 
Globally, the cultivation of illicit opium poppy plants in 2013 was estimated to be 
296,720 hectares. This was the highest amount since the estimates became available in 1998. 
The cultivation of poppy plantations has increased in both Afghanistan and Myanmar where 
the main increase was found to be in nine provinces of the southern and western part of 
Afghanistan, where the poppy cultivation increased by 36%. This caused an increase from 
154,000 hectares in 2012 to 209,000 hectares in 2013. South-East Asia, specifically the Lao 
People’s Democratic Republic, is another country that has a massive contribution towards the 
cultivation of opium poppy production with an estimate of 3,900 hectares being produced in 
2013 alone. However Afghanistan still produces the largest amount of opium globally with an 
estimate of 80% of the world’s heroin being produced in Afghanistan.  
South Africa tends to be affected by the increase in the opium and heroin trade as 
South Africa is one of the regional hubs for drug trafficking, and the largest zone for illicit 
drugs. Various drug cartels have established contacts with Asia and far Eastern producers to 
use South Africa as a conduit for smuggling heroin and opium to Europe and the United 
States of America (USA). The World Drug Report of 2013 showed that Afghanistan, 
Pakistan and South East Asia are some of the biggest sources of opiates worldwide. East 
Africa has been reported to be the point of entry for heroin entering the African continent, 
intended for South Africa and trafficked through countries on the East African and South 
African coast. The estimate use of heroin in West and Central Africa is above the global 
norm with small scale trafficking occurring by air, notably through Nigeria (Davis et al., 
2014). 
 The prevalence of heroin use is seen as very low when compared to other illicit 
substances such as cannabis. According to the UNODC (2009) it was estimated that between 
15 and 21 million people aged between 15 and 64 years used opioids in the preceding year 
globally. This indicates that between 0.3% and 0.5% of the global population have made use 
of an opioid during 2010. Rates appear to be highest per capita in Europe ranging from 0.6%-
0.7%, followed by the Americas and Oceania with 0.4%. Africa falling within the 0.2%-0.5% 
margin and Asia between 0.3%-0.5%. As these proportions indicate, opioid use is truly an 
international phenomenon. Heroin constitutes a large proportion of global opioid use, with at 
least 9 million estimated users globally. Recent use estimates that major heroin markets 
include the United Kingdom (0.1%), the United States (0.2%) and Australia (0.2%) 
(UNODC, 2009). 
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 The misuse and abuse of illicit substances emerged in South Africa during the 1960s 
and the 1970s, where globalisation has caused a widespread introduction to potent dependent 
drugs such as heroin, cocaine and ecstasy in the South African context. According to Leggett 
(2002) access to these type of highly dependent substances was not readily available to 
society prior to the lifting of political and economic sanctions in1994. The development of 
South Africa’s communication, transportation and advanced banking systems during the 
country’s reintegration into the worldwide community during the 1990s, has opened certain 
pathways for the trafficking of a number of illicit commodities that includes illicit substances. 
Thus the end of the Apartheid era marked a new opportunity for the trafficking, consumption 
and distribution of various illicit substances between the source countries such as Asia and 
South America and the major consumer markets such as Western Europe and North America. 
Although South Africa is not the most direct route between the areas for major trafficking, it 
is used for trans-shipment of illegal substances. This is due to the opportunity that has now 
been open due to the end of Apartheid, where quality air and sea travel connections via South 
Africa to many areas of the world offer the trafficking world an attractive drug transit country 
(Davis et al., 2014). 
2.4.2 Heroin Epidemic in South Africa 
South Africa has a reported increase in the use of heroin, where treatment facilities 
across the country have reported that the use of this substance is of growing concern. Heroin 
use has nearly doubled since 2012 in Southern Africa, with the price of heroin being lowered 
dramatically causing the drug to be more affordable for heroin users and heroin dependent 
individuals. It has been specifically marketed in certain townships and areas around the 
country (Davis et al., 2014). 
 Data presented by SACENDU (Dada et al., 2014) of in-patient treatment centres 
indicate that within the Gauteng region the amount of in-patient treatment admission has been 
decreasing significantly since 2009. The most common primary substance of abuse in 2013 
was found to be cannabis with a 40% of the population preferring cannabis as their primary 
choice of drug. The concern regarding the use of cannabis is that the illicit cocktail known as 
‘nyaope’ which main component of illicit substances is a form of cheap heroin, is usually 
smoked with cannabis. However, it is unclear from the data whether the same percentage of 
users had made use of ‘nyaope’ and cannabis as a drug cocktail. The use of nyaope recorded 
from 2012 and the data indicates that in the Gauteng province the use of nyaope has been 
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stable up until the recent findings of 2013 with an indication that only 4% of the population 
had made use of nyaope as their primary substance of abuse.  
In southern suburbs of KwaZulu-Natal known as Chatsworth, heroin is referred to as 
‘sugars’ and affects at least 70% of households. In the area of Tshwane people are especially 
vulnerable to nyaope which has become very popular. 
Evidence from SACENDU that was sourced from 2684 individual admissions to 17 
different treatment centres recorded in the first half of the year 2010 showed that within the 
Gauteng area, 44% of the patients’ primary substance of abuse was alcohol, followed by 
cannabis with 27% and heroin with 12%. Admissions for various drugs have remained fairly 
stable except for an increase in the use of heroin (Dada et al., 2014). Treatment centres within 
the Johannesburg area are already overwhelmed with people seeking help, where it has been 
reported that a lack of staff as well as a lack of funds contribute to the lack of recovery rates 
from substances such as heroin (Gosh, 2013). 
2.4.3 Heroin Administration  
Heroin is one of the most popular opiates of use in the South African context. Due to 
its ability to cross the blood-brain-barrier more rapidly as compared to other opiates, it tends 
to results in instant intoxication. There are three main routes of administering heroin into the 
human body. Firstly, heroin can be smoked by means of carefully heating the drug on the 
surface of a piece of tin foil, resulting in the inhalation of the volatile drug vapour (referred to 
as ‘chasing the dragon’). Secondly, a method consists of insufflating the substance directly 
into the nasal cavity (‘snorted’), and finally the substance can be injected by means of the use 
of a hypodermic needle that is put into the skin of various parts of the body (called skin-
popping). The other method of administration is intravenous consumption (which is referred 
to as spiking or mainlining), where the user will heat the heroin within water (typically a 
spoon) in order to obtain the injectable solution. The ‘spiking’ method is favoured due to the 
type of opiate ‘high’ that is caused within a few seconds (Iversen, Iversen, Susan, Bloom, & 
Roth, 2009). The intravenous administration of heroin is also seen as the most practical and 
efficient method of use for low-purity heroin. 
With the injection of heroin, users describe four different components of intoxication 
that may overlap over time. The first component has been noted by various users as an 
intense feeling of euphoria called a ‘rush’ that usually tends to occur within ten seconds after 
the heroin has been administered. This euphoric feeling is described by the users in sexual 
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terms as an ‘orgasmic wave’ of euphoria. The euphoria is followed by a high that is 
associated with a general feeling of well-being that lasts for hours after the ‘rush’ has 
occurred. Corresponding with the high is the ‘nod’, which consists of a state of sleepiness 
that represents a state of escaping from reality. During the phase of the ‘high’ and ‘nod’ the 
external world tends to become uninteresting to the user, calmness and detachment from 
reality then starts setting in. In the last stage of ‘being straight’ the user stops experiencing 
the ‘high’, ‘nod’, ‘euphoric feeling’. Subsequently, the physical and psychic feelings of the 
withdrawal stages, usually occurs eight hours after the last administration of the substance 
(Iversen et al., 2009).  
According to SACENDU the primary method of administration of heroin is smoking, 
although there seems to be a steady increase of patients reporting injecting heroin. Patients 
from treatment centres have also reported the injecting of other drugs such as cocaine, 
methcathinone (CAT), methamphetamine and over-the-counter/prescription medication 
(Dada et al., 2014). There seems to be no results or records on the various methods of heroin 
consumption within South Africa. 
A study conducted in London interviewed a sample of 408 heroin users regarding 
their predominant route of heroin administration. Clear preferences of heroin administration 
indicated that there were two predominant routes of administration which indicated that 
injecting (54%) was the primary route of administration and that smoking or ‘chasing the 
dragon’ (44%) was second in line for the preferred method of administration. More than a 
third of the sample reported changing their primary route of administration. There was only 
one transition reported from the administration of smoking to injecting, however the 
transition to injection was not inevitable: the majority of individuals that had used chasing as 
a method of administration had never moved to injecting despite reporting that they had been 
using large amounts of heroin for many years. It was found that many chasers give up heroin 
and tend to remain abstinent without moving to injecting. When it came to gender it was 
indicated that women were less likely to move from chasing to injecting. A small group of 
injecting user (16%), both male and female, had shifted from injecting to chasing heroin 
(Griffiths, Gossop, Powis, & Strang, 1994).  
2.4.4 Heroin Pharmacology 
Heroin tends to have various street names that include Thai white, horse, black tar, 
junk or smack, however, the more accepted term for heroin in the medical community is 
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diacetylmorphine. The production of this illicit substance starts off by collecting the raw 
opium obtained from the poppy plant (Papaver somniferium). Collecting the milky exudate 
from the incising capsule after the flower has bloomed, this milky substance is then air-dried 
and rolled into balls that has a resin like consistency. This raw opium is dissolved in hot 
water where it is then ‘purified’ by the addition of lime salts, the addition of this substance 
causes the precipitation of organic waste which leaves a suspension of morphine. The process 
following filtration and reheating consists of the addition of ammonia as a precipitant, and the 
morphine is re-filtered and packaged for shipment. In this process the morphine base has 
been reduced to one-tenth the volume of the original raw opium. This extraction process is a 
simple process and can be performed at almost any location (Stimmel, 1975). 
 The process involving the synthesis of heroin from a morphine base, however, 
involves several steps which requires a laboratory for its production and may even take up to 
24 hours to complete. Synthesising heroin starts off by treating the morphine base with acetic 
anhydride in equal amounts and is then heated for six hours, wherein the conversion to heroin 
or diacetylmorphine occurs. Impurities are removed by means of treating the substance with 
chloroform, this is then followed by precipitation of the heroin with sodium carbonate. This 
step is repeated several times until the desired purity is then achieved. This repeated process 
results in a cocoa-coloured substance that is bleached with activated carbon and alcohol. It is 
then neutralised with hydrochloric acid with conversion to the hydrochloride. The heroin is 
then baked and shifted which results in a white coloured substance that is ninety percent free 
from impurities. Alternatively, the morphine base may be initially treated with acetone, 
bleached and purified prior to the addition of acetic anhydride to produce the heroin  
(Stimmel, 1975). 
 When heroin is injected into the bloodstream of the human body it is rapidly 
diacetylated at the third position to 6-monoacetyl morphine (MAM), which in turn is 6-
deacetylated to morphine at a slower rate. Levels of MAM are detected within minutes after 
injection and are followed shortly thereafter by the appearance of morphine in increasing 
concentrations. This indicates that deacetylation of heroin probably precedes its specific 
pharmacologic effect with MAM and morphine becoming subsequently responsible for most 
of its pharmacologic effect. Within a short period of time, cerebral levels of heroin are not 
present although the pharmacologic action of the drug continues unabated. Heroin appears to 
have a greater lethal effect than morphine when used parenthetically. This may be due to the 
greater ability of MAM to transverse the blood-brain barrier due to its increased lipid 
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solubility (Stimmel, 1975). The rush that is experienced by the injectable use of heroin is 
almost immediate, which is due to the heroin reaching the brain before the drug has had time 
to be diffused through the bloodstream and changed into morphine. It is this effect that 
accounts for heroin’s greater power (Kaplan, 1983). 
 
Figure 1. The metabolic pathway to morphine (Qiao, Han, & Zhan, 2014, p. 2215). 
 Opioid receptors have been demonstrated in all vertebrates. The primary effects of 
opioids are mediated through the opioid receptors. The µ-opioid receptors are involved in the 
regulation and mediation of analgesia, respiratory depression, constipation and dependence; 
the κ-opioid receptors, with analgesia, diuresis and sedation; and the δ-opioid receptors, 
possibly with analgesia. In 1974, an endogenous pentapeptide with opioid-like actions called 
encephalin was identified. The discovery of this pentapeptide led to the identification of three 
classes of endogenous opioids within the brain, these included the endorphins and the 
enkephalins. These endorphins are responsible for neural transmission and pain suppression. 
These endorphins are released naturally when an individual is physically hurt and experiences 
pain symptoms, where these natural endorphins are then responsible for controlling the pain 
during acute injuries. These opioids also have some effect on the dopaminergic and 
noradrenergic neurotransmitter systems. Data has indicated that the dependent rewarding 
properties of opioids are mediated through the activation of the ventral tegmental area 
dopaminergic neurons that project to the cerebral cortex and the limbic system (Sadock & 
Sadock, 2007). 
 Heroin as a highly addictive narcotic imitates natural chemicals in the central nervous 
system. Endorphins tend to activate the body’s opioid receptors which are proteins in the cell 
membrane. Heroin is an antagonist that binds to the receptors in order to initiate the 
receptors’ effects. A high level of these natural receptors are located in the limbic system of 
20 
 
the brain-this is the region of the brain that controls memories, emotions, smell and hunger. 
Other opioid receptors are found in other regions of the body including the spinal cord, 
intestinal tract, and other regions of the brain such as the periqueductal gray region and the 
medulla oblongata (Gottås et al., 2013). 
Heroin modifies the action of dopamine in the nucleus accumbens and the ventral 
tegmental area of the brain – these areas form part of the brain’s ‘reward pathway’. Once 
crossing the blood-brain barrier, heroin is converted to morphine, which acts as a powerful 
agonist at the mu opioid receptors subtype. This binding inhibits the release of GABA from 
the nerve terminal, reducing the inhibitory effect of GABA on dopaminergic neurones. The 
increased activation of dopaminergic neurons and the release of dopamine into the synaptic 
cleft results in sustained activation of the post-synaptic membrane. Continued activation of 
the dopaminergic reward pathway leads to the feelings of euphoria and the ‘high’ associated 
with heroin use. Morphine is a weak agonist at the opioid kappa and delta receptor subtypes 
and activation of these receptors has a weak activating effect on the dopaminergic reward 
pathway (Gottås et al., 2013). This process can be viewed in Figure 2. 
 
Figure 2. The mechanism of action of heroin at the mu (m) opiate receptors (CNS forum, 
2014). 
 Given the crucial role of reward, motivation and emotion in learning and information 
processing that are associated or linked to these neurological systems, it therefore seems 
likely that the endogenous opioids affect even the highest cognitive functions in humans. 
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Under natural conditions, the releasing stimuli for the endogenous opioid system are probably 
emotional. Exogenous opioids like morphine and heroin presumably operate by taking the 
place of endogenous opioids at the opioid receptors. Such unnatural ligands cannot match the 
fine tuning that the system shows when it operates under natural conditions, using its own 
endogenous chemicals. The effect of exogenous opioids is inflexible. Since their 
administration is under external rather that situational control, opportunities for ‘misuse’ are 
much greater (Krivanek, 1988). 
2.5 Heroin Dependence Potential 
 A psychoactive substance is any substance that, when taken into the living organism, 
may modify one or more of that organism's functions. This in return produces mood-altering 
changes and distorted perceptions. Many psychoactive substances involve a direct activation 
of the brain reward system which produces reinforced behaviours. This causes normal 
activities in the brain to be neglected, thus causing the reward pathways to be directly 
activated when the substances are abused, resulting in a feeling of pleasure or often called a 
‘high’ (American Psychiatric Association, 2013). One of the significant long-term effects of 
heroin is the physical dependency that the person may develop which causes a chronic 
relapsing disease (National Institutes of Health, 2014). 
 Illicit substances tend to be extremely rewarding, which promotes continuous or 
repetitive use. In some individuals, those whom are prone to the development of substance 
use disorders, repeated use of an illicit substance can lead to the development of severe 
substance-related disorders whereby the individual loses control of the use of the illicit 
substance. As the individual continues to use the substance in a chronic manner, the 
dependent individual’s nervous system adapts to repeated exposure. Indeed, when the drug is 
then withdrawn from the system, similar unpleasant emotional reactions and changes in the 
brain will occur, regardless of the specific drug. It is these effects that are responsible for 
craving and relapse, even after long periods of abstinence (Julien, Advokat, & Comaty, 
2011). 
 Almost all substances of abuse have a similar effect on the neural system of the 
human body that tends to serve as a reward circuit. This system constitutes one of the major 
brain pathways for dopamine, called the mesolimbic dopamine pathway. This pathway begins 
with a structure that is located in the midbrain known as the ventral tegmental area (VTA) 
which consists out of a group of dopamine neurons. The axons of these dopamine neurons 
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extend to several other brain structures, where they release dopamine when the VTA is 
activated. The most relevant structures are the nucleus accumbens (NAc), the amygdala, the 
hippocampus, and the prefrontal cortex. In addition to the dopamine neurons, there are also 
other types of neurons within the VTA that interact with dopamine neurons. Some release the 
neurotransmitter known as GABBA, this inhibits dopamine neurons and under baseline 
conditions, reduces dopamine release (Julien et al., 2011). 
 A converging body of evidence has indicated that, regardless of the specific effects of 
abused drugs, they share a common action with respect to this mesolimbic dopamine 
pathway. Each drug increases dopamine transmission in this pathway, this means that most 
abused drugs increase the amount of dopamine transmission that is released from the VTA 
onto the NAc, amygdala, hippocampus and the frontal lobe. Opioids tend to act on the 
receptors that are located on the GABBA neurons and inhibit GABBA release. When 
GABBA release is reduced, there is less inhibition of dopamine neurons and dopamine 
release increases (Julien et al., 2011). 
  
Figure 3. Dopamine pathways (Okinawa Institute of Science and Technology, 2013). 
Specifically, heroin use tends to be extremely dependent, which causes regular users 
to seek for higher doses in order to experience the same effect. The most worrisome property 
of the use of heroin is the related effects of tolerance and dependence. Tolerance starts to 
develop as soon as the effect of a certain dose diminished with repeated use. As an individual 
becomes more tolerant to the use of a certain substance, the dosage of use needs to be 
increased in order to obtain the similar effect of the substance (Kaplan, 1983). Therefore a 
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much larger dose of heroin would be required in order to obtain the same euphoric effect as 
previously experienced and this causes fatal respiratory-depression in the drug experiencing 
individual as compared to the non-heroin user (Siegel, 2001).  
Heroin dependency can be viewed as a severe condition to suffer from, however it is 
not so easy to become dependent to the use of heroin as people believe. Numerous ‘rookie’ 
users become violently ill after the first time that they try heroin (Kaplan, 1983). Studies 
indicate that injecting heroin is seen as the end stage of a long opioid-use career that 
dependent individuals reach after 2-12 years of non-parenteral opioid use (Jafari, Movaghar, 
Craib, Baharlou, & Mathias, 2009). There seems to be at least two key transitions in the 
progression from opium smoking to non-injecting heroin use to injecting heroin use. The 
transition from opium smoking to injecting heroin can be explained by the built up of one’s 
drug use tolerance with the increase of dosage that tend to cause switching to a more potent 
opioid preparation, eventually switching to the injecting of heroin (Malekinejad & Vazirian, 
2012).  
The long-term use of opioids results in changes in the number of sensitivity of opioid 
receptor cells, which tend to mediate at least some of the effects of tolerance and withdrawal. 
Although long-term use is associated with the increased sensitivity of various 
neurotransmitter systems that include dopaminergic, cholinergic, and serotonergic neurons, 
the effect of opioids on the noradrenergic system is the primary mediator of the symptoms of 
opioid withdrawal (Sadock & Sadock, 2007). Heroin dependent individuals can however 
inject a large amount of heroin that results in death. Fatal overdoses are usually evident by 
individuals with a history of long-term heroin abuse. It would be expected that they would be 
very tolerant to the use of heroin (Siegel, 2001). There may be various factors contributing to 
the overdose of heroin, one factor highlighted by Darke and Zador (1996) is that the cause of 
an overdose may likely be attributed to the synergism between the opiate and other drugs that 
are concomitantly administered, or from the adulterants in the heroin. Another explanation 
that can contribute to the causation of a heroin overdose is the opiate dependent individual’s 
tolerance, where they would usually be able to tolerate huge amounts of heroin and are on the 
last occasion unable to tolerate a large amount of heroin (Siegel, 2001). 
2.6 The Epidemiology and Aetiology of Heroin Use 
A study by Van Etten and Anthony (1999) indicated that 20% of those individuals 
who had an opportunity to use heroin did so, and 17% did so within 12 months of the initial 
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offer. Results showed that males were twice as likely as females to have had the opportunity 
to use heroin. There seemed to be no sex differences in the likelihood of use once an 
opportunity arose, with 18% of males and 26% of females using after being given the 
opportunity. It seemed that gender differences in the epidemiology of heroin use are due to 
opportunity and that it is not due to any differences in susceptibility in the transition of use. 
When it comes to the psychosocial factors associated with the aetiology of heroin use 
disorder it can be seen that opioid dependence is not limited to the low-socioeconomic classes 
as one would assume, although the incidence of opioid dependence is greater in these groups 
than in higher socioeconomic classes. An estimated 50% of urban heroin users are children of 
single parents or divorced parents, and tend to be from families in which one or other family 
member suffers from a substance-related disorder. Children that are exposed to these settings 
tend to be high at risk for the development of opioid dependence, especially if the child 
expresses some sort of behavioural problem in school or other signs of Conduct Disorder 
(Sadock & Sadock, 2007). 
Evidence from previous studies has indicated that common and drug-specific, 
genetically transmitted vulnerability factors increases the likelihood of developing drug 
dependence. It was evident that individuals that tend to abuse a certain substance from one 
drug category is most likely to abuse a substance from another category. Monozygotic twins 
are more likely than dizygotic to be concordant for opioid dependence. Multivariate 
modelling techniques that not only was genetic contribution high for heroin abuse in this 
group, but also a higher proportion of the variance because of genetic factors not shared with 
the common vulnerability factor- that is, it was specific for opioids. It was found that a person 
with an opioid-related disorder may have had genetically determined hypoactivity of the 
opiate system. A biological predisposition to an opioid–related disorder may also be 
associated with abnormal functioning in either the dopaminergic or the noradrenergic 
neurotransmitter system (Sadock & Sadock, 2007).   
Studies conducted on populations of heroin users have suggested that genetic factors 
may be one of the most associated with the risk for the development of opioid use disorders 
and heroin dependence. These studies indicated that one particular polymorphism of the mu 
receptor gene, this gene is called the A118G SNP, which was found in 90% of heroin users in 
a European Caucasian population. Other studies have pointed to polymorphism in the gene 
encoding proenkephalin that leads to the increased expression of the neuropeptide precursor 
that can be found in 79% of heroin users. These various studies have indicated that 
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dysfunction in the mu opioid receptor system may be a key factor underlying heroin 
dependence (Iversen et al., 2009). 
Two major socio-demographic factors tend to stand out from the backgrounds of 
heroin users. The first factor is that they are likely to have a disadvantaged background. It is 
documented that that social disadvantages are associated with poorer physical and mental 
health. Each increment in socio-economic status reduces the odds of the child becoming 
substance dependent and moreover children from more disadvantaged backgrounds tend to 
experience more abuse, neglect, depression and hopelessness. The second factor of relevance 
concerns their parents, indicating that a third or more of the general population of heroin 
users’ parents had at least one substance-dependent parent (Graham & Power, 2004).  
2.7 Dangers of Heroin Use 
 The use of different kinds of opioids, including heroin, is not very common when 
compared to other illicit substances such as psychostimulants, alcohol and cannabis. The 
numbers of opioid users are also found to be low in many populations around the globe, 
however, it is of great clinical and public health importance to deal with these cases 
regardless of its low commonality within society. Of all the illicit substances and opioids tend 
to carry the highest degree of harm as well as the highest demand for treatment. These harms 
are articulated with extremely high amounts of death seen amongst heroin and other opioid 
users. Some of the major harms that are associated with regular use include the direct effects 
of the substance itself, serious life-threatening psychopathology and the indirect effects such 
as the involvement of criminal activity and the marginalisation of society that arise from the 
use of this illicit substance. Many of these effects are associated with the high dependency 
level of heroin and the consequent longevity of dependence in individuals (Darke, 2011). 
 One other major direct harm that is associated with the use of heroin is that of 
overdose. Heroin and other opioid overdose is one of the major contributors to premature 
death, and non-fatal overdose is associated with a range of serious health sequelae that 
includes brain damage and cognitive impairment. Heroin users also tend to have very poor 
health in general, much of this that is related to injection of the drug as a route of 
administration which in return may cause viral disease transmission. There is also the risk for 
vascular collapse and pulmonary diseases due to injecting and smoking of the substance 
(Darke, 2011). There are many functional consequences that are related to opioid use 
disorder. Opioid use is associated with a lack of mucous membrane secretions that causes dry 
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mouth. It tends to cause problems with the gastrointestinal functioning where it slows down 
the function causing decrease in gut motility that in reaction causes severe constipation. 
Visual perception can also be affected where as a result of pupillary constriction with acute 
administration of opioids. Individuals that inject opioids or heroin tend to be affected by 
sclerosed veins and puncture marks on the lower portion of the upper extremities. The acute 
injection of opioids may also cause severe sclerosis of the veins that causes peripheral edema, 
this causes the acute user to switch from injecting into the veins to legs, neck or groin. In 
severe cases where the individuals no longer has access to veins they tend to inject into the 
subcutaneous tissue also known as ‘skin-popping’, which results in cellulitis, abscesses, and 
circular-appearing scars from healed skin lesions (American Psychiatric Association, 2013). 
 When contaminated needles come into play, it tends to cause very rare cases of 
Tetanus and Clostriduim botulinum infections, which is a life-threatening illness that is 
associated with food poisoning. Infections may also occur in other organs within the body 
resulting in hepatitis, bacterial endocarditis and HIV infection. Hepatitis C infections may 
occur in up to 90% of persons who inject opioids. In addition, the prevalence of HIV 
infection can be high in individuals that inject opioids, a large proportion of these individuals 
that are diagnosed with opioid use disorder. It has been reported that HIV infection rates have 
been as high as 60% among heroin users with opioid use disorder in some areas of the United 
States and Russian Federation (American Psychiatric Association, 2013). There seems to be a 
growing concern regarding the emerging epidemic of HIV among Injecting Drug Use (IDU) 
in several countries in sub-Saharan Africa against backdrop of high HIV prevalence in the 
general population (Reid, 2009). 
The burgeoning number of drug injectors is believed to be linked to the role of 
African countries now playing a role in trans-shipment routes in the global trafficking 
networks of heroin, cocaine, and many other drugs (Reid, 2009). HIV epidemics among IDUs 
exist in Nigeria, Kenya, Tanzania, South Africa and Mauritius (Strathdee & Stockman, 
2010). Injecting drug use in South Africa is low when compared to other countries, however 
with the increase over time in the use of drug such as heroin, the potential exists for this to 
change rapidly (C. D. H. Parry, Plüddemann, & Myers, 2005). According to a study done by 
Parry et al. (2008) IDUs in South Africa have reported that they tend to engage in a number 
of high-risk injecting practices, even though the majority of them were aware that HIV could 
be transmitted through the sharing of needles and exchange of blood. Some of these factors 
including the sharing of needles with people that they know or close friends; re-use of 
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needles that was quite common; cleaning of the needles and syringes, where they claim that 
they have washed the needles after use. 
 Tuberculosis is a severe problem among individuals that inject drugs, especially those 
who are dependent on heroin; infection is usually asymptomatic and evident only by the 
presence of a positive tuberculin skin test. Many cases of active tuberculosis have been found 
in individuals who are infected with HIV; these individuals often have a newly acquired 
infection but also are likely to experience reactivation of a prior infection because their 
immune system is impaired. Snorting or sniffing of heroin into the nose often causes irritation 
of the nasal mucosa that is usually accompanied by preformation of the nasal septum. 
Another difficulty experienced by individuals using this illicit substance is sexual dysfunction 
where males often experience erectile dysfunction during intoxication and might even cause 
permanent erectile dysfunction due to chronic use of opioids. Females commonly have 
disturbance of the reproductive system and might also experience irregular menses 
(American Psychiatric Association, 2013). 
As with most substance use disorders, heroin dependent individuals are at risk for 
suicide attempts or suicide ideations. Something that is also quite notable is both accidental 
and deliberate opioid overdoses. Some suicide risk factors overlap with risk factors for an 
opioid use disorder. Evidence suggest that repeated opioid intoxication or withdrawal may be 
associated with severe depression, this might even be temporary depression, however it can 
be so intense that it may lead to suicide attempts and completed suicides (American 
Psychiatric Association, 2013). The mental health of heroin users also seems to be at risk. At 
least half of any group of heroin users will qualify for a psychiatric diagnosis other than drug 
dependence, with the most common diagnoses being mood, anxiety and personality disorders. 
2.8 Diagnostic Criteria of Heroin Use 
2.8.1 Opioid Use Disorder 
The following diagnostic criteria provide medical description of what it entails for an 
individual to be diagnosed with Opiate Use Disorder. It should be noted that the individuals 
that took part in this study were not diagnosed during the research process. In the Diagnostic 
Statistical Manual of Mental Disorder Fifth Edition (American Psychiatric Association, 
2013), opioid use disorders, like all substance use disorders, have been changed to a spectrum 
of pathology and impairment. The criteria for opioid use disorder remain relatively the same 
as in DSM-IV-TR. The diagnostic criteria for DSM-IV-TR abuse and dependence were 
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combined in DSM-5 except for two changes: (1) the criterion for recurrent legal problems has 
been removed and (2) a new criterion for craving, or a strong desire or urge, to use opioids 
has been added. In DSM-5, the two disorders of opioid abuse and opioid dependence are 
replaced by a category of opioid use disorder. A patient must meet at least 2 diagnostic 
criteria to qualify as having an opioid use disorder. Severity is characterised as "mild" if 2 or 
3 criteria are met, "moderate" if 4 or 5 criteria are met, and "severe" if 6 or more criteria are 
met (Brezing & Bisaga, 2015). 
The diagnostic features associated with Opioid Use Disorder include signs and 
symptoms that reflect compulsive, prolonged self-administration of opioid substances that are 
used for no legitimate medical purpose or, if another medical condition is present that 
requires opioid treatment, these opioid substances should however be used in doses that are 
greatly in excess of the amount needed for that medical condition. People with Opioid Use 
Disorder tend to develop such regular patterns of compulsive drug use that their daily 
activities are planned around obtaining and administering opioids. Opioids are usually 
obtained on the illegal market but may also be purchased from various physicians by 
falsifying or exaggerating general medical problems. Most individuals with Opioid Use 
Disorder have significant levels of tolerance and will experience withdrawal on abrupt 
discontinuation of opioid substances. Individuals with opioid use disorder often develop 
continued responses to drug-related stimuli. These responses are seen as contributing to the 
cause of relapse, are difficult to extinguish, and typically persist long after detoxification is 
completed (American Psychiatric Association, 2013). Table 2.5.1 indicates the Diagnostic 
Criteria for Opioid Use Disorder 
 Table 2.5.1 Diagnostic Criteria for Opioid Use Disorder  
Diagnostic Criteria: Opioid Use Disorder 
A. A problematic pattern of opioid use leading to clinically significant impairment or distress, 
as manifested by at least two of the following, occurring within a 12-month period: 
 
1. Opioids are often taken in larger amounts or over a longer period than was intended. 
2. There is a persistent desire or unsuccessful efforts to cut down or control opioid use. 
3. A great deal of time is spent in activities necessary to obtain the opioid, use the opioid, or recover 
from its effects. 
 
4. Craving, or a strong desire or urge to use opioids. 
 
5. Recurrent opioid use resulting in a failure to fulfil major role obligations at work, school, or home. 
 
6. Continued opioid use despite having persistent or recurrent social or interpersonal problems caused 
or exacerbated by the effects of opioids. 
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7. Important social, occupational, or recreational activities are given up or reduced because of opioid 
use. 
 
8. Recurrent opioid use in situations in which it is physically hazardous. 
 
9. Continued opioid use despite knowledge of having a persistent or recurrent physical or psychological 
problem that is likely to have been caused or exacerbated by the substance. 
 
10. Tolerance, as defined by either of the following: 
a. A need for markedly increased amounts of opioids to achieve intoxication or desired effect. 
b. A markedly diminished effect with continued use of the same amount of an opioid. 
Note: This criterion is not considered to be met for those taking opioids solely under appropriate medical 
supervision. 
 
11. Withdrawal, as manifested by either of the following: 
a. The characteristic opioid withdrawal syndrome (refer to Criteria A and B of the criteria set for opioid 
withdrawal, pp. 547-548). 
b. Opioids (or a closely related substance) are taken to relieve or avoid withdrawal symptoms. 
Source: (American Psychiatric Association, 2013, p. 541). 
2.8.2 Opioid Intoxication 
The most typical features presented in opioid intoxication are seen when the 
individual presents clinically significant problematic behaviour or psychological changes that 
develop during, or shortly after, opioid use. These problematic behaviours or psychological 
changes may include initial euphoria followed by apathy, dysphoria, psychomotor agitation 
and impaired judgement. The course of the intoxication process is accompanied by pupillary 
constriction and signs of drowsiness, slurred speech, and impairment in attention or memory. 
Inattention to the environment is also common in opioid intoxication, even to the point of 
ignoring potentially harmful events (American Psychiatric Association, 2013). Symptoms of 
opioid intoxication may last for several hours, where severe intoxication following an opioid 
overdose can also lead to coma, unconsciousness and eventually death of the individual 
(American Psychiatric Association, 2000). 
 In a well-known novel of The Wizard of Oz (Baum, 1900), the wicked witch of the 
west puts the main character Dorothy, Toto, and their friends to sleep by misdirecting them 
through a field of poppies. Just as the poppies lull the bunch of them drop into an opiates 
induce euphoria, drowsiness and slowed breathing. High doses may in fact lead to death if 
respiration is completely depressed (Barlow & Durand, 2012). The extent to which 
behavioural and physiological changes occur due to opioid use depends on the dose being 
used as well as the characteristics of the individual that include tolerance, chronicity of use 
and the rate of the absorption of the substance in the body (American Psychiatric Association, 
2000). Table 2.5.2 indicates the Diagnostic Criteria for Opioid Intoxication. 
Table 2.5.2 Diagnostic Criteria for Opioid Intoxication 
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Diagnostic Criteria: Opioid Intoxication 
 
A. Recent use of an opioid. 
 
B. Clinically significant problematic behavioural or psychological changes (e.g., initial euphoria 
followed by apathy, dysphoria, psychomotor agitation or retardation, impaired 
judgment) that developed during, or shortly after, opioid use. 
 
C. Pupillary constriction (or pupillary dilation due to anoxia from severe overdose) and 
one (or more) of the following signs or symptoms developing during, or shortly after, 
opioid use: 
 1. Drowsiness or coma. 
 2. Slurred speech. 
 3. Impairment in attention or memory. 
 
D. The signs or symptoms are not attributable to another medical condition and are not 
better explained by another mental disorder, including intoxication with another substance. 
 
Source: (American Psychiatric Association, 2013, p. 546). 
2.8.3 Opioid Withdrawal 
The result of regular drug use can be the development of a delayed, cumulative 
rebound reaction known as withdrawal symptoms that waits for the cessation of the drug use. 
The reactions to the cessation of regular drug use often seem to be the opposite of the drug’s 
effects. Opioid withdrawal symptoms are related to our everyday use of language, one of 
these withdrawal symptoms is a contraction of the muscles just beneath the skin which causes 
waves of ‘goose flesh’ which resembles the skin of a plucked turkey. This gave rise to the 
well-known expression of ‘cold turkey’ that is present with the abrupt withdrawal of opioids. 
In addition to the explanation above, the muscle spasms in the long muscles of the leg 
produce kicking movements, which may be the basis for the expression ‘kicking the habit’ 
(Kaplan, 1983). 
The severity and time of onset regarding withdrawal symptoms in individuals 
dependent on opioids depend on the half-life of the opioids used. Withdrawal symptoms 
starts to surface within 6-12 hours after the last dose, this occurs when the individual is 
physiologically dependent on short-acting drugs such as heroin. Symptoms may take 2-4 days 
to surface in the case of longer-acting drugs that were used such as methadone or LAAM (L-
alpha-acetylmethadol). Acute withdrawal symptoms for short-acting opioids will peak within 
1-3 days and gradually subsides over a period of 5-7 days (American Psychiatric Association, 
2013). Biochemical and subclinical differences that are usually unnoticed by the dependent 
individual, last up to twelve additional months after the date of cessation (Kaplan, 1983). 
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One of the main reasons that compulsive users of opioids such as heroin tend to 
continue the use of this drug is to avoid the unpleasant withdrawal syndrome that they 
experience if they discontinue the use of the substance. The opioid withdrawal process 
consists of both physical and mental components. The physical component involves major 
disturbances of autonomic nervous system origin that include lacrimation, rhinorrhea, 
perspiration, tremor, gooseflesh, dilated pupils, anorexia, nausea, emesis, diarrhea, 
dehydration, elevated temperature and blood pressure, and yawing. These physical symptoms 
tend to accompany a negative mental state of dysphoria, depression, and anxiety (Iversen et 
al., 2009). 
Table 2.5.3 Diagnostic Criteria for Opioid Withdrawal 
 
Diagnostic Criteria: Opioid Withdrawal 
 
A. Presence of either of the following; 
 
1. Cessation of (or reduction in) opioid use that has been heavy and prolonged (i.e., 
several weeks or longer). 
2. Administration of an opioid antagonist after a period of opioid use. 
 
B. Three (or more) of the following developing within minutes to several days after Criterion A: 
 
1. Dysphoric mood. 
2. Nausea or vomiting. 
3. Muscle aches. 
4. Lacrimation or rhinorrhea. 
5. Pupillary dilation, piloerection, or sweating. 
6. Diarrhea. 
7. Yawning. 
8. Fever. 
9. Insomnia. 
 
C. The signs or symptoms in Criterion B cause clinically significant distress or impairment 
in social, occupational, or other important areas of functioning. 
 
D. The signs or symptoms are not attributable to another medical condition and are not 
better explained by another mental disorder, including intoxication or withdrawal from another substance. 
Source: (American Psychiatric Association, 2013, p. 547). 
2.9 Heroin and Relapse 
 Definitions regarding relapse are varied, ranging from a dichotomous treatment 
outcome to an ongoing, traditional process (Brownell, Marlatt, Lichtenstein, & Wilson, 
1986). A large volume of research has yielded no consensus operational definition of the 
term. Therefore, for the purpose of this study, relapse can be defined as “a setback that occurs 
during the behaviour change process, such that progress toward the initiation or maintenance 
of a behaviour change goal is interrupted by a reversion to the target behaviour” (Hendershot, 
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Witkiewitz, George, & Marlatt, 2011, p. 2). Relapse is also best conceptualised as a dynamic, 
ongoing process rather than an isolated or terminal event when it comes to a compensatory 
model view to relapse. 
Relapse tends to be one of the most problematic areas to the recovery process of 
abstaining from heroin. As a fundamental feature of the dependency to illicit substances after 
short or even prolonged periods of abstinence, relapse remains as problematic as the idea of 
dependence (Giuliano et al., 2013). As a result of chronic use, the dependent nervous system 
of the individual user adapts to repeated exposure. If the drug is withdrawn, similar 
unpleasant emotional reactions and changes in the brain will occur, regardless of the specific 
drug. These effects are responsible for the craving of the substance and relapse, even after 
long periods of abstinence from the use of the drug. After all traces of the specific abused 
drug are absent from the body by means of going through a detoxification process, the 
dependent individual experiences urges to use the drug again and is at risk of relapsing. As a 
result of long-term drug use the brain has changed by means of neuroadaptation which 
explains the development of cravings and the need to use again (Julien et al., 2011). 
Relapse is extremely common in the first few days after opiate withdrawal. Reasons 
related to this is the doubt associated with becoming abstinent from opioids, other factors 
might include the persistence of withdrawal symptoms, insomnia and many other 
physiological factors. Other opiate free responses take time to become established as opposed 
to medications that replace heroin such as methadone. So the ability of the individual to resist 
temptations and ignore drug-related cues is not easily learned (Foster, Brewer, & Steele, 
2003). 
Relapse can be viewed as a modal outcome for individuals who receive substance 
abuse treatment. It is determined that approximately 40% to 60% of individuals that have had 
a substance use disorder tend to return to substance use within a year of treatment. In a study 
of relapse of heroin users after residential treatment, Gossop et al. (2002) found that one third 
(34%) of the sample used heroin within three days of leaving treatment, 24% used within 
seven days of treatment and 50% used within 14 days after leaving treatment. After 30 days 
after leaving treatment 57% of the sample of 145 individuals had used again. Understanding 
the process of relapse is central to treatment of substance dependence and use disorders and 
can help clinicians and their clients to intervene in the process to guard against relapse or to 
reduce the severity or length of relapse (Brownell et al., 1986). One particular theory and also 
one of the most prominent among psychological models is the cognitive behavioural 
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approach that looks at relapse and dependent behaviour including contemporary factors such 
as high-risk situations that may have an influence on the relapse process as a whole (Marlatt 
& Gordon, 1985b). 
2.9.1 Marlatt’s Relapse Prevention Theory 
 As mentioned above, relapse tends to present a fundamental barrier to the treatment of 
dependent behaviours. Preventing relapse or the minimising of its degree is an essential task 
in attempting successful, long-term changes in dependent behaviours (Hendershot et al., 
2011). Relapse prevention is seen as a tertiary treatment strategy that enables individuals to 
remain abstinent and reduce the likelihood of relapse after the cessation or reduction of 
problematic behaviour (Hendershot et al., 2011). Relapse has been described as an outcome 
consisting of a dichotomous view that the individual is either ill or well which stems from the 
disease model. This perspective originated with the belief that the development of dependent 
behaviour is due to heredity, physiology and genetics that is beyond the individual’s control. 
The disease model viewed relapse as a reactivation of a progressive disease which is the 
dependent behaviour, where some sort of medical treatment would be necessary, such as 
pharmacotherapy. In contrast, cognitive-behavioural theory has described relapse as a process 
that encompasses any transgression in the process of behavioural change (Witkiewitz & 
Marlatt, 2004). So for the purpose of this study relapse can be viewed as a dynamic, ongoing 
process rather than a discrete or terminal event. Following is a description of the historical 
foundation and overview of the Relapse Prevention Model (RPM) developed by Alan. G. 
Marlatt. Furthermore, this theory informs and guides the process of the study which will be 
discussed throughout. 
 The Relapse Prevention (RP) model developed by Marlatt is based on social-cognitive 
psychology which provides a conceptual framework for understanding relapse together with a 
set of cognitive and behavioural treatment strategies designed to limit relapse likelihood and 
severity. However, for the purpose of this study the focus would remain on the understanding 
of the process of relapse prevention as described by Marlatt in order to give foundation to the 
findings of the current study.  
Relapse is also seen as a highly individualised treatment approach that attempts to 
target proximal and distal factors that are related to relapse in order to prevent the actual 
relapse from occurring (Dimeff & Marlatt, 1998; Larimer, Palmer, & Marlatt, 1999; Marlatt 
& Gordon, 1985a). Relapse prevention was initially used in order to denote the clinical 
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intervention programmes (Marlatt & Gordon, 1985a), however it has now formed an integral 
part of many psychosocial treatment strategies targeting substance use (McGovern, Wrisley, 
& Drake, 2005). Relapse prevention stems from the cognitive-behavioural model of relapse 
and was primarily regarded as a product of the traditional behavioural approaches to 
understanding and treating dependent behaviour. The evolutionary changes that were brought 
on from the cognitive-behavioural theories in relation to substance use and abuse have had an 
enormous change in the thought of relapse, most of which were originally drawn from the 
traditional models of dependence that included the disease-based model which are seen as 
defunct. The reason for this being that traditional disease-based models attributed relapse to 
internal factors such as withdrawal and cravings, where the symptoms that these individuals 
were experiencing were interpreted as an underlying disease state that could be treated by 
making use of medication. In contrast, the cognitive-behavioural approach emphasises the 
contextual factors of relapse that includes environmental stimuli and cognitive factors as 
proximal relapse experiences (Witkiewitz & Marlatt, 2004).  
The main theoretical innovation of the conceptualisation of relapse from Marlatt’s 
perspective rests upon: (a) the distinction between a lapse and relapse in order to insert a 
wedge between the all-or-nothing disease model beliefs and the cognitive-behavioural 
approaches, and, (b) the outlining of a specific cognitive-behavioural model of the relapse 
process as produced in Figure 4. Furthermore, relapse is not viewed as an endpoint that is 
understood as a failure in treatment, which causes an Abstinence Violation Effect (AVE) that 
will be discussed further. 
Marlatt’s model is quite revolutionary in that relapse is rather viewed as a fluctuating 
process that begins before and extends beyond the return to the individual’s target behaviour 
(Witkiewitz & Marlatt, 2004). From this standpoint, Marlatt proposed three outcomes to an 
attempt to change problematic behaviour (such as staying abstinent from the use of heroin). 
The first is known as a lapse or as Marlatt termed it as ‘falling off the wagon’, which is the 
first instance of a transgressive behaviour where there is a chance that an individual would 
return to the target behaviour after a period of volitional abstinence. This is viewed as an 
initial setback and not a dead-end road or the signalling of failure on the part of the individual 
attempting to change their drug use behaviour. The model does acknowledge the possibility 
that a lapse might prompt a full-blown relapse, however, the other possible outcome would be 
that the problem behaviour would be corrected and the desired behaviour would then be re-
instantiated- a term that is known as prolapse or ‘getting back on the wagon’. Compellingly, 
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this model introduced a comprehensive, flexible and optimistic alternative to traditional 
approaches by means of viewing relapse as a common event through highlighting contextual 
antecedents over internal causes, and distinguishing relapse from treatment failure 
(Hendershot et al., 2011; Witkiewitz & Marlatt, 2004). 
 A central aspect to the outline of the cognitive-behavioural model to relapse 
prevention as proposed by Marlatt and Gordon (1985a), is the detailed classification of 
certain factors or situations that can trigger potential relapse episodes know as high-risk 
situations. High-risk situations can be defined as any context in which an individual’s attempt 
to refrain from the use of a substance is threatened and might trigger the individual’s 
vulnerability for reengaging in substance use. These situations might include emotional or 
cognitive states (for example, negative affect such as anger and anxiety or diminished self-
efficacy), environmental contingencies (for example, interpersonal conflict, conditioned drug 
cues, exposure to drug related stimuli, social pressure) and physiological states (for example, 
acute withdrawal, chronic pain). So in short, high-risk situations can consist of people, places 
and events that could greatly hinder one’s recovery process due to its ability to remind one of 
substance use. According to this model, an individual who has initiated a behavioural change 
should start to gradually experience a growing sense of personal control and self-efficacy in 
order to master his or her behaviour in a high-risk situation. With this in mind, one of the key 
factors of the relapse prevention model is how an individual is then able to respond to this 
high-risk situation. An effective coping response defined as a cognitive or behavioural 
compensatory strategy that reduces the likelihood of lapsing would be able to view a high-
risk situation as a potential lapse and therefore eliminate the tendency to give in to the 
temptation of substance use and decreasing the probability of a relapse. In turn, an ineffective 
coping response may decrease self-efficacy and a return to target behaviour will increase the 
probability for future lapses (Hendershot et al., 2011; Larimer et al., 1999; Witkiewitz & 
Marlatt, 2004). For example, when an individual has decided to stop the use of a certain 
substance (stay abstinent), he or she creates a ‘rule’ for themselves where they would refrain 
from the use of a substance. If this individual breaks this ‘rule’ (they have a lapse), the way 
the individual thinks about this situation of ‘breaking the rule’ would have an influence on 
whether or not they will continue the use of the substance in an uncontrollable manner and 
would lead to the abandonment of the abstinence ‘rule’ (a full-blown relapse). 
Marlatt and Gordon (1985a) have termed this type of reaction the abstinence violation 
effect, which may influence whether an initial lapse may lead to a relapse. This reaction 
36 
 
focuses on the individual’s emotional response towards an initial lapse and on the causes to 
which the individual attributes the lapse. Individuals who tend to attribute the lapse to their 
own personal failure are most likely to experience negative emotions and guilt which may 
then lead to the increase of substance use as an attempt to escape the feelings of guilt and 
failure. Individuals that attribute lapses to stable, global and internal factors beyond their 
control are most likely to abandon the abstinence attempt which may result in a full-blown 
relapse. Individuals who are more likely to attribute their lapse to the inability to cope 
effectively with a high-risk situation are more likely to recover or prolapse than the later. 
With this in mind, the coping factor plays a vital role in the recovery process, 
specifically in relation to the RP Model. Although it was mentioned that the high-risk 
situation is the cause to the relapse trigger, it was found that the individual’s response to the 
high-risk situation is the determinant for the experience of relapse (resume the use of heroin). 
The individual’s coping behaviour in a high-risk situation is noted to influence outcome 
behaviour. Therefore, if an individual is able to execute effective coping strategies they are 
less likely to experience a relapse as compared to individuals lacking an effective coping 
strategy (Larimer et al., 1999). An effective behavioural coping strategy may include the 
individual leaving the high-risk situation, or utilising a cognitive strategy such as positive 
self-talk. It is assumed that individuals that tend to cope effectively with high risk situations 
experience a heightened sense of self-efficacy (Bandura, 1977). 
The concept of self-efficacy introduced by Bandura (1977) was found to be a final 
common pathway that mediates behavioural change which can be linked to relapse in 
dependant behaviour. Self-efficacy can be defined as the degree to which an individual feels 
confident and capable of performing certain behaviours in a specific situational context. In 
other words, self-efficacy refers to individuals holding the belief that one is capable to cause 
some effect on one’s environment-that one is indeed effective. According to the cognitive 
behavioural model of relapse, a higher level of self-efficacy is a predictor of improved 
treatment outcomes across various types of dependent behaviours. Accordingly, the self-
efficacy theory verified that behavioural changes produced by different types of treatment are 
mediated by a common cognitive mechanism called efficacy expectancy. The expectancy of 
being able to cope with successive high-risk situations as they develop is closely associated 
with the idea of self-efficacy. So when an individual feels confident to cope effectively with a 
high-risk situation, they would then indirectly influence their perception of their own self-
efficacy.  
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Another important factor to the RP model would be the outcome expectancies that 
individuals experience. These are typically described as an individual’s notion regarding the 
consequences of substance use, which might influence an individual’s ability to use a 
substance depending on the strength and behaviour of the expectancy which includes the 
previous effects that the substance had on the individual. These types of expectancies consists 
of both short- and long-term expectancies with both positive and negative outcomes attached 
to them, where they may have varying levels of pertinence to the individual. Furthermore, 
short-term reward contingencies tend to reduce negative mood states, inducing the sense of 
euphoria from making use of the psychoactive substance, including a change in the 
individual’s cognition where it tends to create a positive sense of self and then tends to reduce 
the stress whether physical or emotional. Short-term negative consequences consist of a loss 
of behavioural inhibition that may result in various social problems that consist of legal and 
financial problems as well as impaired functioning. In contrast to short-term negative 
consequences are the long-term contingencies of abstaining from the use of illicit substances 
that will result in improved role functioning, improved interpersonal relations, better health 
and greater stability (Marlatt & Gordon, 1985b). 
According to Marlatt and Gordon (1985a), the extent to which short-term rewards 
tend to predominate over short-term negative consequences or long-term rewards of 
maintaining abstinence depends on the effect of the situational factors that the individual is 
faced with. As an example, the importance of long-term versus short-term rewards may 
fluctuate with the decision of preference from one over the other relying on reasons such as 
stress levels, mood states and social pressure. So in other words, if short-term positive 
expectancies for making use of a substance are high and the long-term negative expectancies 
of substance are less important and the illicit substance is available at that moment, the 
likelihood of a relapse to occur tends to increase. It is also noted that an individual’s low self-
efficacy combined with heightened positive outcome expectancy would also increase the 
probability of a lapse. 
A considerable amount of research has focused on identifying the predictors of the 
causes of relapse in order to develop treatment strategies for the prevention thereof. It was 
found that one of the strongest predictors of the causes of relapse in substance dependence is  
the occurrence of cravings (Breese, Sinha, & Heilig, 2011; Shadel et al., 2011). The tolerance 
in the act of the desire of the use of a substance may be expressed as urges or cravings which 
are hypothesized to be mediated by the positive outcome expectancies of engaging in the 
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prohibited behaviour. Cravings can be defined as an individual’s subjective experience of an 
urge or desire to make use of a substance. Numerous models conceptualising the 
phenomenon of craving have consistently acknowledged that it can be experienced as 
intrusive thoughts and their elaboration, an impulse drive or motivation, a stress response, an 
emotional state, a physical sensation, substance wanting or any other manifestation that is 
relevant for an individual who endorses experiencing a craving or urge to make use of a 
substance (Cox & Klinger, 2002; Kavanagh et al., 2006; Paulus, 2007; Robinson & Berridge, 
1993; Sinha & O’Malley, 1999; Tiffany & Wray, 2009). The roots to craving can be 
attributed to biological, affective, or cognitive motivators of the individual. In the biological 
models of craving, the dependent behaviour of individuals can be seen as a brain disease 
whereby the causes of such cravings and use of the substance are born from neurobiological 
and physiological states (Witkiewitz, Bowen, Douglas, & Hsu, 2013). Cravings can be 
reflected in neural states where neurotransmitters such as dopamine, serotonin and gamma-
aminobutyric acid (GABA) can be linked to drug use. It is evident that dopamine in the 
dorsal striatum has been associated with reported cravings and that GABA dysregulation has 
been associated with a craving drive that has been described as a relief of tension. From a 
cognitive perspective of craving, it is suggested that craving originates in cognitive processes 
such as memory, that reflect higher order information processing that evolved into automatic 
processes of use. Marlatt and Gordon (1985a) suggest that cravings are a result of cognitive 
expectancies for drug use as mentioned previously. 
In sum, the relapse prevention model proposed by Marlatt and Gordon (1985b), 
consists of a cognitive-behavioural approach to the relapse process that centres around the 
high-risk situation and how the individual tends to respond to the high-risk situation. If the 
individual does not have an effective coping response or some form of confidence in order to 
deal with the high-risk situation, the probability for the individual to resume drug use would 
be high. The individual’s decision to make use of a substance or stay abstinent is then 
mediated by their outcome expectancies for the effect of the use of the substance. Individuals 
that tend to make use of a substance may be susceptible to the abstinence violation effect 
which causes self-blame and the sense of loss of control over the use of a substance. This 
may then result in the increased probability to make use of a substance and therefore increase 
the probability of a full-blown relapse. On the other side, if the individual posits an effective 
coping response towards high-risk situations through means of an increased or higher self-
efficacy, the probability of the occurrence of a full-blown relapse is then decreased. 
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Figure 4. Cognitive-behavioural model of relapse (Marlatt & Gordon, 1985b). 
 Although Marlatt and Gordon’s view focuses on behavioural intervention modalities, 
pharmacotherapies are increasingly used to treat and prevent relapse to dependent behaviours. 
Various psychosocial methods that may include therapeutic modalities such as therapeutic 
communities, 12-step programmes and group therapies were some of the most common and 
effective therapies that were available for the treatment of various substance abuse disorders. 
 Yet, evidence suggests that pharmacotherapies have a powerful effect on treatment 
outcomes, especially when combined with behavioural intervention strategies for relapse 
prevention (Brandon, Vidrine, & Litvin, 2007). The use of opioid replacement therapies (such 
as the use of methadone) has been in place since the late 19
th
 century, this was the only real 
expectation to the treatment of opioid misuse. To date pharmacotherapies are widely used in 
the treatment of substance dependence, however, as with the process of treating various 
chronic psychiatric conditions the use of medications are far less effective when used alone 
(in isolation to cognitive behavioural therapeutic modalities). Therefore it can be argued that 
full efficacy is attained when the medications are used in combination with psychological 
treatments (Welsh & Liberto, 2001).  
  Pharmacological treatments that are associated with preventing relapse differ and 
tend to be specific to certain substances that have been abused. These can be divided into two 
broad categories: a) approaches that aim to reduce relapse from substance use by means of 
extending treatment effects instrumental in the initial achievement of cessation, and b) 
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approaches that have certain mechanisms of action with particular relevance to relapse. The 
former includes the use of agonists such as methadone maintenance and nicotine 
replacements (for example, nicotine patches) for the treatment of opioids and tobacco 
dependence respectively. The latter includes methods such as the use of aversives and 
antagonists. Aversives such as Disulfiram (Antabuse) is intended to prevent relapse by means 
of creating extreme discomfort upon the consumption of alcohol, which means that this 
reaction to the use of alcohol might cause anticipation and eventually inhibits relapse to 
alcohol use. Antagonists are a form of pharmacotherapy that tends to attenuate the reinforcing 
effects of substance use. So according to theory, they should contribute to the extinction of 
drug use when taken prior to cessation. As such, once a lapse occurs, the attenuated 
reinforcement should inhibit the reinstatement processes (Brandon et al., 2007). 
 In relation to the above mentioned, the administration of a pharmacological 
intervention such as the use of naltrexone pellet implantation (which is a form of antagonist-
based treatment) together with some form of therapy, will ensure a more positive outcome in 
terms of relapse prevention. However, for the purpose of this study, the research was 
interested in the subjective experiences that these individuals went through while on the 
naltrexone maintenance therapy with pellet implantation. Moreover, this study explored 
various experiences that included their physical, psychological as well as social experiences 
with the use of naltrexone maintenance therapy with pellet implantation. The goal of this 
study was, however, not to prove that naltrexone did in fact prevent relapse from occurring 
by means of measuring blood-serum levels in clinical trials as many other studies 
(Colquhoun, 2013; Hulse et al., 2004; Mannelli, Peindl, & Wu, 2011) have tried to indicate. 
Rather the goal was to explore what these individuals subjectively experienced while going 
through their period of treatment with the foundation and guidance of the relapse prevention 
theory as suggested by Marlatt and Gordon (1985b).  
2.10 Pharmacological Intervention for Heroin Use Disorder 
As mentioned previously, drug treatment modalities tend to traditionally consist of 
three main domains: detoxification, inpatient residual rehabilitation and outpatient 
pharmacotherapies. In this section the focus will consist of the pharmacotherapies that would 
traditionally be implemented for heroin misuse with special attention on the two main forms 
of pharmacotherapies namely, agonist and antagonist treatment.  
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2.10.1 Agonist vs Antagonist 
 This section will explore the difference between an agonist and antagonist including 
their functions and properties when being used for opioid dependence. The purpose of this 
section is to inform the reader as to outline the different pharmacotherapeutic modalities that 
can be made available for the treatment of heroin misuse. An agonist is a substance that binds 
to (has an affinity) the cell receptors of the neurotransmitter system which induces changes in 
the cell characteristic of the neurotransmitter chemical for the receptor on the neuron. 
Substances such as morphine and methadone are prototypical opioid analgesics, however, 
methadone is usually an orally active, long-acting opioid that is used to treat opioid 
dependence. These strong opioids tend to bind to the mu receptors that cause the same effects 
as if one would be making use of an illicit substance such as heroin. These effects include 
analgesia, respiratory depression, and euphoria which has a tendency to cause dependence 
(Julien et al., 2011).  
 Antagonists tend to also have an affinity to the mu receptor sites, however, after 
attaching to the receptor sites they tend to elicit no change in cellular functioning due to the 
reason for lacking intrinsic activity on the receptor cites. This means that they compete with 
the mu agonist for the receptor which hastens withdrawal in an opioid-dependent individual 
and reverses the analgesic response that would originally be caused by the agonist. The one 
example of such a substance would be the use of naltrexone that is clinically used for the 
treatment of heroin dependence as this causes the individuals to experience no analgesic 
effects of heroin after the administration of the antagonist (Julien et al., 2011). 
Simply put, agonist therapy is the administration of long-acting opioid receptor 
agonists with the aim of reducing or eliminating illicit drug use. This therapeutic technique is 
controlled by means of supervision when the substance is administered. The aim is to 
increase the retention rate in treatment and to help reduce many of the risk factors that are 
associated with illicit drug use (Soyka et al., 2011). One of the most common 
pharmacological treatment modalities for the treatment of heroin and other opioids consist of 
maintenance treatment. The basis of pharmacological intervention and maintenance 
modalities for heroin dependence is to minimise withdrawal symptoms and attenuate the 
reinforcing effects of illicit heroin, leading to the reduction or even cessation of the use of 
heroin. Internationally opioid maintenance treatment has been one of the most common 
medical treatments since the 1960s, therefore, it is a well-established method of treatment for 
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heroin dependency internationally (Bell, 2014).  The current most common therapies used for 
opioid dependence consist of methadone (Dolophine and Methadose), buprenorphine 
(Subutex and Suboxone) and then one that is less frequently used, levomethadyl acetate.  
The use of Methadone treatments became the first available agonist treatment, in the 
1960s, this was followed by the use of buprenorphine that was available in doctors’ offices by 
the year 2000. These therapies showed promising results and it was concluded by the World 
Federation of Societies of Biological Psychiatry and the World Health Organisation that there 
is a rather large evidence base that supports the efficacy of both methadone and 
buprenorphine for the treatment of opioid maintenance and withdrawal in human subjects 
(Soyka et al., 2011; World Health Organization, 2009). 
Surely enough, there is evidence to suggest the efficacy of the use of agonist based 
treatment in opioid dependence and in the reduction of various social-related problems such 
as crime and its ability to reduce HIV transmission through keeping the individual away from 
the use of needles in the use of “street heroin”. Methadone produces minimal euphoria and 
rarely causes drowsiness or depression when taken for a long time. Methadone also tends to 
allow patients to engage in meaningful employment instead of criminal activity. Many 
countries and various US states have made the use of agonist therapies unavailable or have 
severely restricted their access to the general population for reasons unknown. Even when 
agonist treatments are in fact available for use in certain countries, the supply of methadone 
itself is of great concern, also the ability to have access to these type of treatments seem to be 
problematic. Furthermore, not all patients tend to agree on this method of treatment due to 
barriers associated to treatment entry which includes a ubiquitous waiting list for methadone 
due to the lack of funding for the supply of methadone, lack of identification and lack of fees 
in order to purchase the methadone due to poverty. There has also been evidence to suggest 
that various other factors have had an influence in individuals deciding whether to make use 
of agonist therapies. Influential factors included the fear of withdrawal from the agonist 
treatment, beliefs that methadone is far worse than heroin in terms of health and that it may 
be used as a form of self-medication due to its similarity of effect that are related to the use of 
heroin (Mathers et al., 2010; Peterson et al., 2010) 
In addition, some practitioners are concerned with the prescription of agonists to 
patients due to the long-tern side effects with the prolonged use of agonists such as 
methadone. Research has indicated that the chronic use of opioids can in fact affect the 
functioning of the immune system which then in return makes heroin dependent individuals 
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susceptible to a variety of infectious diseases (Toskulkao, Pornchai, Akkarapatumwong, 
Vatanatunyakum, & Govitrapong, 2010). A vast amount of research has indicated that 
agonist treatments are deemed effective however, the concerns and limitations that are 
associated with this form of treatment had led to the need to introduce other effective 
antagonist treatment methods. All in all, pharmacotherapy of opioid dependence can be 
effective for opioid dependent individuals when treated effectively which in return has major 
benefits for the patient and society. However, society should be able to offer effective 
treatment for opioid dependent individuals, who should have the right to gain access to both 
agonist and antagonist therapies where governments enable access to these therapeutic 
modalities (Julien et al., 2011). 
2.10.2 Antagonist-Based Treatment for Opioid Dependence 
 There are three major opioid antagonists that are clinically available to the general 
public internationally by means of prescription: naloxone, naltrexone and nalmefene which 
are the structural formulas, it should be noted that various pharmaceutical companies have 
different brand names when it comes to the manufacturing and distribution of these 
substances. Each one of these substances are a derivative of oxymorphone which is a pure 
opioid agonist, they also tend to have an affinity for opioid receptors so when they bind to the 
receptor sites they do not exert agonistic effects but rather antagonise the effects of opioid 
agonists (Julien et al., 2011). 
 Naloxone is a prototype opioid antagonist which injected into opioid dependent 
individuals that has an effect of rapid withdrawal. This substance is not subject to abuse but 
rather its use would be to reverse the respiratory depression that is caused by acute opioid 
intoxication (overdose). This substance has a limitation to use due to its short duration of 
action and its parenteral route of administration. Nalmefene, has similar components of action 
as naloxone where the only difference is the increased half-life of the substance that consist 
out of 8 to 10 hours which could be effective for relapse prevention purposes in a therapeutic 
setting. Naltrexone, on the other hand, has a longer half-life than any of its antagonist 
brothers which is deemed more effective for the purpose of treating opioid dependent 
individuals in a more long term situation (Julien et al., 2011). 
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2.10.3 Naltrexone 
In order to understand how naltrexone works when consumed by the human body, a 
focus is needed on the way that the human brain functions in relation with the 
neurotransmitter systems and the affects these endorphins have on human behaviour in daily 
functioning. When a human engage in activities it causes the brain to release chemicals that 
impact mood, feelings and behavioural aspects of daily functioning. When an individual 
engages in a certain activity that is enjoyed, the brain releases certain chemicals called 
endorphins or neurotransmitters, some of these endorphins tend to make an individual feel 
good. These endorphins tend to attach to opioid receptors which in return unlock the 
receptors and when these receptors are unlocked they tend to release a chemical known as 
dopamine. Dopamine is associated with certain pleasure principles that are linked to 
behavioural aspects, which tends to induce a good feeling (euphoria) in individuals partaking 
in pleasurable activities. This reward is what prompts individuals to repeat these behaviours 
in order to receive the euphoric effect. So in relation, when an individual makes use of 
opioids or more specifically opioid-based street drugs such as heroin, they tend to attach to 
same receptors sites but in a way that result in release of greater amounts of dopamine 
release. This enormous amount of dopamine that has been released into the human brain 
causes pleasure that is more intense than the brain’s natural sensation without the use of any 
illicit substance. This sensation created by the increased amount of dopamine release is also 
very well known as the ‘high’ (euphoria) that individuals experience when making use of 
illicit substances, specifically in the use of heroin. In terms of the development of opioid 
dependence, many factors do play a role in whether or not a person would become dependent, 
however it has been indicated that individuals that continue the use of opioids tend to have an 
increased risk of becoming dependent due to the intense feeling of pleasure they can cause. 
Hence, the popular use of heroin known as ‘chasing the dragon’, which also refers to the 
chasing of the euphoric effect that heroin produces when ingested by the user (Vivitrol, 
2015). 
Naltrexone, also known as naltrexone hydrochloride is sold under the trade names 
Revia, Depade or Vivitrol is a highly specific, non-dependent µ -opioid receptor antagonist 
which has a high attraction and combines to all opiate receptor sites. Naltrexone has an active 
metabolite, 6-ß-naltrexol, that tends to be a competitive antagonist at the µ -opioid receptor 
sites. These receptor sites are involved with the development of opioid dependence, so the 
naltrexone will be the mechanism of action for the management of opioid dependence (Ling 
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et al., 2011). This means that it tends to attenuate or completely block the effects of 
exogenous opioids such as heroin, which causes the blocking of the euphoric and 
physiological effects of opioids which in return displace the euphoric effect of opioids when 
ingested by the human body (Kjome & Moeller, 2011; Tucker & Ritter, 2000). This potent 
antagonist has shown to have valuable properties for the effective treatment of the 
dependence to opioids such as heroin and methadone. It has shown to make relapse to regular 
opiate use almost impossible during the period of compliance. So far, research has indicated 
that a dose of 50-100 mg of naltrexone in oral form can block the effects of opiates for about 
two to three days. The plasma concentrations tend to peak one hour after the oral format of 
naltrexone has been administered, where the half-life varies between 2 and 6 hours 
(Krupitsky & Blokhina, 2010). The opioid receptor blockade cannot be overcome even by 
four or five times the average daily heroin dose of most dependants. It is the only treatment 
for heroin abuse for which it is possible to give patients a virtual guarantee that if they take it 
regularly in the prescribed dose, they cannot become dependent on heroin (Kenny, 1999). 
Research has indicated that naltrexone has an anti-craving effect in individuals with opioid 
use problems; this means that naltrexone tends to eliminate the cravings caused by obsessions 
and compulsive thoughts of the illicit substance once individuals have ceased the use of 
opioids. The precise mechanism for craving reduction has not quite been determined, 
however, it is most likely linked to the antagonistic mechanism of the opioid pathways to the 
nucleus accumbens, which in return reduces the total amount of dopamine being released 
(Kunøe et al., 2012). The rationale behind the use of naltrexone for Opioid Use Disorder as a 
treatment method lies behind the idea that it tends to motivate the reduction of the use of 
opioids such as heroin when the individual is unable to experience the pleasurable ‘euphoric’ 
effects of the illicit substance (Larney et al., 2014).  
Looking at the history concerning naltrexone, the development of this substance 
started in the early 1970s where it was tested in early studies with heroin and other opioids in 
the USA. It was originally approved as an oral medication for the management of opioid 
dependence, but its effectiveness was limited by poor adherence and low retention in 
treatment. In this study of the medical literature oral naltrexone, with or without 
psychotherapy, was no better than placebo or no pharmacological treatments with regard to 
retention in treatment. According to Larney et al. (2014) the medical literature regarding oral 
naltrexone with or without psychotherapy, was no better than a placebo or no 
pharmacological treatments with regard to retention of re-incarcerations by about a half, 
46 
 
however these results were only found evident in two studies. At that time there was only a 
small demand for the drug, it was not initially registered for use in various countries.  
During the 1990s, there was an increase in the prevalence of opioid use disorders, and 
increasing interest in using naltrexone (Martin, Jasinski, & Mansky, 1973). Naltrexone was 
originally approved in the oral format for the use of opioid dependence, however, studies 
have indicated that oral naltrexone tablets that are taken daily or bi-daily have failed to show 
pre-eminence over its placebo, which was evident in rapid dropout an low retention rate in 
the active naltrexone group (Minozzi et al., 2011). This non-compliance is often associated 
with individuals that withdrew from the treatment process and returned to the use of heroin. 
Even individuals who had made progress with the oral format tended to relapse periodically 
(Hulse et al., 2004). This may be due to various psychological as well as social factors would 
have played a role in the major dropout rates linked to the use of oral naltrexone. These 
factors that may be related to the relapse prevention theory suggested by Marlatt (1985b), 
stating that various high-risk situations may play an essential role in relapse to certain 
substances. However, discreetly enhanced results can be achieved when the oral format of 
naltrexone is taken as part of a compliance-reinforcing scheme such as contingency 
management (Minozzi et al., 2011). Due to the lack of success with compliance and 
discontinuation typical of oral naltrexone format, research efforts were employed in order to 
develop a Sustained Release Naltrexone formulation (SRX) which will enable the decreasing 
the problem of compliance that would essentially reduce the amount of dropout opportunities 
in human subjects. These formats consist of a depot injectable and implant format of 
naltrexone that would be given intramuscularly or be implanted and removes the onus from 
patients to use daily oral naltrexone (Kjome & Moeller, 2011). 
Specifically, the pharmacokinetic characteristics of the injectable format of naltrexone 
are as follows: when the intramuscular injection is administered, the naltrexone is released 
from the proprietary polymer microspheres in phases via diffusion and polymer erosion. This 
then causes the release of naltrexone to occur in phases where the initial phase occurs in the 
first 24 hours which in return releases the surface drug from the injectable site. Subsequently, 
the site of injection tends to undergo hydration within 48 hours of injection which causes a 
30-day sustained release phase which causes plasma naltrexone levels to stay above 2 ng/ml, 
which is the amount needed for the therapeutic level for opioid relapse prevention (Kjome & 
Moeller, 2011). Comer et al. (2002) demonstrate that 384 mg of naltrexone delivered in a 
sustained-release depot formulation can block the reinforcing, subjective and physiological 
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effects of up to 25 mg of street heroin. It provided therapeutic plasma levels of 30 days which 
indicates that naltrexone can be actively present within the human body for up to one month. 
This amount of naltrexone dosage resulted in better than 80% retention in treatment at six 
weeks versus the 40% for the placebo. This indicated that the depot formulation of naltrexone 
showed significantly higher rates of abstinence and better treatment outcomes at a 12-month 
follow-up. The extended injectable release format of naltrexone is not a new agent of 
pharmacotherapy in the USA and has had FDA approval for the use of relapse prevention in 
both alcohol and opioid dependent individuals since 2006 (Kjome & Moeller, 2011). Russia 
is also one of the countries at the forefront in approving the use of the naltrexone implant 
format for the treatment of opioid dependence due to their high rates of heroin abuse (Larney 
et al., 2014). 
After the development of the injectable format of naltrexone came a more 
technological advanced format of extended release known as the pellet implant formulation 
of naltrexone. This formulation of Slow Release Naltrexone SRX consists of pellets that are 
stored in a syringe with biodegradable solid polymer and are surgically inserted or implanted 
under the skin or fatty tissue with the use of local anaesthetic. The wound is then sealed after 
the implant has been inserted, and the patient is encouraged to return for a follow-up session 
within one week after the implant has been administered to ensure that no form of infection 
has occurred. There are two main types of surgically implantable SRX that have been used in 
various controlled studies, a type originating in Australia (Hulse et al., 2004) consisting of 30 
pellets that has a release period of up to seven months. The latter is a type originating in 
Russia (Tiihonen et al., 2012) with a release period of two to three months. It should be noted 
that there are other manufacturers of naltrexone implants however due to a lack of research 
regarding their reliability and format of manufacturing being published it will not be 
discussed (Kunøe et al., 2012).  
The effectiveness of the naltrexone implant can be explained by two randomised 
studies that have made use of the Russian naltrexone implant. This study was conducted over 
a period of 10 weeks with a sample of 100 patients (n=50 in the SRX and placebo group 
respectively) with a sample of individuals that were both amphetamine and heroin dependent. 
This study indicated that the naltrexone implant sample indicated a higher retention rate than 
the later placebo group which resulted in a significant reduction of heroin use were evident 
by using urine samples as a form of assessment. However, one of the limitations of the study 
was a time period of only 10 weeks, which is a short period when considering the chronic 
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nature of concurrent opioid dependence. It was recommended that further research be 
conducted with a two to three month interval to assess long-term recovery from dependence 
(Tiihonen et al., 2012). 
Furthermore, poor outcomes treating opioid dependent individuals with the use of 
naltrexone have been related to the short time that the individuals have spent in treatment. 
After all, it has been indicated that the longer individuals spend in treatment the better the 
long-term outcomes of abstinence. In relation to this, psychosocial interventions provide the 
recovering individuals with the necessary skills to be able to maintain sobriety which include 
therapies such as Cognitive Behavioural Therapy, Motivational Enhancement Therapy and 
spiritual 12-step programmes. This is interlinked with the recovery process as well as the 
process of relapse prevention in order to maintain abstinence in heroin dependent individuals 
(Weich, Perkel, van Zyl, Rataemane, & Naidoo, 2008). Additionally, various studies (Bell et 
al., 1999; Rawson et al., 2001) have indicated that if there are no after-care counselling, 
social support or compliance strategy made available for individuals undergoing naltrexone 
treatment that it will predict poor long-term outcomes. However, when naltrexone is 
combined with effective programmes that would be presented after the treatment of 
naltrexone together with strong social support, the results are deemed to likely be promising 
in terms of abstinence (Shufman et al., 1994). 
However, there have been reports raising concerns about an increased rate of 
overdose of heroin in the period following cessation from naltrexone use which may involve 
the tolerance factor associated with the detoxification during treatment. Therefore, 
individuals that make use of naltrexone as an aid for relapse prevention from heroin should 
be educated around the loss of tolerance. Another problematic factor associated with the use 
of naltrexone is the use of analgesic treatment following surgery or severe trauma which may 
occur during the treatment of naltrexone. Due to the fact that naltrexone tends to block opioid 
receptors, it in return causes any analgesic to be ineffective, therefore, medications such as 
morphine would not be effective for the treatment of pain (Weich et al., 2013). 
In sum, the available forms of naltrexone for the treatment for Opioid Use Disorder 
consists of (1) tablet form which can be taken orally, (2) an injectable form, that is injected 
intramuscularly, (3) the implant type which usually consist out of a pellet implantation which 
is inserted through surgical procedure and this is inserted either beneath the skin in the area of 
the lower abdomen or buttocks.  
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It should be noted that the main focus of the current study lies on the implant format 
of naltrexone and not the later tablet or depot format as the implant format of naltrexone has 
shown greater results in compliance. The sample used in the current study constitutes of 
individuals that have made use of the naltrexone implant format that is made available for the 
general public from various trained physicians in South Africa. The rationale for the use of 
naltrexone in opioid dependence is concerned with the prevention of relapse in which the 
patient knows that taking naltrexone blocks the euphoric effects of heroin. It has been 
recorded that detoxified heroin users have indicated that the use of naltrexone is a form of 
‘insurance’,  in that it protects them from the ‘sudden temptations’ to revert to the use of 
heroin. Clinical research has indicated that heroin users that tend to make use of naltrexone in 
the hope of helping them to stop wanting heroin, or will maintain their motivation to remain 
abstinent, tend to be disapointed. Therefore, the use of naltrexone should be viewed as a 
medication that which will motivate them (aid them) to remain abstinent, rather than a 
“miracle drug” that reduces patient’s desire to use heroin (Krupitsky et al., 2013). 
2.10.4 The Use of Naltrexone Implants in South Africa 
As indicated previously, naltrexone maintenance therapy can be used as an aid to 
relapse prevention for individuals who have successfully been detoxed from heroin use. The 
current study focused on the pellet implantation SRX form in a South African context where 
it is still a new and understudied phenomenon in this context. Following is a description into 
the use, availability and guidelines for the administration of naltrexone in the South African 
context. 
When it comes to the prescription and use of the oral format of naltrexone, it is 
evident that the availability to the general public is restricted to scheduling of naltrexone. 
This means that only a trained physician would be able to prescribe this medication, 
preferably with experience of opioid dependence treatment.  
As for the availability of SRX such as the injectable or implant formats of naltrexone 
it is only available outside of South Africa. The reason being that sustained release 
formulations of naltrexone are not yet registered in South Africa by the Medicines Control 
Council (MCC). The MCC as a body is enacted by statute to regulate the performance of 
clinical trials and registration of medication for the use of treatment for diseases. The MCC 
holds the responsibility to ensure that clinical trials of non-registered medicines as well as 
newly developed medicines do comply with the necessary requirements. In the interim, 
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individual cases of making use of the naltrexone pellet implants within South Africa occur by 
importing foreign naltrexone pellet implants which will be legally available to the general 
public through the Section 21 approval from the MCC. This is done by means of individual 
applications (for each patient) that are assessed and approved if deemed appropriate (Weich 
et al., 2013). 
 For the purpose of this study, the researcher focuses on a particular practitioner’s 
guideline in having access to and administering the naltrexone maintenance implant. When a 
patient decides to make use of the naltrexone maintenance treatment with pellet implantation 
for the purpose to remain drug-free, he/she would make an appointment with the relevant 
practitioner stating the reason for doing so. Once the appointment is made the practitioner 
assesses the patient for any additional chronic illnesses or organ functionality. This is due to 
the reasons mentioned previously that naltrexone cannot just be given to any individual 
before assessed in order to refrain from causing major health complications such as liver or 
kidney failure. After being assessed the practitioner informs the patient how naltrexone 
works, the side-effects associated with the use of naltrexone, the procedural steps of inserting 
the implant surgically and informing them about a follow-up meeting. The practitioner 
prioritises informing their patients that there is still a significant risk of overdose from the use 
of naltrexone. This is due to the tolerance build up through the use of opioids, which, when 
the same amount would be used after naltrexone has been administered might result in an 
overdose of the illicit substance such as heroin (de Wet, 2015). 
 Once the patient is deemed fit for the naltrexone implant the practitioner sends the 
individual patient’s relevant documents to the MMC of South Africa whereby they assess the 
documentation and give their approval for the patient to be able to make use of the naltrexone 
implant.  
The procedure of the insertion occurs at international standard where an antiseptic 
will be applied in order to clean the area, this is followed with the administration of a local 
anaesthetic where the wound will be made for the implant to be inserted. The wound would 
then be sutured and dressed. A follow-up session is required in order to avoid infection and to 
remove the sutures (de Wet, 2015). 
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In South Africa, naltrexone is only considered if the patient adheres to the following 
conditions: 
 The patient is opioid free for at least 5- 10 days (detoxed), however, this period can 
be reduced in selected cases for up to 72 hours. It is deemed important for the 
practitioner to inform their patients regarding the opioid-free period due to the risk 
of rapid opiate detoxification. 
 The patient should be willing to take the naltrexone. 
 The patient does not present with severe or active liver or retinal problems 
 The patient is not allergic to naltrexone 
 
In general, it is recommended that patients go through at least 6-months of naltrexone 
maintenance treatment, to ensure that the patient make the necessary behavioural changes in 
order to remain abstinent. For many individuals this form of treatment may take up to two 
years which means that follow-up implants would be recommended after three months (de 
Wet, 2015). This leads to the main focus of the study that is interested to explore what these 
individuals have experienced through the use of naltrexone maintenance therapy with pellet 
implantation specifically. Thus the aim of this study is to explore the experiences that these 
individuals undergo whilst on the naltrexone pellet implantation in relation to relapse 
prevention as this is quite understudied with regard to the use of naltrexone within the South 
African context.  
2.11 Conclusion 
 In order to conclude, the researcher ensured that this chapter included the various 
factors, detentions and components related to this specific topic. This was due to ensure that 
the reader had a general overview of the topic at hand that included various factors related to 
the main components that were discussed in this particular study. These components 
consisted of epidemiological aspects regarding the use of heroin in order to highlight an 
overview of the use of heroin and various opioids from a general to a more specific overview 
regarding the use of heroin in the South African context. The researcher furthermore 
discussed the different components related to the use of heroin and the neurobiological 
effects that this particular illicit substance has in the human body. The reason for this was to 
indicate the relationship between the use of heroin and how the naltrexone pellet implant 
would work on the same components in order to aid the individual in remaining abstinent 
from the use of heroin.  
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Moreover, the researcher included a general overview of naltrexone to a more specific 
description of the various components related to the use of the naltrexone pellet implant and 
its effects on the human body. The discussion regarding naltrexone covered a historical 
perspective of the development of naltrexone to the use of the naltrexone pellet implant in the 
context of South Africa specifically. The researcher decided that an outline of these different 
modalities and the important components to the design of the study would be of great 
importance for the reader that might not be aware of this particular topic at hand.  
Furthermore, the chapter delineated the various aspects related to relapse from heroin 
abstinence and the different modalities linked to this process in order to guide the reader 
through the difficulties experienced by a heroin dependent individual and the attempt to 
remain abstinent from the use of heroin. This included a discussion regarding relapse and 
relapse prevention as this was one of the most important factors related to this study. 
Specifically, the literature review outlined the theoretical perspective of the current study, 
namely, the Relapse Prevention Model (Brownell et al., 1986).  
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CHAPTER 3: RESEARCH METHODOLOGY 
3.1 Introduction 
 This chapter outlines the research methodology and the research design employed in 
completion of the study. A vast amount of studies have given evidence on the effectiveness of 
the naltrexone pellet implant in relation to relapse prevention and sustaining abstinence from 
the use of opioids such as heroin. Many of these findings have made use of a quantitative 
methodology for the reason that it consists mostly out of clinical trials that measure the 
amount of naltrexone in the blood system that would then be correlated with the relapse rate 
in order to indicate its effectiveness.  
However, quantitative studies have not captured the human experience of the process 
involved with going through the naltrexone pellet implantation treatment for relapse 
prevention (Colquhoun, 2013; Hulse et al., 2004; Tiihonen et al., 2012). Therefore, the focus 
of this study was to explore the experiences and perceptions that heroin dependent 
individuals had when they made use of the naltrexone maintenance therapy with pellet 
implantation and whether they felt such treatment had any changing outcome in terms of 
relapse prevention from heroin dependency.  
The aim of conducting this research study was to explore the experiences and 
perceptions of heroin dependent individuals that made use of naltrexone maintenance therapy 
with pellet implantation as an alternative treatment method in order to prevent relapse from 
occurring.  
Since the research question is based on the personal experiences and perceptions of 
heroin dependent individuals that make use of naltrexone maintenance treatment with pellet 
implantation in order to prevent relapse, the study will make use of a phenomenological 
research design, in particular Interpretative Phenomenological Analysis (IPA), a qualitative 
interpretive paradigm. The rationale behind the use of this paradigmatic perspective, research 
design and approach are discussed in this chapter. The choice of the target population and 
sample will also be discussed during this chapter as well as the method of data collection and 
data analysis used in this particular study. Ethical issues are further discussed, with an 
exploration of the measures to ensure trustworthiness within this study.  
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3.2 The Research Design 
3.2.1 Qualitative method 
 The researcher has chosen to employ a qualitative, exploratory research design for 
this particular study. Exploratory research focuses on providing relatively new information on 
an unknown subject or topic (Terre Blanche et al., 2006). With this in mind, the naltrexone 
pellet implantation therapy can be seen as a relatively new form of treatment for heroin 
dependence within South Africa, which needs research. Johnson and Christensen (2012) 
stated that qualitative methods would be employed when there is little known about a certain 
phenomenon or topic, and when one wants to know more about this particular topic. Since 
naltrexone maintenance therapy with pellet implantation is not that common in South Africa, 
and very little information is made available to the general public, the researcher found that 
the qualitative method would be more appropriate in order to be able to explore the subjective 
experiences of the individuals that make use of this treatment. This method enabled the 
researcher to find out more about the experiences that these people went through and was 
therefore able to answer the research questions at hand.  
 Qualitative research seeks to find a deeper understanding of the way things are the 
way they are and how other individuals experience these things in context (Gay, Mills, & 
Airasain, 2009). The qualitative method fits this study well in terms of exploring the 
experiences that these individuals went through during their interaction with the use of 
naltrexone implant therapy. This study explores what individuals experience in terms of the 
physical, psychological as well as social consequences that individuals live with or face when 
they make use of the naltrexone implants. The reason for exploring these recovery 
experiences in this form of therapy is specifically created to help the individual move through 
and cope with the phases that usually cause relapse. This form of alternative therapy acts as 
an aid in the recovery process from heroin dependency. The selection of the qualitative 
method of research in this particular study is based on the relapse prevention theory that is 
described in chapter two of this study. This approach allowed the researcher to have some 
form of guidance and foundation when this study was conducted. 
 Gray (2013) stated that the role of a qualitative researcher is to gain a deep, intense 
and holistic overview of the context under study. Qualitative research is a naturalistic 
approach that seeks to understand phenomena within their context-specific setting. The above 
statement also highlights the motivation for the use of a qualitative method in this particular 
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study. Each participant was provided with the opportunity to express and explain their 
experiences with the use of naltrexone in preventing relapse from occurring. 
3.3 The Research Approach 
3.3.1 Interpretive Phenomenology 
 The researcher decided to employ phenomenology as the approach of choice for this 
particular study. Phenomenology is concerned with the world as it is experienced by human 
beings within a particular context at particular times. It is concerned with the phenomena that 
appear in human beings’ consciousness as they tend to engage with the world around them. 
Phenomenology tries to return to things themselves, as they appear to individuals as the 
perceivers and to bracket what each individual thinks they know about themselves (Willig, 
2008). This means that individuals’ preconceived ideas, attitudes and perceptions do not 
matter so much when one embarks upon phenomenology. 
Working with individual that made use of naltrexone as a form of recovery and to 
remain abstinent from the use of illicit substances from a phenomenological perspective, 
allowed the researcher to bracket his presuppositions, assumptions, ideas and interpretation 
regarding this topic. However, it is often impossible to, therefore the researcher has decided 
to make use of interpretative analysis (Smith, Flowers, & Larkin, 2009). The blocking of 
one’s own biases and assumptions through means of bracketing in order to gain an 
understanding of a phenomena is quite a difficult process and is one of the major 
cornerstones described by Willig (2008) as epoche. This means that one should be able to 
reflect critically on one’s own ways of knowing, while constructing an interpretation of the 
participants’ world. For the purpose of this enquiry, the researcher’s approach was 
interpretive in the sense that it consists of the interpretation of the participants’ account of 
emotions, cognitions and thought processes during the use of naltrexone maintenance therapy 
as an aid in the recovery process that the researcher engaged in. For the purpose of this 
particular study the researcher was not able to completely bracket himself from this research 
process, although the bracketing of personal biases, prejudices and discriminations were 
applied as to ensure that the research findings were not contaminated by these subjective 
interferences. 
Phenomenology is often central to the interpretive paradigm and commonly used 
paradigmatic perspective known as hermeneutic phenomenology was employed to this 
particular study. Hermeneutic (interpretive) phenomenology is concerned with interpretation 
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of the structures of experiences and with how things are understood by people who live 
through these experiences and by those who study them, so in other words, the 
epistemological assumption of this approach is phenomenological in nature (Wojnar & 
Swanson, 2007). 
The main purpose of this study was to explore the experiences of heroin dependent 
individuals that made use of naltrexone maintenance therapy with pellet implantation in 
relation to relapse prevention. Through conducting this study the researcher wished to learn 
what the experiences are that these individuals went through in the time making use of 
naltrexone maintenance therapy with pellet implantation. This included a holistic approach to 
their experience with naltrexone that covered physical, psychological as well as social 
experiences with the use of naltrexone maintenance therapy in relation to relapse prevention. 
One of the reasons that the relapse prevention theory was used as a guide throughout this 
research process is due to the reason that naltrexone is designed to reduce relapse from the 
use of various opioids. Phenomenology as a qualitative approach allows participants to 
express their experiences, views and meaning with the use of naltrexone as an aid for relapse 
prevention. This approach allowed for elements of individuality as well as those of 
commonality to emerge from their descriptions of their encounters with the use of naltrexone 
(Smith et al., 2009). 
 According to Willig (2008), there are two schools of thought within phenomenology 
that consist of descriptive phenomenology and interpretative phenomenology. Descriptive 
phenomenology is firmly rooted in the tradition of transcendental phenomenology, arguing 
that perception can be more or less infused with ideas and judgements. This means that it is 
quite possible for the researcher to analyse and make sense of certain phenomenon without 
being overly influenced by his or her own subjective interpretations of the world. Descriptive 
phenomenology is concerned with the world as it presents itself and with a phenomenon as it 
occurs naturally. It requires the researcher to adopt a phenomenological attitude in which he 
or she brackets all past knowledge about the phenomena under investigation. This causes the 
researcher to be truly present to the phenomena as it presents itself in a particular instance. 
Therefore, the focus of the research study was the phenomenon as it presents itself through 
the research participant, rather than the phenomenon as a material reality (Willig, 2008). 
In contrast, interpretative phenomenology falls within the hermeneutic tradition. This 
tradition argues that lived experiences are already meaningfully organised and interpreted 
through language since it is the tool used for knowledge production in everyday life and it 
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argues that all description constitutes a form of interpretation. The hermeneutic argument is 
rooted in the notion that everyday experiences and knowledge has a profound effect on 
individuals’ cognition and therefore the divorce between the researcher’s experiences and the 
participants’ lived experiences cannot be possible. In order to make use of interpretative 
phenomenology, researchers must work with their presuppositions and assumptions in order 
to reach a better understanding of a phenomenon (Willig, 2008). 
 With the above mentioned in mind, the researcher decided to employ interpretative 
phenomenology, specifically Smith’s Interpretative Phenomenological Analysis (IPA). The 
reason being is that it is quite impossible to gain direct access to participants’ lived 
experiences. When it comes to the analysis of the participants’ experiences and perceptions, it 
is seen as an interpretation by the researcher which is facilitated by his or her interaction and 
a co-creation of understanding of the phenomena at hand (Wojnar & Swanson, 2007). IPA is 
deeply rooted in phenomenology to data analysis in that it aims to capture the quality and 
textures of individual experiences, and to try and capture the subjective meanings that 
individuals ascribe to their experiences (Smith et al., 2009). This study aimed to understand 
the subjective experiences of heroin dependent individuals making use of naltrexone 
maintenance therapy with pellet implantation as an aid for relapse prevention. 
 Smith et al. (2009) highlighted important concepts to IPA consisting of double 
hermeneutics, empathetic hermeneutics and critical hermeneutics that were evident in the 
interaction with the research participants for this study. The process of double hermeneutics 
can be described as the situation where the participants are trying to make sense of their 
world while the researcher is also trying to make sense of the participants trying to make 
sense of their world. Therefore, IPA is intellectually connected to hermeneutics and theories 
of interpretation. It was evident to the researcher that when the interactions with the 
participants occurred, the researcher attempted to emphasise the participants’ situation and to 
allow the participants to explore their own sense of the world by means of ‘standing back’. 
The researcher also participated in second-order sense making through constantly attempting 
to vision how the participant was viewing the researcher and how he attempted to imagine 
their world. The researcher managed to adjust accordingly. 
 This probes the attention to the discussion of empathetic hermeneutics and critical 
hermeneutics (Smith et al., 2009). Empathetic hermeneutics is concerned with trying to 
understand what it is like, from the participant’s point of view. This in essence amounts to the 
researcher taking the participant’s side or attempting to put oneself in the shoes of the 
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participant in order to visualise the same mental faculties that the participant explains in that 
particular moment.  
In contrast, critical hermeneutics refers to taking a step back and asking critical 
questions of the participant’s accounts. It is crucial for the researcher to find a middle ground 
to this approach, as without the caution, the researcher may be too involved with the 
participant’s world or it may cause the participant to feel like they are being interrogated. 
This may cause interpretation for the sake of analysis to become quite impossible (Smith et 
al., 2009).  
 To summarise, interpretative phenomenology is a research methodology useful for 
describing human experiences of caring, healing and wholeness in relation to historical, 
social and political forces that shape meaning of wellness, illness and personhood. 
Hermeneutic phenomenology is grounded in the belief that the researcher and the participant 
come to the investigation with fore structures of understanding shaped by their respective 
backgrounds, they cogenerate an understanding of the phenomenon being studied. Therefore, 
the researcher had decided that this particular form of phenomenology would be the best fit 
for the purpose of this study due to its thick description of what the individual experiences in 
this particular context (Wojnar & Swanson, 2007). 
3.4 Research Methodology 
 The researcher employed a data collection procedure that consisted of semi-structured 
interviews with heroin-dependent individuals that made use of the naltrexone maintenance 
therapy with pellet implantation in relation to relapse prevention. All the procedures that the 
researcher has followed in order to acquire the desired outcome to the findings of the research 
conducted are discussed below. 
3.4.1 Sample and Sampling 
Sampling in qualitative research is usually purposive, meaning that participants are 
selected according to whom are most likely to produce the needed data for this proposed 
research study (Terre Blanche et al., 2006). The focus of this study was to explore and 
investigate the subjective experiences of heroin-dependent individuals that underwent 
naltrexone maintenance therapy with pellet implantation in relation to relapse prevention. In 
order to have achieved this goal, the researcher employed a non-probability, purposive, 
snowball sampling technique for the selection of participants in order to filter and select 
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candidates who were suited as “information-rich” for the research sample (Patton, 1990). The 
snowball sampling technique enabled the researcher to recruit other participants that 
underwent the same naltrexone therapy as the initial participants and who recommended the 
study to other potential participants. This is due to the difficulty in finding participants in this 
criterion because to the small population of individuals that makes use of this type of therapy 
in the South African context. 
A relatively small sample size was gained from the naltrexone therapy group. This is 
due to the small amount of individuals that receive the naltrexone pellet implantation with the 
necessary criteria proposed previously. The researcher managed to recruit four participants 
that consisted of heroin-dependent individuals that made use of the naltrexone maintenance 
therapy with pellet implantation as an aid for relapse prevention. It should be noted that one 
particular participant (Participant 1) has a vast amount of knowledge based on the naltrexone 
pellet implant and the use thereof and this particular participant can be seen as possessing 
expertise in this particular field as he went through the process of making use of the 
naltrexone pellet implant for the use of relapse prevention to heroin use. He also acts as a lay 
counsellor for the participants involved in this research study whereby weekly and bi-weekly 
support sessions are held for this particular group. It would be important to state that the 
researcher has no involvement with the processes of this particular support group and that this 
group was created long before this particular research study was conducted.  
3.4.1.1 The Sampling Criteria 
 The following criteria were identified according to which participants were chosen: 
The participants for this study should have received the 800mg- naltrexone pellet 
implantation from a professionally recognised physician. The physician that was approached 
in the use of this study was Dr. X, whom is located in the Randburg/Florida area in 
Johannesburg, South Africa. Dr. X played a crucial role in the completion in this study due to 
his role as one of the gatekeepers in the selection of participants for this particular study. It 
should also be noted that a second gatekeeper played a role in the selection of participants for 
this particular study, this gatekeeper is a lay counsellor for the naltrexone support group. This 
individual played a crucial role in the selection of these participants whereby the specific 
inclusion criteria for these particular individuals was sent to him. Under his own professional 
scrutiny, together with the inclusion criteria given to him by the researcher, a selective group 
of participants for this study seemed fit (Smith et al., 2009). 
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With regards to the inclusion criteria regarding this study it was however, also 
important that the participants had encountered difficulties in remaining abstinent from 
heroin and other forms of heroin such as nyaope by which it has caused social difficulties, 
caused clinically significant distress and the inability to function properly. This means that 
even though the participants did not have to be diagnosed according to the DSM-5 criteria in 
order to participate they should have received the implant by means of the professional 
opinion of the physician.  
The participant should have stayed on the naltrexone pellet implantation for the 
duration of three months. The time duration that has been chosen for the proposed study is 
connected to the lifetime of the naltrexone implant, where the implant would remain active 
within the body for a period of up to three months. The participant may have received a 
second implant or may have decided to withdraw from receiving a second implant. This 
however does not matter due to the reason that the purpose of this study was to explore the 
subjective experiences of heroin-dependent individuals when receiving the first implant in 
relation to relapse prevention from heroin abuse. 
The majority of the participants were recruited from the naltrexone support group in 
Johannesburg. It should be noted that this study is focused on participants that reside in the 
Gauteng province of South Africa. As mentioned previously, these participants were difficult 
to recruit due to the strict criteria that needed to be met. There were no requirements 
concerning race or gender, however, the participants needed to been 18 years or older to be 
able to partake in this study. 
3.5 Data Collection Method 
3.5.1 Interviews 
 The researcher made use of interviews as a form of data collection whereby 
interviewing participants for a research study is the hallmark of qualitative research 
(Rossman & Rallis, 2012). The interview in a research setting is a method of generating 
conversation with other individuals with regards to a certain topic at hand (May, 2010). The 
researcher applied a semi-structured interview within this study due to its compatible format 
with various methods of data analysis. 
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3.5.1.1 Semi-structured interviews 
 Semi-structured interviews are one of the most popular forms of data collection in 
qualitative research within the discipline of psychology. Interviews require careful 
preparation and planning, especially when it comes to the development of the appropriate 
questions to pose to the participants. This form of data collection tends to be somewhat easier 
to arrange when a form of interpretation of what the participant is trying to portray is 
analysed. Furthermore, this form of data collection enabled the researcher to reach a small 
number of volunteers in a certain amount of time, as recruitment of participants in this 
particular sample was difficult to secure (Willig, 2008). 
 Since the researcher’s goal was to learn and explore the subjective experiences of 
heroin-dependant individuals that made use of naltrexone maintenance therapy with pellet 
implantation, the researcher felt that semi-structured interviews would allow the respondents 
to elaborate on particular questions if they wished to do so, by means of making use of their 
own words. Moreover, the researcher decided that by making use of this particular form of 
data collection would create space for the interviewer and the interviewee to explore all the 
factors associated with their experience with naltrexone, therefore ensuring that a rich 
description of the respondent’s experience was recorded. 
An interview schedule containing a semi-structured interview with open-ended 
questions was designed prior to the data collection process. This interview schedule was 
designed by means of the researcher spending time familiarising himself with the field of 
naltrexone and heroin dependence. The interviewer also ensured that this interview schedule 
was fit for the interview session by means of collaborating with various professionals, 
academics, colleagues and peers regarding the interview schedule before the attempts were 
made for data collection (Willig, 2008). Open-ended questions with alternative sub-questions 
or probes were added to the interview schedule as to clarify the questions that were asked.  
3.6 Data Analysis 
 This section will discuss the way in which the data collected from the interviews were 
analysed. The intention of collecting this particular data was to answer the research questions, 
“What are the subjective experiences and perceptions of individuals who are on the 
naltrexone maintenance therapy with pellet implantations with regards to relapse prevention 
from heroin dependence?”, and, “Does the use of naltrexone maintenance therapy with pellet 
implantation have any changing effect on preventing relapse form heroin use from the user’s 
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perspective?” When one interprets qualitative data, the aim is to develop an organised, 
detailed, plausible and transparent account of the meaning of the data. For the purpose of this 
study the researcher made use of the interpretive phenomenological analysis (IPA) method as 
a form of analysis which is inductive in nature (Smith et al., 2009). 
 The assumption in IPA is that the researcher is interested in learning about the 
participant’s psychological world. Participants’ verbalisations may be in the form of beliefs 
and constructs that are manifested or suggested by the participant’s way of language usage. 
Moreover, IPA suggests that the way the researcher holds the participant’s story can in itself 
be said to represent a piece of the respondent’s identity. Furthermore, the meaning of the data 
collected is central, and the aim is to understand the content and complexity of those 
meanings rather than measure their frequency. This involved the researcher to engaging in an 
interpretive relationship with the transcripts. 
Participants in this study were interviewed and the transcripts were subjected to IPA. 
This particular study made use of four participants that adhered to the criteria created by the 
researcher. All four interviews were recorded and transcribed in order to facilitate structured 
and detailed interpretative phenomenological analysis. The transcription of the English 
recordings were conducted by the researcher for the purpose of gaining a better 
understanding of their subjective experiences and perceptions of the use of naltrexone 
maintenance therapy with pellet implantation as an aid of relapse prevention from heroin 
dependency. Furthermore, gaining an understanding of how participants’ experiences shaped 
their emotions and thought patterns when making use of the naltrexone pellet implant. One 
major advantage to making use of IPA is that it allowed the researcher to immerse himself in 
the data collected from the participants. This allowed for a more detailed account of creating 
themes that will help in completely understanding the phenomenon at hand (Willig, 2008). 
 Subsequent to the interviews, the researcher made use of member-checking in order to 
ensure that what was mentioned is an accurate reflection of the participant’s story being told 
during the interview session. This was implemented by means of identifying potential themes 
from the transcriptions whereby the researcher would then make contact with the participant 
in order to enquire whether this is in fact an accurate reflection of what had been shared. 
Generally, the participants agreed with the initial analysis, however there where some 
scenarios where additional material and different perspectives arose after member checking. 
The researchers made note of these changes and amended the analysis accordingly. 
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 Smith et al. (2009) identified four stages in the IPA process that consist of the 
following: 
 Stage 1: Initial reading of the transcript. In the first and most important phase of 
IPA, the researcher aimed to garner an overall feel of each interview. The researcher 
examined the first transcript in detail before moving on to examine the other transcripts case 
by case. Moreover, the researcher followed an idiographic approach to analysis which 
consisted of beginning with particular examples and slowly working his way up to more 
general categories or claims for the purpose of the analysis (Smith et al., 2009). According to 
Weber (1990), it is important to read and re-read the text in the transcriptions. Smith et al. 
(2009) recommended that the researcher should start off with writing notes and to pay careful 
attention to detail, the researcher can however decide to write reflective accounts or an 
interpretive account of each interview. Due to the reason for the researcher writing notes and 
paying careful attention to detail and transcribing his own material, it was quite easy to get a 
feel of the text and context of what the participants had attempted to convey during the 
interview. 
  The researcher developed a set of descriptive comments on each interview transcript. 
The purpose for this was to describe the content of the data. The researcher made use of the 
comment function within Microsoft Word in order to complete these descriptive comments. 
At the next level of analysis, the researcher focused on how the transcripts reflected the ways 
in which the content and meaning were represented linguistically, the researcher also took 
notes in a linguistic format that was structured in the format of comments. The researcher 
considered the ‘how’ along with the ‘what’ of the textual data that contributed to the meaning 
behind the participants’ words (Cooper, Fleischer, & Cotton, 2012). 
 Stage 2: Identifying and labelling themes. The researcher should be able to return to 
the transcript and make use of the notes that were written in the margin in order to identify 
potential themes. The combination of notes and transcripts will help clarify themes that were 
found in the process. The researcher should be aware that when theories and psychological 
constructs are introduced, that the participants’ stories and subjective meanings should not be 
overwritten (Smith et al., 2009). With this in mind, the researcher moved into a more 
interpretive stage of analysis in making conceptual comments. At this stage the researcher 
began to develop insight into the data in order to develop themes in the next stage of analysis. 
In making conceptual comments, the researcher noted preliminary concepts regarding the 
participants’ overarching understanding of the use of naltrexone pellet implants for the aid in 
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relapse prevention. After initial noting on each participants responses, the researcher searched 
for emerging themes across all participants’ by examining discrete sections of transcripts and 
simultaneously recalling what was being learned through the analysis (Cooper et al., 2012). 
 Stage 3: Linking themes and identifying thematic clusters. In this particular stage 
the researcher attempted to narrow the themes where connections are identified between 
preliminary themes. This is where potential themes were either removed from the analysis or 
integrated into new themes, depending on the context of the topic at hand. This stage called 
for superordinate themes where the introduction of structure to the analysis was implemented 
(Smith et al., 2009; Willig, 2008). 
 Stage 4: Producing a summary table of themes with illustrative quotations. In 
this stage the researcher attempted to organise superordinate themes into a table with their 
sub-themes with illustrative quotations made by the participants. These themes and 
quotations should be accompanied by references where extracts can be found in the transcript 
(Smith et al., 2009; Willig, 2008). The researcher accomplished the above mentioned through 
means of returning to the first transcript whereby the data was then coded in order to mark 
segments of data with descriptive words. This process was then repeated with each individual 
transcript. Each transcript was coded and the codes were written down on a whiteboard in 
order to find similarities or discrepancies in the other transcripts or to connect the various 
codes in order to create categories. Categories started to emerge whereby the main themes for 
this research study were created. 
The transcribed data for each interviewee was awarded a code for the purpose of 
anonymity. The code for each interviewee appeared on the interview schedule for each 
research participant. As an example, the researcher had eight different codes to represent the 
eight participants and one code to represent the researcher. The codes that appeared are P1, 
P2, P3 and P4. The code P stands for the research participant. The researcher used R to 
represent the researcher in this study. The researcher also made use of bracketing in 
Microsoft Word in order to segment the data in the transcripts in order to demarcate where 
each segment started and ended as recommended by Jonson and Christensen (2012). The 
final layout of the analysis was then laid out on an Excel spreadsheet in order to simplify the 
data for the write-up of the next chapter which will discuss the findings of this study in detail. 
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3.7 Measures to Ensure Trustworthiness 
This study made use of measures of trustworthiness as prescribed by qualitative 
research to ensure credibility, transferability, dependability and confirmability. Many critics, 
mainly positivists, are hesitant regarding the trustworthiness of qualitative research. Guba’s 
(1981) constructs have won considerable favour in ensuring rigour in naturalistic inquiry by 
means of ensuring the application of the four constructs mentioned above in order to 
complete and present trustworthy studies. Following are the four main constructs that have 
been contextually applied by the researcher to enhance the trustworthiness of this particular 
study. 
3.7.1 Credibility 
 Credibility is one of the key constructs in ensuring trustworthiness. This particular 
construct is well known to the positivist researcher as internal validity. This construct ensures 
that the study measures what is actually intended to be measured by asking the question of, 
‘How congruent are the findings are with reality?’ (Shenton, 2004). The following measures 
were taken by the researcher in order to promote confidence that the information that has 
been recorded regarding the phenomena has been done under scrutiny. The adoption of 
research methods was carefully implemented by means of ensuring that the procedures that 
were employed in this study were done with accuracy. 
The interview framework in the data-gathering sessions and the method of data 
analysis were derived from previous studies that have been successful in gathering 
information in other related studies or projects (Lincoln & Guba, 1985). This was done by 
means of various literature searches that included the investigation of the effectiveness and 
duration of the use of naltrexone pellet implantation for relapse prevention. The researcher 
made an effort to consult with various professionals in the particular field of methodology 
and the field of naltrexone maintenance therapy as to ensure a rigorous flow of this study. 
Preliminary visits to literature and organisation were made before the first data collection 
dialogue took place in order to be familiarised with the culture of the participants in this 
study. The factor of triangulation was incorporated by means of including both interviews 
with patients that underwent naltrexone maintenance therapy with pellet implantation as well 
as professionals in its field. One particular participant underwent the naltrexone maintenance 
therapy with pellet implantation and is now one of the counsellors for the naltrexone 
maintenance therapy group, therefore, this particular participant can be seen as a professional 
66 
 
in the field of naltrexone therapy due to the vast knowledge that he gained when working in 
the field for many years. Peer scrutiny of the research study was adhered to by means of 
allowing peers, colleagues and various academics to give feedback on matters discussed 
throughout this study with regards to methodological, paradigmatic and contextual 
discussions (Shenton, 2004). The researcher employed a co-analyst in order to strengthen the 
credibility of this particular study. 
3.7.2 Transferability 
 This particular construct is well known to the positivist researcher as external validity 
which is concerned with the extent to which the findings of one study can be applied to other 
situations in the same context. When it comes to qualitative inquiry, it is almost impossible to 
demonstrate that the findings of a particular study could be applicable to other situations and 
populations. This is due to reason that the nature of the findings in qualitative research is 
specific to a small number of particular environments and individuals. Many of the 
naturalistic enquirers trust that in practise even conventional generalisability is never possible 
as all the observation that are made are defined by the specific context it occur in. It was 
therefore up to the researcher to ensure that sufficient contextual information about the 
fieldwork sites was provided as to enable the reader to make such a transfer. Therefore, the 
researcher ensured that a rich description of the phenomenon at hand was provided as to 
enable other readers to have a proper understanding of the topic at hand. This was adhered to 
by means of providing a description of the selection of participants which includes the 
inclusive and exclusive criteria that the individuals had to adhere to before they were able to 
take part in this study. Furthermore, the literature gives a rich description of the various 
factors involved with the topic at hand. This indicates the use of naltrexone maintenance 
therapy with pellet implantation starting from a global scale and then filtering down to a local 
scale of use (Shenton, 2004). 
3.7.3 Dependability 
 This particular construct is well known to the positivist researcher as addressing the 
issue of reliability. In the positivistic approach the researcher would employ techniques to 
show that, if the work should be repeated in the same context, making use of the same 
methodology and sample, the same results would be obtained (Fidel, 1993). However, within 
the qualitative naturalistic inquiry, dependability can be achieved by means of reporting the 
processes within the study in detail, thereby enabling a future researcher to repeat the work to 
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ensure that they gain similar results. A rich description of the planning and execution of the 
study was given on a strategic level by means of clearly indicating the research design, 
approach, selection of participants and form of data collection as mentioned previously. The 
researcher ensured that operational detail of data gathering was given as well as a reflective 
appraisal of the project was made available (Shenton, 2004). 
3.7.4 Confirmability 
 The last criterion for ensuring rigorous and trustworthy research is confirmability. 
This concept is concerned with the qualitative researcher’s comparable concern to objectivity. 
It is vital to ensure that the information and ideas gathered are those of the research 
participants rather than the subjective influences of the researcher. Therefore, for the purpose 
of this study the researcher ensured to make use of triangulation as mentioned previously as 
this ensures that investigator bias is reduced. This was done by ensuring that the reason for 
the particular approach was explained in detail which is embedded in the research report and 
that the methodology was explained so that the reader would be able to follow an audit trail 
that is attached to this particular study  
3.8 Ethical Considerations 
Ethics can be defined as the application of moral rules and professional codes of 
conduct to the collection, analysis, reporting, and publication of information about research 
participants in a study, in particular active acceptance of participants' right to privacy, 
confidentiality, and informed consent (Terre Blanche et al., 2006). These ethical 
considerations are important as they would protect the rights of the participants as well as the 
rights of the researcher. The researcher received permission from the Ethics Committee of the 
Department of Psychology, University of South Africa to commence with the study on 20
th
 
August 2014 whereby a copy of this ethical clearance letter can be found in the Appendices 
section of this study (See Appendix C). This application was approved by the departmental 
Ethics Committee on the understanding that due to the sensitivity of the information being 
sought and the fact that the participants come from a vulnerable population, it is required that 
all ethical principles related to informed consent, the right to withdraw, anonymity and 
confidentiality should be followed to the satisfaction of the supervisor. Furthermore, any 
medical procedures must be conducted by and supervised by suitably qualified medical 
personnel and that referral services should be available if required. Therefore, it should be 
noted that this research process did in fact require no medical procedure as the aim of this 
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study was to explore the subjective experiences of individuals that made use of the naltrexone 
pellet implant whereby the medical procedure was already done outside the parameters of this 
particular study. The participants in this research study participated voluntarily and the 
physical and psychological safety of the participants was also be ensured. 
The participants were provided with information letters clearly stating the purpose 
and aims of the study, the way that the information in the study was used, including 
information about anonymity. It was also important for the participants to know that they will 
be able to withdraw from the study whenever they wish to do so, including that the 
participants were informed of any potential harm the study may have caused by triggering 
negative experiences or emotions (Terre Blanche et al., 2006). The participants were given 
the contact details of a registered Clinical Psychologist should the need have arisen for 
debriefing after they were interviewed. 
 The following ethical factors were considered when this study was conducted. 
 Informed Consent 
In any academic research project there should be informed consent from participants 
before they take part in any proposed research study. This simply means that the participants 
should be informed of what they are being asked to do, and what the risks are, before they 
agree to take part (Moerdyk, 2012). Within the current study, the participants were also 
informed as to which individuals will have access to the data, which were the researcher and 
the research supervisor. The participants were required to sign a consent form as to confirm 
their willingness to participate in the study. All the participants were informed about the 
overall purpose of the study. A copy of the consent form is attached as Appendix A. 
 Confidentiality, Privacy and Anonymity 
It is important to ensure the confidentiality of the participants when conducting 
research, especially when one makes use of in-depth interviews when collecting the data for 
the study (Moerdyk, 2012). In this particular study, the names of the participants were kept 
confidential by means of making use of pseudonyms instead of their real and identifying 
details were removed for the purpose of anonymity. The researcher honoured the agreement 
made with the participants in that the information would only be used for research purposes. 
The audio recordings and transcripts were kept in a safe format. The researcher did not make 
the information acquired during the research available to any third party. 
 Justice 
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During this research study no form of deception was present during the collection of 
data or any other part of the study. Justice refers to treating all participants with respect 
during the course of the research study. Each participant was treated fairly and equally to 
ensure justice within this study (Terre Blanche et al., 2006).  
 Non-maleficence 
The duty of the researcher in this study is to ensure that no harm towards the 
participants was done during the interviewing phase, as well as the rest of the research study. 
Due to the explorative nature of the study and the characteristics of the participants, it is not 
anticipated that this ethical consideration would have been contravened. The participants 
were debriefed after the interview session as to ensure that no harm would come to their 
psychological health due to any sensitivity of the research topic (Moerdyk, 2012). 
3.9 Conclusion 
 The purpose of this chapter was to discuss the research approach and method that was 
employed during the course of this study that aimed to explore the subjective experiences of 
heroin-dependent individuals that made use of naltrexone maintenance therapy with pellet 
implantation in order to aid in relapse prevention. The rationale behind the selection of these 
methods was outlined in the previous sections. The strategies that were employed for the 
process of data collection were explained. The research methodology and design that was 
selected for the purpose of this study were found effective in the sense that the data that was 
collected was sufficient to be able to answer the research question of the proposed study. The 
researcher ensured to adhere to the ethical procedures of conducting a research study that 
involved human participants and followed measures to ensure the trustworthiness of the 
current study. 
  
70 
 
CHAPTER 4: FINDINGS AND DISCUSSION 
4.1 Introduction 
 This chapter commences a description of the research participants and a narrative 
summary of each participant involved in this research process. This summary of each 
narrative will include a brief background related to each participant’s history with heroin use, 
an interpretation of the use of the naltrexone pellet implant as an aid to their recovery process 
will be explored, concluding with their future with regards to their use of the naltrexone pellet 
implant as an aid to recovery and remaining abstinent from the use of heroin. Moreover, this 
will be followed by a presentation of the superordinate and subordinate themes that was 
extrapolated from the transcripts of the interviews. This will be concluded with a discussion 
of the themes that emerged from the data in relation to the existing literature and contextual 
theory related to the subject at hand. 
The findings of the study are structured according to the overall research question of 
this particular study. The overall question that guided this particular study namely, “What are 
the subjective experiences and perceptions of individuals who made use of the naltrexone 
maintenance therapy with pellet implantations with regards to relapse prevention from heroin 
dependency?” In order to analyse each participant’s subjective experience and perceptions 
with the use of naltrexone maintenance therapy with pellet implantation as an aid for relapse 
prevention, the researcher used an Interpretative Phenomenological Analysis (IPA) as the 
method of data analysis that served as a lens through which the subjective experiences of 
these individuals could be examined and interpreted (Smith et al., 2009).  
4.2 Research Process Overview 
 In this particular section the researcher will provide a brief overview of the research 
process by means of describing the emerging process that occurred prior, during and after the 
collection of data materialised. The collection of data occurred over a period of six months 
whereby the feedback sessions occurred a month after the six-month period. The researcher 
ensured that all the required research procedures including ethical requirements were adhered 
to. The researcher received ethical clearance from the Ethics Committee of the Department of 
Psychology at Unisa on the 20
th
 of August 2014 in order to commence with this particular 
study. This was implemented by means of various processes that include some but not limited 
to, the protection of participants’ identities through the use of pseudonyms. The researcher 
ensured that the length of time for each interview was kept to less than one hour as to protect 
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against interview fatigue (De Vos, Strydom, Fouche, & Delport, 2011). Interviews were 
designed in a semi-structured format as to ensure the comfort for both the researcher and 
participant to support a more explorative format of data collection. The researcher decided to 
approach a physician in Florida, Johannesburg for the recruitment of participants, seen as this 
physician is one of the few that surgically inserts the naltrexone pellet implant. The physician 
introduced the researcher to a naltrexone pellet implant support group that was held every 
week. This was the method that the researcher made use of gaining participants for this 
particular study. Before the interviews were scheduled, the researcher discussed the aim and 
purpose of the study via telephonic communication with potential participants and followed 
up with an email stating the aim and purpose of the research study. This email consisted of a 
description of the aim and purpose of the research study together with two documents, one of 
which provided a description of the research study at hand followed by the actual interview 
questions, and a second that was an informed consent letter describing all the ethical 
principles pertaining to the research study.  These documents can be found in Appendix A 
and Appendix B. This was followed by the scheduling of a face-to-face interview whereby 
the researcher and the participant agreed upon a specific time and venue for these interviews 
to take place. The majority of these interviews were conducted in the comfort of the 
participant’s home where the researcher ensured that no disturbances were made during the 
process of data collection. It should be noted that one out of the four interviews were 
conducted via skype in the comfort of the participant’s own private home. In order to have 
avoided common pitfalls where the interview setting might be interrupted by background 
noises and environmental disturbances the researcher made use of the participants’ personal 
space in order to conduct the interviews (Easton, McComish, & Greensberg, 2000). In order 
to ensured respect, trust and cooperation, these interviews were held at each participant’s 
home as mentioned previously. This procedure ensured that privacy of the content shared was 
adhered to due to the nature of the study. 
 The research question was supported by various sub-questions and probes that guided 
the researcher and the participants through the data collection process, however, allowing the 
participant to explore their own interpretation of the experiences of the use of the naltrexone 
pellet implant. The purpose of the probes were to remind both the researcher and the 
participants about the context of this particular study, which allowed for recall of previous 
participant reactions, which might enlighten or inform the next participants’ response to the 
questions at hand. A copy of the interview guidelines used for this particular study can be 
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found in the Appendices section (Appendix B). The Interview schedule included an 
introductory section whereby the participants were introduced to the study at hand. The 
purpose of the introductory section was to enlighten the participant regarding the study, so 
that they would be more comfortable about the discussion held at that present moment. 
Furthermore, the participants were provided with the overall research question, which was 
followed by the researcher explaining to each research participant that the interview guideline 
consists out of three sections. These three sections consisted of (1) their past experiences with 
the use of substances with the use of heroin as the main focus of this study, (2) their 
experiences of the use of the naltrexone pellet implant and then, (3) their future thoughts 
around the use of the naltrexone pellet implant. The reason why this interview guideline was 
structured in this particular way was to ensure that the participant did not get confused as to 
the structuring of their explanation and interpretation of the particular experience regarding 
the use of the naltrexone pellet implantation. The researcher attempted to ensure the 
participants were comfortable in the structuring and expression of their personal experiences 
with the use of naltrexone pellet implantation treatment as an aid for relapse prevention as to 
ensure that the true self-expression was portrayed. 
 When the interviews were conducted, the participants seemed quite eager to share 
their story with the researcher. The researcher at first assumed that these individuals would be 
reluctant to share a side of them that they are trying to recovery, in retrospect, this was not the 
case as the participants ensured that this would enhance their reflection on their progress that 
they have made and that talking to someone about their experience seemed to reflect 
reassurance of the recovery process. It also came to the researcher’s attention that some of the 
potential participants were not ready to share their experiences regarding the use of the 
naltrexone pellet implantation with regards to relapse prevention. This could be that the 
potential participants (that were not included in this particular study) were not ready to share 
their experiences as they are currently in the recovery process and on their own personal 
journey to recovery whereby they are still processing their recovery and abstinence. The 
researcher thanked them for their time and bid them well on their process of recovery and 
abstinence. After the interviews were conducted, the transcripts were created by the 
researcher as to ensure that he immersed himself in the data at hand. The transcripts were 
read and re-read in order to identify potential superordinate and subordinate themes.  
73 
 
4.3 Research Study Participants 
 For this study the researcher managed to recruit four participants in total of which are 
three male participants and one female participant. This amount of research participants fall 
within the prescribed range of research participants for a phenomenological study. It should 
however be noted that there is not one right answer in obtaining the perfect amount of 
research participants. What is important however is that the number of participants should 
provide sufficient cases for the development of meaningful points of similarity and difference 
between participants (Smith et al., 2009). Four participants deemed sufficient due to the 
amount of data collected from each of them for this exploratory study. All of the research 
participants recruited for this research study met the criteria set by the researcher in chapter 
three. It should be noted that none of the research participants withdrew from this study. 
There was, however, some difficulty in gaining participants due to the nature of the study. It 
was found that some of the potential research participants felt that they were not ready to 
partake in this research study.  
During the recruitment phase of the current study, some of the potential participants 
mentioned that they were not in the right psychological state to share their experiences with 
someone else besides their counsellor. The recruitment of participants for this particular study 
was, in itself, quite a difficult task because the researcher found that the majority of the 
potential research participants were mainly dependant on so called ‘uppers’ which did not 
form part of the inclusion criteria. These uppers refer to various illicit substances that fall 
under the class of psychostimulant substances such as cocaine, cat, crystal meth and 
crystalized cocaine (crack). Initially this research study required the research participant to 
be/ had to be dependent on heroin. It was found that the majority of the individuals who had 
made use of heroin, which was also their main drug of concern, did however also make use of 
various other substances whilst making use of heroin. This did not negatively influence the 
research study as the researcher realised that the use of various substances including the use 
of heroin was quite a common practise among heroin dependent individuals- this is referred 
to polydrug use. 
4.4 Understanding the Participant’s Lived Experiences 
 The purpose of this study was to explore the participants’ lived experiences and to 
interpret these lived experiences and the meanings that they derived from the use of 
naltrexone maintenance therapy with pellet implantation as an aid to relapse prevention from 
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the use of heroin phenomenon. The data collection procedure commenced with heroin 
dependent individuals that sought an alternative method of recovery in order to prevent 
relapse from occurring. These interviews centred around these participants’ personal lived 
experience with the use of the naltrexone pellet implant in relation to relapse prevention to 
heroin specifically.  
Due to the nature of how naltrexone implants function in the human body, the 
researcher thought that it would be interesting to investigate this phenomenon of alternative 
form of therapy and how these individuals experience this particular recovery process. Here 
the researcher explored past experiences with various well-known recovery processes that the 
participant participated in, in order to recover from their heroin dependency. As mentioned 
the researcher also explored the phase where these individuals had made use of naltrexone as 
well as the future use of this substance. It is worthwhile mentioning that these participants 
differed in the amount of implants that they made use of as well as the time period that they 
last made use of naltrexone as an aid for relapse prevention and recovery. However, the 
amount and timeline of last use is not of importance in this particular study as the focus lies 
with the experiences of the use of the naltrexone pellet implant. The researcher was interested 
in the participants’ experiences of the first initial implant and how these participants 
experienced this particular stage in their life. This particular timeline would be a three-month 
period (half-life of the naltrexone pellet implant) that the participant made use of naltrexone 
as a form of recovery. It should also be noted that the researcher did in fact explore the 
experiences of these participants even if these spurred beyond this particular criterion, for 
example, if they made use of more than one implant. 
 Given that information from the participants’ past is susceptible to recall bias 
information related; and that information related to current life circumstances in the 
recovering process may be distorted. It should be noted that the qualitative nature of this 
study permits for such ambiguity. Therefore the researcher ensured that an interview schedule 
was forwarded to the participant prior to the interview so that they would be able to 
familiarise themselves with the questions and also allow them the space to recall some of the 
experiences that they encountered throughout the recovery process. It is of great importance 
that the participants’ lived experiences should be narrated by themselves; therefore the 
researcher allowed the participants to tell their own story and allowed for the space to share 
their particular lived experiences. According to Smith and Pietkiewicz (2014), IPA is 
concerned with a detailed account of a participant’s lived experience wherein the aim was to 
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conduct research in a way that enabled the lived experience of the individual to be expressed 
in its own terms, rather than according to a predefined category system.  
4.5 Summary of Participants’ Narratives 
 Following is an outline and summary of each participant’s narrative regarding their 
history, previous history with the use of illicit substances, previous attempts at recovery, their 
experiences with the use of the naltrexone pellet implant and what they aim to achieve in 
future regarding the use of the naltrexone pellet implant use. Furthermore, these narratives 
will explore their experiences with therapy while making use of the naltrexone pellet implant 
as an aid to recovery, including their future plans of the use of naltrexone maintenance 
therapy with pellet implantation. The researcher will start off by providing a short summary 
of each participant’s lived experience in which the recurring themes will be understood once 
they are discussed. It should be noted that the research made use of pseudonyms to refer to 
these participants for anonymity purposes. 
Participant 1 (Age 39): 
Participant 1 is a 39 year old male that resides in Gauteng. For most of his life he has 
battled with his dependency to various illicit substances that included crack, heroin and 
crystal meth. However he remembers that the main substance that he was particularly 
struggling with was heroin. Participant 1realised that he was entrapped by his dependency for 
over 20 years, he believed that for 10 years he had to make use of these substances to be able 
to survive. The excessive use and dependency to these substances caused him to end up in jail 
ten times in his lifetime due to housebreaking in order to feed this dependency to heroin, he 
eventually ended up in the streets and was hospitalised seven times for drug overdose. 
Participant 1 remembered a specific heart-breaking moment where he woke up one 
day to find the unresponsive body of his girlfriend next to him, he remembers that they last 
used heroin together and the first thing he was looking for was not her pulse but rather 
checking her pockets for a fix of heroin. He remembered that he did in fact realise that his life 
was falling apart and did want to find help in order to stay clean. Throughout his lifetime he 
recalled attending 29 rehabilitation centres in order to remain abstinent from the use of illicit 
substances, but he did not manage to stay abstinent for too long. Everytime, he was thrown 
back into society, wherein he felt that the temptation was just too much for him to resist the 
use of heroin and crack. 
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After all the years of turmoil and struggling with his dependency Participant 1 
decided that it was time for a change. He was introduced to the naltrexone implant therapy 
through a friend. At first, Participant 1 believed that naltrexone maintenance therapy was a 
hoax and was quite sceptical about making use of this form of recovery. However, he later 
believed that he had nothing left to lose and so he decided to go for the naltrexone pellet 
implant. Participant 1 shared that he was extremely sick for the first few days after the 
implant and was surprised with the results that the naltrexone implant had on him. He 
recalled that it was one of the worst detoxification experiences that he had because he made 
use of heroin before going for the implant.  
Participant 1 soon noticed that this time his road to recovery is quite different from 
the previous methods that he had made use of, as he had felt that he had the energy to now 
change his life for the better. Participant 1, however, mentioned that this was not a miracle 
cure to dependency and he suggested that one should be attending some form of counselling. 
To him the naltrexone pellet implant was an aid to recovery, yet, he needed to still work on 
himself psychologically. Participant 1 continued to make use of three implants and stated that 
he is now completely off the naltrexone pellet implant and feels that he has the capacity to 
deal with his continuous recovery process on his own, without it. 
Participant 1 stated that he has never looked back since and is now a successful lay 
counsellor for a group that he started called the Naltrexone Support Group. He has been clean 
of all illicit substances for eight years including heroin and has developed a passion for 
helping those that went through the similar lifestyle he experienced for the past 20 years of 
his life. Participant 1outlined that he has developed a seven-step programme for his clients 
that are undergoing the naltrexone pellet implant therapy and believes that his programme 
together with the use of naltrexone has a great success rate in the rehabilitation of individuals 
dependent on various illicit substances. Participant 1 shared that he strongly believes that if it 
was not for the use of naltrexone he would not have been alive today. 
Participant 2 (Age 26): 
 Participant 2 is a 26-year-old female residing in Gauteng. She has been dependent on 
various illicit substances that include cat, LSD, ecstasy, crystal meth and heroin for the most 
of her young life. Due to her dependency on these various substances she reported that she 
believes that she had lost her sense of self. Participant 2 shared that she is motivated to take 
on life without drugs. 
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Participant 2 shared that as the years progressed with her drug dependency she started 
manipulating, stealing, lying and cheating her way through everyone and everything in order 
to feed her dependency. She became emotionless and lost most of her humanity, she lost all 
her short-term jobs, never finished university and became a streetwise drug dependent 
individual where she could not account for seven years of her life. Participant 2 relayed that 
she had attempted suicide on a number of occasions and was jailed four times. She shared 
that she had gone for rehabilitation five times in order to rid this dependent behaviour. 
However, every attempt at joining a rehabilitation centre ended up in a process of relapsing as 
soon as she was placed back in society. According to her, she had not committed to the 
recovering process due to not being in the right mindset of staying clean and being committed 
to the recovering process. She also blamed her adventurous behaviour that caused her to go 
back and make use of heroin as soon as she was discharged from rehab. She stated that she 
always looked forward to finishing rehabilitation just to be able to go back to society and start 
using again.  
 Participant 2 was made aware of the naltrexone pellet implant therapy through family 
and friends but decided that she does not want to make use of this due to the taboo around a 
‘cure’ for heroin dependency. Eventually, she became sick and tired of being sick and tired 
for chasing fixes, and thus she decided to pursue a life fulfilled with passion and success. So 
after her last arrest for the possession of heroin she decided to make the change that she was 
so passionate about. Her sister’s boyfriend told her about Participant 1 and the wonderful 
work he has done for so many people in recovering from substance dependence. This then 
caught her attention and she decided to go for the naltrexone pellet implant. She was not too 
keen on this and thought that this would be the last resort. Participant 2 recalled that after 
fifteen minutes went by after the implant was inserted she started feeling very sick. She 
recalls that it felt like a bad trip and that it is quite different from the usual withdrawals that 
she usually experienced in rehabilitation centres.  
Three days after her first implant, Participant 2 stated that she had started to feel better 
and the cravings and obsessions for heroin were gone. Although, she reported that she at 
times was still a bit shaky she felt more confident to work on her life from now on. 
Participant 2 stated that naltrexone is not a cure and that one needs to undergo some form of 
therapy in order to change the behaviour of dependency. Participant 2 relayed that she went 
for two implants and would be receiving a third implant. She concluded that she believes that 
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the third implant would help her through the recovery process and that she will be able to 
carry on with an abstinent lifestyle from there on out. 
Participant 3 (Age 30): 
Participant 3 is a 30-year-old male residing in Gauteng. Participant 3 has struggled 
with his dependency to various substances for 15 years. He was dependent on numerous 
types of substances that included CAT, cocaine, ecstasy and heroin. One particular substance 
that started to become a problem for him was the use of heroin. Participant 3 was also very 
persistent in the use of CAT and would cheat, lie and steal in order to pay for his next fix. He 
shared that he caused a lot of heartache and shame towards his friends and family and felt 
that he was cheating himself and got lost in the process. He could not keep a job and always 
seemed to look for jobs where he would not have to take on too much responsibility. He was 
mostly aiming for lower paid jobs as a representative for companies where this would allow 
him to be on the road most of the time. This allowed him to get high and even go and see 
clients when he was high. Participant 3 noticed that his use of these substances became a 
problem when his heroin use escalated from every weekend to making use of heroin 
throughout the week. 
Participant 3 was arrested for the possession for CAT and that was when he decided 
to seek help, mostly he wanted to be a better person through changing his ways. He felt like 
life was not worth living and had various suicidal thoughts but came to realise that he was 
petrified of taking his own life. After various attempts to remain clean through the attendance 
of rehabilitation centres and a constant disappointment of using as soon as he got out of 
rehabilitation, he decided that naltrexone would be worth a try. 
At first, Participant 3 was quite hesitant to making use of the naltrexone pellet 
implant. He remembered that the procedure was quite nerve-racking to have the implant 
inserted and he felt the naltrexone implant had an immediate effect on him. He remembered 
that he became a little sick the first time that he had the implant, as soon as he got home. He 
believes that the reason for becoming sick is that he has been using before he went for the 
implant as well as the belief that the naltrexone implant is pushing out the toxins from his 
body. He shared that there were times when he had thought about taking out the implant 
himself in order to make use of heroin again, however, he shared, in relation to 
detoxification, that he managed to pull through it all. 
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Ever since his first encounter with the naltrexone implant he shared that he has 
received three implants and remains abstinent up until today. He emphasised to the researcher 
that this form of therapy is not a cure and that one needs to fix oneself psychologically in 
order to remain abstinent from illicit substances such as heroin. Participant 3 believes that the 
naltrexone gave him enough energy to work on himself and to also not constantly think about 
using heroin. He also mentioned that the craving disappears which is a major factor to him 
when it comes to working on oneself on the road to recovery. Participant 3 stated that he has 
big plans for his future and that he would like to wean himself off the naltrexone in order to 
prove to himself and his counsellor that he will be able to cope without the use of naltrexone. 
Participant 4 (Age 21): 
 Participant 4 is a 21 year old male that resides in Cape Town. It should be noted that 
this participant did in fact receive the naltrexone pellet implant in the Johannesburg area and 
formed part of the therapy process, therefore making him a relevant sample for this study. He 
relayed that he was quite an anxious teenager that started experiencing panic attacks, and in 
order to stop these panic attacks from occurring he smoked cannabis in order to elevate the 
anxiety. This seemed to help him with his panic attacks and he shared that he has never since 
experienced another panic attack. However, the moment that Participant 4’s mind opened to 
what cannabis did for him he became quite curious as to what other illicit substances would 
offer him. He started making use of heroin at the age of 16 years and progressed to injecting 
heroin at a later stage. The use of heroin helped him with his psychological difficulties that 
included insecurity, vulnerability and all other emotions that he could not really deal with. 
Participant 4 mentioned that when he started injecting heroin it started taking over his life, he 
verbalised that he used drugs for three years before he attempted to remain abstinent from the 
use of heroin. He remembered that the reason for the choice of remaining clean was due to 
him stealing, lying and all the behaviour that goes with heroin dependency. 
 Participant 4 mentioned that he had “a personal relationship” with heroin and as a 
result of that there were various attempts where he tried to remain abstinent. He shared that 
he had gone to various rehabilitation centres and followed various rehabilitation programmes 
which ended up in constant relapses. Participant 4 disclosed that he was not quite ready to 
stop making use of heroin when he was placed in these programmes. There were even times 
where he made use of therapeutic substances such as suboxone, subutex and methadone. He 
mentioned that he even used when he was on this form of therapy for heroin dependency, 
moreover, he mentioned that he was even injecting methadone in order to get high. 
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Participant 4 relayed that he was taken off one substance and put on another but nothing 
seemed to work for him. He mentioned that these forms of therapy never really seemed to 
block the heroin from “getting into his system”. When making use of these substances, he 
remembered that he could even make use of heroin and he would experience the full affect 
that heroin had on him. The antagonistic therapy never seemed to stop him from making use 
of heroin. Participant 4 outlined some of the main triggers of making use of heroin were 
mainly people, places and things up till a point where he would not be able to even have 
money with him as this was a trigger to go and use. Shortly after being discharged from the 
rehabilitation centres, participant 4 started overdosing on heroin, this became a huge problem 
for him as he realised that his life was in danger. 
 Participant 4 shared that his mother was quite concerned for her son’s life and decided 
to undertake some research online, this is where she got hold of information related to the 
naltrexone pellet implant and decided to phone Participant 1 who works with individuals that 
were making use of naltrexone implant therapy. Participant 4 remembered that he heard about 
this form of therapy a few years ago, however, he remembers that he read something 
regarding naltrexone implants not being registered in South Africa. This made him quite 
hesitant to make use of this form of therapy until one of his friends decided to make use of 
this form of therapy. This was the time that he decided that he would give the naltrexone 
pellet implant a chance. 
He decided to detox before the use of the implant, he recalled that his biggest fear was 
being cut off from heroin and not being able to use, this is because he was made aware of the 
danger that awaited him if he decided to make use of heroin while on the naltrexone implant. 
Participant 4 remembered that he felt sick when the implant was inserted and had experienced 
some withdrawal symptoms just after the implant was inserted, however, he also shared that 
it was the best clean time that he has ever experienced. He recalled that all the cravings, 
obsessions and triggers that he had previously experienced with various other treatments were 
not present with the use of the naltrexone pellet implant. This was quite a different experience 
for him due to the reasons that he was not isolated from society and had the opportunity to 
face his triggers, obsessions and psychological well-being whilst in society.  
 Participant 4 shared that he had made use of three naltrexone implants and is now 
making use of naltrexone tablets as a form of weaning himself of the naltrexone. Counselling 
played an important part in the recovery process for him, as he believes that naltrexone is not 
a cure but rather the crutches that one needs in order to learn to walk again, therefore, he 
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attends counselling sessions with Participant 1 every day for 15 min via telephonic 
conversation in order to remain abstinent from the use of heroin.  
Furthermore, Participant 4 did in fact make use of heroin while he was on the 
naltrexone pellet implant therapy, yet to his surprise the heroin had no effect on him at all and 
that was when he decided that it was not worth wasting time to try and use again due to the 
fact no effect was evident when he attempted to use. He felt that he still needs to make use of 
the tablets until he is ready to function without the use of naltrexone, moreover, he mentioned 
that it is a more cost-effective alternative to the pellet implant. Participant 4 shared that he 
believes that he would not be clean today if it was not for the naltrexone pellet implant 
therapy.  
4.6 Presentation of the Findings 
 Below is a table that summarises the superordinate and subordinate themes that 
emerged from the analysis of the transcripts in this particular study. In addition to the titles of 
the themes produced, a representative extract that illustrates each superordinate theme and 
subordinate theme is provided. This is followed by an individual discussion of each 
superordinate and subordinate theme. 
Table 4.1: Superordinate themes and Subordinate themes emerged from the transcripts 
Superordinate themes Subordinate themes 
4.7.1) Life before the use of the 
naltrexone pellet implant. 
4.7.1.1) No one starts off making use of heroin. 
4.7.1.2) Involved in criminal activities in order to feed 
dependency. 
4.7.1.3) Numerous attempts in remaining abstinent. 
4.7.1.4) Heroin use as a way of living. 
4.7.1.5) Admitted to rehab against one’s own free 
will. 
4.7.1.6) Rehabilitation centers deemed ineffective. 
4.7.1.7) Tempted to use after being released from 
rehab 
4.7.1.8) Used prescribed agonist medication to get 
high. 
4.7.2) Giving naltrexone a chance 4.7.2.1) The will to remain abstinent. 
4.7.2.2) Initial thoughts about the naltrexone implant. 
4.7.2.3) The decision to make use of the naltrexone 
implant. 
4.7.2.4) Fear of receiving the naltrexone implant. 
4.7.3) Physical experiences of the 
use of the naltrexone pellet 
implant 
4.7.3.1) Detox and withdrawal before receiving the 
naltrexone implant. 
4.7.3.2) Experiencing anxiety in the doctor’s office. 
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4.7.3.3) Getting sick after the naltrexone implant was 
inserted. 
4.7.4) Naltrexone pellet implant as 
an aid for relapse prevention 
4.7.4.1) Naltrexone as an aid and not a miracle cure. 
4.7.4.2) People, places and things as a trigger. 
4.7.4.3) Naltrexone increases self-efficacy. 
4.7.4.4) Naltrexone decreases cravings and 
obsessions. 
4.7.4.5) Using or thinking of using while on the 
naltrexone pellet implant. 
4.7.4.6) Ceasing the use of naltrexone. 
4.7.5) Psychological aspects 
related to the use of the 
naltrexone pellet implant 
4.7.5.1) Recovery with naltrexone in society. 
4.7.5.2) Counselling is necessary when on naltrexone. 
4.7.5.3) Dealing with high-risk situations when on the 
naltrexone pellet implant. 
 
4.7 Discussion of the Themes Emerging from the Data 
 As previously mentioned, the aim of this study was to explore participants’ subjective 
experiences regarding the use of naltrexone pellet implant maintenance therapy in relation to 
relapse prevention from heroin dependency. To this end, both the superordinate and 
subordinate themes that transpired during the analysis will be presented and discussed in 
relation to theory and literature contextually related to the purpose of this study. 
It is important to note that these themes are in fact interrelated and should be seen as a 
whole. As such the table of superordinate and subordinate themes was developed to serve the 
reader with an organising format of the information gained by the participants. These themes 
are interrelated and should not be viewed in isolation as this serves the holistic experience of 
the individuals making use of naltrexone pellet implant as an aid for relapse prevention to the 
use of heroin. 
This data analysis process consisted out of three phases. The initial phase consisted of 
the familiarisation of the data by means of spending time thoroughly listening to the audio-
recordings for the researcher to immerse himself with the data. The next phase consisted of 
thoroughly reading through the verbatim transcribed data. During this process the researcher 
took note of potential subordinate themes that may contribute to informing the whole of the 
analysis process. The researcher created a codebook in order to explore and describe the 
potential subordinate themes. The codebook enabled the researcher to search for meaning in 
the data from the participants while they were in the process of making meaning of their own 
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reality during the interviewing process. Once this phase was completed, the researcher 
revisited the transcripts in order to finalise the analysis of the transcripts. 
4.7.1 Life before the use of the naltrexone pellet implant 
 This superordinate theme was constructed from the eight subordinate themes listed in 
the first section in table 4.1 above. Central to this superordinate theme are the life situations 
and experiences that the participants found themselves in before being introduced to the 
naltrexone pellet implant as a form of aid to relapse prevention. The researcher found it 
important to explore the historical view regarding the participant’s experience to heroin use 
and dependence, this includes life experiences related to the use and dependency of 
substances, specifically, the use of heroin and the different factors related to the historical 
perspective from the participant’s interpretation. Moreover, the researcher was interested in 
inquiring information regarding the will to remain abstinent and the different modalities 
linked to these situations that might link to the reason for making use of the naltrexone pellet 
implant as an alternative method in order to remain abstinent. This section discusses the 
subjective experiences that these individuals had to undergo before being aware of the 
naltrexone pellet implant, furthermore, including the life trajectories that these individuals 
followed when making use of heroin before seeking treatment. 
4.7.1.1 No one starts off making use of heroin 
Amongst various substance dependent individuals it can be found that they started 
making use of a certain substance that was not quite as potent and addictive as the use of 
heroin. This code refers to the instances where the participants refer to a period in time when 
they started experimenting with a substance or substances. These substances might include a 
less addictive or potent kind of substance such as cannabis or alcohol. This subordinate theme 
refers to the participants relating back to the times when they initially started making use of 
substances for recreational purposes. It usually consisted of a time where they remember that 
those were the days where they were not completely dependent on various substances as they 
are now. In some sense, they believed that they had some sense of control of the substances 
that they experimented with. Furthermore, in this sense heroin is seen as the more ‘potent’ 
sort of substance that poses a more dependent nature as compared to other substances such as 
cannabis and alcohol (not disputing the fact that both these substances have dependent 
properties). Evident in these participants’ statements is a sense of the dependency which can 
be referred to as a disease model of dependency. This relates to various debates regarding 
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dependency as a chronic relapsing brain disease whereby the human brain reward system can 
be seen as being ‘high-jacked’ through the use of various illicit substances (Darke, 2011). In 
this sense the hope exists that reducing stigmatisation and self-blame will reduce social 
barriers treatment seeking. Critics of this model argue that it will fail to deliver benefits and 
could possibly create more negative consequences for the dependent individual in that it 
might absolve personal responsibility for drug use (Meurk, Carter, Partridge, Lucke, & Hall, 
2014). This might be associated with the stigma regarding heroin that tends to be fueled by 
public disclaimers such as the media. In this sense, it is believed and portrayed that a heroin 
dependent individual is more frowned upon than individuals who are dependent on alcohol 
for instance. Heroin is seen as the dead-end road in this sense. One participant indicated the 
following: 
P1: "…Was very simple, I grew up starting like the normal kid, but, started smoking dagga 
when I was like eleven, twelve years old. But the thing is the disease of addiction and the 
ways I have seen it today, and what I preach to my clients, it’s progressive and it was… it’s 
shown within me and within everybody that I believe is an addict." 
 He indicated that he did not start off making use of heroin at first and referred back to 
a time where he started off like the normal child who then veered into experimenting with 
dagga between the ages of eleven and twelve years of age. He interpreted the use of 
substances as a progressive lifestyle where one would not cease the curiosity of 
experimentation. He referred to dependency as a disease in which case is should be seen as 
other diseases requiring regular treatment, something that one cannot get rid of easily and that 
should be treated. The participant referred to himself as an example of this disease of 
dependence indicating that he had experienced, within himself, and others that tend to 
experiment with illicit substances is however progressive and could possibly turn out to be 
problematic and become a progressive disease which is associated with a vicious cycle of 
substance abuse. A similar case can be found within the next participant’s experiences: 
P2: "Ok, uhm… well, basically I started like any other person just using simple substances: 
alcohol, weed, and, my worst enemy started becoming CAT and crystal meth. By the age of 
twenty one I was a full-blown crystal meth addict, and, then obviously you start searching for 
more. With friends I started chasing the dragon, that is called smoking heroin." 
As with P1, P2 also experienced a similar instance, whereby, she shared that she 
started off her drug use by making use of “simple substances” such as alcohol and cannabis. 
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However, she indicated that her experimentation with substances progressed to the use of 
crystal meth. Crystal meth can be viewed in this instance as a more potent substance when 
compared to alcohol or cannabis. She indicated that by the age of twenty years she found 
herself dependent on crystal meth. For her the road to experimentation did not cease with the 
use of alcohol and cannabis but rather progressed to crystal meth, she indicated that she did 
however start searching for more whereby the experimentation of various substances led to 
the use of heroin. She referred to the smoking of heroin as “chasing the dragon” which is a 
common term used for this particular method of heroin use. It furthermore refers to the 
euphoria experienced by the participant when making use of heroin (Iversen et al., 2009). She 
particularly stated that she started smoking heroin, which at that time was not seen as a big of 
a deal. However, this participant continued with the next statement: 
P2: "Eventually, I started injecting heroin, but, not at a hectic amount. Obviously, I started 
stealing, I started staying away from my house, I was missing my mom and them… I got 
arrested four times… basically, I was lost, I never came home." 
 The progression of substance use - in particular the use of heroin - progresses to the 
point where the smoking of heroin no longer induces a similar euphoric effect as with the 
initial use of this substance. This leads to the use of a more potent format of ingestion such as 
injecting heroin in order to experience the euphoric effect. This also relates to the tolerance in 
heroin whereby dependent individuals build a tolerance to the use of heroin and would 
require an increase of the amount of the substance that leads to excessive use and then 
eventually becomes dependent on heroin. According to Griffiths et al. (1994), the transition 
from smoking to injecting of heroin is not so common as it would be their second choice of 
administration whereby heroin users tend to stop or make use of another substance before 
moving to the use of a needle as a form of administration. However, it is evident in the 
interpretation of this participant that she did in fact transition from smoking to injecting as a 
form of administration. Associated with the dependency to heroin in this manner as described 
by P2 is the relationship with stealing, lying and being reported missing. She indicated that 
she would steal and lie which is a common factor among individuals that abuse substances 
such as heroin. This is related to the constant need for the substances and the affordability 
thereof which becomes problematic, this is directly related to the lying factor associated with 
substance dependence in a sense that she had to lie in order to use (Darke, 2011). She also 
indicated that she has been arrested four times during the use of heroin which is related to the 
substances being illegal and the stealing factor to feed her dependency. A similar case 
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regarding the degrading social factors and increased use of substances related to the use and 
dependence to heroin is also evident in P3 responses: 
P3: "I started smoking dope around standard six and seven; standard eight I started taking 
pills every now and then, going to a rave or two with my buddies once a month maybe, then 
I… round about standard nine or matric… once or twice… around there I snorted with okes 
(male friends)..." 
As found evident in the previous participants (P1 and P2), P3 also started making use 
of “dope”, which refers to cannabis, in early adolescence. He further explained that by 
middle adolescence he had started experimenting with other forms of substances such as pills 
in which his case specifically refers to ecstasy. It is known that the rave culture is related to 
the use of ecstasy. Furthermore, P3 attended raves with some of his friends. He also indicated 
that as he got older, around the age of seventeen and eighteen, he started to snort heroin with 
some of his friends. This was the starting point of the use of heroin for this particular 
participant. The following statement was followed by Participant 3: 
P3: "I stopped fucking gyming, and this is when the heroin started, I mean. For the last two 
and a half to three years, heroin has been the problem, so for the past ten years, or so. CAT 
was an on-and-off issue, nothing more serious than that. I think I tried heroin once or twice 
then but up until about three, maybe three and a half to four years ago, uuhm, heroin was an 
experiment that got out of hand." 
 Participant 3 indicated that his life started to deteriorate in a sense that his daily 
activities started to take a toll. He specifically indicated that he stopped being active, which 
was an important aspect to his life, in order to stay in shape due to becoming dependent on 
heroin. It was only then that he started noticing that the use of heroin became problematic. 
Participant 3 indicated that he had made use of CAT as well during the days that he was 
experimenting with various substances, however he indicated that it was an “on-and-off 
issue”. He further indicated that it became nothing more serious than that, this refers to the 
use of CAT on specific occasions; this is related to making use of this substance when he was 
around friends, partying or even only making use of CAT on weekends when he was going to 
a rave. However, he did mention that it was an “on-and-off issue” which indicates that he did 
find the use of CAT also problematic. This particular instance can be referred to as 
polysubstance use and is quite common among heroin dependent individuals (Branson, 
Clemmey, Harrell, Subramaniam, & Fishman, 2012). It should be noted that the researcher 
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became aware of this instance of polysubstance use during the interviewing process of 
participants and noted that the vast majority of the participants in this particular study 
indicated polysubstance use, however, the focus of this study was to concentrate on the use of 
heroin, specifically, as the main problematic substance of use. Furthermore, Participant 3 
indicated that the experimentation with heroin is something that got out of hand, this may be 
due to the fundamental addictive properties related to the use of heroin. This indicated that 
the participant noted himself that his excessive use of heroin had become a problem that 
needed to be dealt with. The next participant has a different interpretation of the use of 
various substances that led to his decision to make use of heroin at the end: 
P4: "Ok, well, it started as like, you know, uhm, I’m going to go back a little bit more to why 
I started smoking weed. I had, I use to get panic attacks like anxiety attacks and then, when I 
started smoking weed I haven’t had another anxiety attack since then, so in that moment 
when I realised that the weed had cured my anxiety, my mind opened up to what other street 
drugs could help me with certain things that I’m not happy with about myself. So when it 
came to heroin, it was more like insecurity, vulnerability, I’m a very sensitive person so also 
my emotions, all those things that I didn’t like about myself, I thought heroin would cut off for 
me. And, so, that’s why I started with the heroin, and it, it works, it cut my emotions off. So 
that would be the reason why, and then also it just felt better than anything I’d ever done. So 
that was also a huge driving force” 
As found with all the other participants, who had started off making use of substances 
such as alcohol, cannabis and CAT, Participant 4 had a similar experience in the sense that he 
too started off making use of cannabis. For Participant 4, the use of cannabis was a form of 
self-medication for his panic attacks and anxiety, he indicated that when he made use of 
cannabis it took away his anxiety and panic attacks which provided a sense of relief to the 
psychological difficulties that he was facing at a young age. This self-medicating behaviour 
opened up a world of opportunity in dealing with psychological factors that was threatening 
his well-being. These opportunities were the use of other illicit substances in order for him to 
deal with daily problems that he had to face. Participant 4 indicated that he is quite a sensitive 
and emotional individual that feels vulnerable and insecure about many things in his life, so 
he shared that the use of substances aided him in dealing with these insecurities. He indicated 
that the use of heroin assisted him to “cut off” the things that he did not like about himself, 
this led to the driving force for him to make use of heroin, where he would be able to feel 
good about all of these difficulties that he had to face. He, furthermore, indicated that it did in 
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fact help with these insecurities and that it “felt better than anything I’d ever done”, which 
can be related to the euphoric effect that is created when an individual consumes heroin. So 
for Participant 4 it was the anxiety that he had attempted to rid himself of through means of 
self-medicating with illicit substances. 
Through reviewing various resources linked to this particular subordinate theme it 
came to the researcher’s mind that heroin dependent individuals have a history in making use 
of various other substances before they end up dependent on a particular substance. Not 
ignoring the fact that there are few individuals that do start off making use of heroin as their 
drug of choice, however this depends on various factors that include the availability and 
environmental factors. Different participants have different reasons for making use of a 
particular substance when they started off experimenting with illicit substances. In this case it 
seems that the more relevant substance that the participant started making use of is cannabis, 
where in this sense can be viewed as a gateway drug for these participants. Moreover, for this 
particular sample of individuals it can be seen that they did not start off making use of heroin 
but underwent a form of experimentation before ending up being dependent on heroin 
specifically. 
4.7.1.2 Involved in criminal activities in order to feed dependency 
 This refers to the participant partaking in any form of criminal activity that is 
associated with the use and dependency on heroin. They do so in order to pay for their next 
fix of heroin or other substances. This might include lying, cheating and stealing from loved 
ones, family and others in society in order to gain some form of currency such as stealing a 
phone in order to sell and pay for the next fix. Lying to others in order to receive money for 
the next fix, cheating others in order to gain some form of currency in order to pay for the 
next fix. Due to the lifecycle of heroin dependency the feeding part of this code refers to them 
actually needing this substance to feed a lifestyle of dependency. Participant 2 indicated the 
following: 
P2: " Eventually, I started injecting heroin but not at a hectic amount. Obviously I started 
stealing, I started staying away from my house, I was missing my mom and them… I got 
arrested four times… basically I was lost, I never came home."  
 She indicated that she got to a point of experimenting with heroin where she had to 
make use of injecting heroin in order to feel a greater effect of the use of heroin due to 
tolerance. This led her to get involved with criminal activities such as stealing in order to feed 
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her dependent behaviour. Heroin use can become costly as the dependent behaviour 
progresses through tolerance, therefore the individual needs to find some way for paying for 
the next larger fix. For Participant 2, she did indicate that she started stealing and staying 
away from home and went missing for some time. This can be due to the need for the next fix 
derailing her from the norm of returning home after using, whereby she would go on a heroin 
binge and be missing for a few days at hand prior to returning home. During this process of 
stealing from family members, her parents started to become concerned as well as frustrated 
as their possessions went missing from home whereby they called law enforcement in order 
to find their daughter for both the concern of her safety as well as theft that took place in 
order to feed her dependency. A similar case can be found in what Participant 3 indicated: 
P3: " …  that DVD shelf, both of those shelfs are full of DVD’s, they’ve been full and 
replaced about eight times, I think my mom bought the same movie eight times, one specific 
movie that she likes, eight times! I kept on selling the fucking things. I would see the phone 
and think money for drugs." 
 Participant 3 indicated that he kept selling his mother’s DVD’s in order to buy his 
supply for the next fix. He referred to the shelf with an enormous amount of DVD’s and 
indicted that it had to be replaced a number of times. DVD’s can be sold very quickly for a 
minimal amount of cash at a local pawn shop, in which case Participant 3 did. He referred to 
a cellphone lying on a table whereby he could sell in order to buy his next heroin fix. He 
became obsessed with finding items at home to sell in order to buy his supply of heroin. In a 
similar case: 
P4: "It became too much of a problem in my life, the stealing, the lying, the, you know, all the 
behaviour that goes with addiction started to get a bit too much…" 
 Participant 4 noticed that his problem with stealing, lying and the behaviour that is 
related to the use and dependency to heroin became too much for him. This type of behaviour 
was noted by each participant. For some participants it became a necessity in order to feed 
the dependency and they slowly noticed that this was becoming a behavioural problem that 
they needed to deal with once they got caught. This indicated that they realise that this 
particular behaviour became problematic only when they got arrested by police. 
4.7.1.3 Numerous attempts in remaining abstinent 
 This refers to the individual attempting to remain abstinent in their lifetime, this 
particular subordinate theme involves the attempt to remaining abstinent through trying to 
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just remain clean without the help of others. This also refers to attempts of remaining 
abstinent through making use of rehabilitations centers or drug therapies, as they came to 
realisation that their problematic behaviour had to be dealt with. This problematic behaviour 
interfered with their daily functioning and negatively impacted their relationships with 
family, friends and people close to them. Moreover, it refers to the individual continuously 
attempting to remain abstinent and their initial failures in attempting to do so. The attempt to 
remain abstinent incorporates many factors that include effective coping strategies, the will to 
remain abstinent, strong or high self-efficacy in order to face a high-risk situation related to 
substances use. It might be that for some of these individuals at the time of use did not 
possess these characteristics in order to remain abstinent from the use of heroin. This 
particular subordinate theme can be viewed in what Participant 1 indicated: 
P1: "Before the implant, I went to 29 rehabilitation centres. I was in prison 10 times. I 
overdosed seven times. My girlfriend died in bed next to me. I remember people say you 
know, in that state you think you love the person that you are with, you know." 
 Participant 1 indicated that before he had made use of the naltrexone pellet implant, 
he was in and out of rehabilitation centres which indicated numerous failed attempts in 
remaining abstinent from the use of heroin. He also indicates that he went to prison for 
criminal behaviour due to attempting to finance his dependency to heroin. Participant 1 
recalled that he overdosed seven times from the use of heroin which is usually related to the 
factor of a high tolerance pre-rehabilitation. Short of being released from rehabilitation 
centres Participant 1 tried to make use of the same amount than he had used before being 
admitted to rehabilitation, which in return caused the overdoses due to the body’s inability to 
consume a vast amount of heroin after detoxification. Participant 1 indicated a particular 
traumatic incident where his girlfriend had died next to him in bed after the both of them 
made use of heroin. This was a fatal overdose incident that he remembered and regrets to this 
day. He further mentioned: 
P1: "So did I try? Jis, 29 rehabs, probably the first 10 rehabs I’d say I’ve tried to learn how 
to use successfully, you know, and I was in a lot of denial and all that…" 
It was evident that Participant 1 had various attempts in remaining abstinent whereby 
he was in and out of twenty nine rehabilitation programmes, for him in particular, the first ten 
attempts of remaining abstinent with the assistance of rehabilitation programmes he has tried 
to use as effectively as possible. He found that he was in significant denial regarding his use 
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of heroin. This is also related to the abstinence violation effect as discussed by Marlatt and 
Gordon (1985a), in that attitudes or beliefs about the causes and meaning of a lapse (initial 
use of a substance after remaining abstinent) may influence whether a full relapse ensues. 
Viewing a lapse as a personal failure may lead to feelings of guilt and abandonment of the 
behaviour change goal. Therefore, in his case this may have led to the various failures in 
remaining abstinent from the use of heroin. A similar instance occurred with Participant 3: 
P3: "I tried to get off of it for about two months, for two months straight I did not touch 
heroin. It was all over the first two weeks when I was at home and snorted a shit load of 
whatever else I could find, but I made sure that I stayed off of heroin for two months. And, 
then I got arrested, and when I got out of those two days in jail I smashed heroin again and 
then for that weekend I was fucked." 
Here Participant 3 attempted to remain abstinent from the use of heroin, however, he 
found himself making use other illicit substances while attempting to avoid the use of heroin 
specifically. He found that heroin was becoming very problematic in the sense that he was 
becoming aware that heroin was having a significant impact on his daily life. He also became 
aware of the dependent components related to the use of heroin and had attempted to detox 
and remain abstinent from it. Following his attempt to remain abstinent, he went to jail for the 
possession of illicit substances, and after the two days that he spent in jail he was making use 
of heroin again. Just before any attempt to remain abstinent, Participant 3 indicated that: 
P3: "You know, if I know that I am going to stop tomorrow I am going to get fucking high, 
but, I never had that fucking high the day that I got caught so I ended up just having that 
mediocre high and that is not a way to go out. I wanted that proper high, and, eventually, it 
will get to you and you will go and use again.” 
At the stage where Participant 3 felt that he would want to remain abstinent from the 
use of heroin, he would always want to get a last good high. However, to his disappointment 
of attempting this he finds that he never quite met that high that he was searching for and 
ended up in disappointment. Therefore, this disappointment that Participant 3 experienced led 
him to attempt using again in order to find that last fix that will satisfy his craving to the 
particular high, whereby, he would then be in a position to stop making use of heroin and 
remain abstinent. For him this would be the ultimate way to stop, however he kept finding 
himself searching for that last good high before ceasing the use of heroin. 
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4.7.1.4 Heroin use as a way of living 
 This particular subordinate theme refers to the use of heroin as a way of living, when 
it becomes part of the individual’s daily life whereby they tend to develop an attachment to 
the illicit substance. This creates a cycle of use wherein the individual cannot cope without 
the use of heroin due to tolerance and the constant need for this substance. This code refers to 
the way that the individual creates their own world around the use of heroin, the effect that 
heroin has on the individual’s daily life and how they have to deal with this illicit substance 
as a daily part of their life. Participant 1 indicated: 
P1: "This is because we all know that it is one of the most difficult drugs to get off of and it’s 
physical and it’s this and that. But, it was due to the uppers, the crack, the cocaine and all 
that because of the comedowns…" 
He indicated that heroin was one of the most difficult illicit substances to terminate 
usage of, which related to the difficulty of remaining abstinent from heroin due to its 
chemical dependent properties. Participant 1, furthermore stated that heroin use and 
withdrawal it is quite physical which relates to the neurobiological factors pertaining to 
heroin and its euphoric properties, this tends to be very rewarding due to the properties of 
heroin playing a significant role in the limbic system that is linked to the pleasure and reward 
system of the human body (Gottås et al., 2013). This also relates to the build-up of tolerance 
as well as the excessive need to make use of this substance in order to both remain 
functioning as well as avoiding withdrawals from occurring (National Institutes of Health, 
2014). Therefore, his indication of heroin being a very difficult substance to remain abstinent 
from makes sense when referring to the physiological component of the use of heroin upon 
the individual. Participant 1 indicated that the use of heroin was also related to the use of 
“uppers” (polysubstance use) as indicated previously, where he would make use of heroin 
just to ease the use of these uppers such as crack and cocaine. The use of heroin would tend 
to ease the “comedowns” of the uppers that he made use of, and it is at this particular 
moment that the heroin started to take over. These comedowns refers to the excessive use of 
stimulant-type illicit substances to a point where the body would not have time for recovery 
or where the individual tends to stay awake for days at end. The upper then starts to wear off 
and the individual experiences a form of withdrawal which is usually coupled with 
uncomfortable psychological experiences such as fear and anxiety (American Psychiatric 
Association, 2013). In order for Participant 1 to have dealt with these factors related to the 
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comedowns he made use of heroin in order to numb himself to these discomforting 
experiences, which is related to his next statement: 
P1: " So, yes, that is how I got on to heroin, and then the way that I felt on heroin… it just 
numbs you completely… there is no pain, not even emotional pain, there is no physical pain, 
no emotional pain… nothing. And, so I wouldn’t use any drug without heroin..." 
He referred to his problematic dependency to heroin as a result of the uppers that he 
made use of. In this sense he numbed himself from the comedowns of the uppers, however, 
Participant 1also indicated that it numbed him completely in the sense that he experienced no 
physical or psychological pain when making use of heroin. He furthermore discussed that he 
would not make use of any other substance without having to make use of heroin as well for 
the fear of comedowns of the upper drugs. This turned into a vicious circle of illicit 
polysubstance use for Participant 1 in particular. This leads to the next indication: 
P1: "But over time it became a way of life, it became a necessity. I wouldn’t really have to 
have a trigger, it was just what I did. Heroin and crack was the…heroin was basically my 
life, it was my partner and I wouldn’t go anywhere without it because I couldn’t live without 
it. I couldn’t exist without the heroin, I just couldn’t." 
This is where heroin became a part of Participant 1’s life, where he needed to make 
use of heroin as a necessity, he would have to make use of heroin just to be able to function 
properly. There was no form of trigger or craving but rather a daily routine that he needed to 
live through just to feel normal. He formed a bond with these particular substances, being 
afraid of letting go of his “partner” in that he would take these substances with him 
everywhere he went. This became a way of living for Participant 1, whereby, he indicated 
that he would not be able to imagine a life without these substances. A different perspective 
to can be seen in Participant 2: 
P2: "Uhmm… Basically it made me feel nothing, I stopped growing as… you stop growing 
emotionally because you don’t feel emotions, you don’t care about feeling emotions on 
everything that you do. Doesn’t matter if it is sex, doesn’t matter if it is like stealing, doesn’t 
matter if it is your mother or your father…you just don’t give a fuck. Okay, you just don’t 
give a damn, it makes you feel… well, basically when I used heroin it was the best feeling 
ever, you just feel relaxed, you just feel like… you just… you are not on this earth, you just 
uhmm… it makes you feel like a superstar basically.” 
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For Participant 2, the use of heroin was ceasing her growth potential in the sense that 
that she did mention that she stopped growing emotionally due to the numbing effect that 
heroin had on her. She stopped caring about various life aspects and individuals involved in 
her life. She became numb towards her parents, the fact that she was stealing and even the 
basic pleasures of life. All that she cared about was the feeling that heroin gave her in the 
end, not caring about anything other than the use of heroin which created her own care-free 
world that made her feel like a superstar. This non-caring mindset together with the use of 
heroin created her own care-free world where she was free of all the real world troubles. This 
brings us to a similar experience in the next statement: 
P4: "It’s almost like being in your own little self-designed world that’s comfortable and just 
right. I mean it’s completely fake and it’s not the real world but it’s still nonetheless, it’s a 
nice comfortable place to be in while you’re in that kind of denial, it’s complete denial... " 
Participant 4 found himself in his own little self-designed world when making use of 
heroin, it became his way of living where everything was just right and comfortable. He 
indicated that this self-created world was manufactured, but nonetheless was real to him in 
not having to deal with real world problems. He was in complete denial, however, it was a 
world where he felt painless and comfortable.  
4.7.1.5 Admitted to rehab against one’s own free will 
 This subordinate theme refers to the individual being admitted to some form of 
recovery against their own free will. This relates to them having to attend a recovery 
programme or attending a closed facility for period of time out of society in order to detox 
and recover so as to remain abstinent to the use of illicit substances such as heroin. This 
particular admission against their own free will was encouraged by either a friend, family 
member, employer or the state that have forced them to attend whereby there were some form 
of consequence involved if they did not attend. These consequences incorporates the loss of 
some form of stability such as a job, place to stay or they were ordered by court to attend 
rehabilitation in order to avoid some form of punishment or to avoid jail time. Often the felt 
coercion causes individuals to not fully commit to their process of attempting to remain 
abstinent because it was not of their own free will to decide to remain abstinent. They might 
not have been in the process of making the decision to remain abstinent, one needs to be 
willing to remain abstinent before attempting to stay clean from the use of illicit substances 
such as heroin (Larimer et al., 1999). 
95 
 
P1: "… the first two or three rehabs, I was there because of getting into crap. You know 
losing my stuff, I was going to lose my work or lose this. So I wasn’t there for the right 
reasons, I didn’t really want to stop, I just wanted the consequences to go away. So, it was 
never going to work, but I’ll tell you from about the fourth and fifth rehab up until my 29th 
rehab I did want it." 
Participant 1 indicated that in his first two or three attempts at rehabilitation where he 
was admitted for getting into trouble with the use of illicit substances, specifically the 
possession of heroin and being under the influence when at work or staying away from work 
due to the excessive use of heroin. He indicated that he was there for the wrong reason, this 
being not to remain abstinent out of his own free will but rather the fact that he was going to 
lose his job and the form of income that supported his lifestyle. He indicated that he went to 
rehabilitation in order for the consequences to his actions to dissipate, rather than having the 
will to remain abstinent. Participant 1 indicated that although during his fifth up until his 
twenty ninth attempt at of rehabilitation he really did want to remain abstinent, instead, he 
found himself continuously relapsing. Still he found that even when he was attempting to 
remain abstinent out of his own free will he was not able to do so, thus indicating that the 
rehabilitation programmes that he was attending did not seem to work for him in remaining 
abstinent from the use of heroin. Participant 2 recalled a similar situation: 
P2: "…the first two rehabs there was only like twenty one days you know… that doesn’t 
really work. I just went there because you know my mom and them said, ”Okay, well, is there 
a problem?” and, I said, “No, I will go just to get clean you know and whatever. You have to 
have the right mindset, every time I got out of that rehab… obviously, I wasn’t in the right 
mindset. The last time when I went to Noupoort for a year and a half, which is just like boot 
camp basically, so uhmm… I didn’t really want to go, that is why I relapsed." 
 Here it can be seen that she also indicated that her first two attempts of rehabilitation 
programmes of in-patient treatment of a total amount of twenty one days did not seem to 
work for Participant 2. She also recalled that she did agree to partake in the rehabilitation 
programme purely because her parents wanted her to remain abstinent as they felt that her 
behaviour was problematic. She did however agree to attend in order to get clean, however 
her intentions to remain abstinent were not clear at that moment of being admitted. She 
further indicated that one has to have the right mindset in order for a rehabilitation 
programme to have an effect on an individual. Participant 2 also indicated that she was not in 
the right mindset to be committed to her own sobriety. She did so to keep her parents’ mind 
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at ease and to have the consequences dissipate. She recalled that every time she was released 
from a rehabilitation programme that she tended to relapse due to the admission against her 
own free will. According to Participant 2, one has to have the right mindset in order to fully 
recover from dependency. A similar case was found in Participant 4: 
P4: "Yes, yes I went to quite a few, I followed programmes, I wasn’t, I wouldn’t say that I 
was prepared to stop using though. So the rehabs didn’t work for me, coz, I was just, I was 
just going through the motions. I wasn’t actually prepared to stop using." 
Participant 4 indicated that the various times that he attended rehabilitation 
programmes he too was not prepared to stop the use of heroin because he did not want to at 
that moment in time. He was also not in the right mind-set as found with Participant 1 and 2. 
Participant 4 also indicated that rehabilitation programmes was not quite effective in his 
recovery process, as he indicated that he was just going through the motions knowing that as 
soon as he is discharged from the programme that he will go back to the use of heroin.  
4.7.1.6 Rehabilitation centres deemed ineffective 
 Following is a subordinate theme that refers forms an indication of the participant’s 
reality that rehabilitation centers are ineffective to the attempt of them remaining abstinent. 
The reason for it being ineffective ranges from being admitted against their own free will by 
loved ones, work, law or any matter that relates to them to remain abstinent that might have 
consequences if they make the decision to lapse or relapse from their abstinence. This 
furthermore includes  their reasons regarding an ineffective system of treatment that might 
not be to their preference of recovering where for each and every individual tend to find 
different was of remaining abstinent “for each his own” and that they find this form of 
recovery ineffective. From the interpretation of Participant 1: 
P1: "Because you know what I believe rehabs do nowadays is you are buying time, that’s 
what it is to me… I mean my family and I spent hundreds of thousands on rehabs okay, and it 
wasn’t that I did not want it, I wanted it… so badly…. Every other person that I know of that 
went to rehab suffer, everyone went back after they went to rehab, every single one. Not 
one… ever stayed clean after a rehab… not one." 
It can be seen that he had the belief that rehabilitations tend to buy time in order to get 
money out of people, for him it seems to be a money-making scheme from people that really 
need the help. He further mentioned that he and his family had spent a large sum of money on 
him to be able to recover from the use of heroin and to remain abstinent. However, going in 
97 
 
and out of rehabilitation centres seemed to be ineffective for Participant 1. He furthermore 
mentioned that he was aware of many other individuals attempting to remain abstinent from 
the use of various illicit substances and as soon as they were released from rehabilitation 
went back to making use of substances. Participant 1 made quite a statement in mentioning 
that he believes that every single individual he knows that attempted to remain abstinent 
through the use of rehabilitation programmes has failed to remain abstinent to the use of 
illicit substances such as heroin. Participant 1 further mentioned the reasons for his not being 
able to remain abstinent from the use of heroin: 
P1: “But, probably, the past five years of rehabs and prison I did want to stop okay, but the 
problem with that was that I found rehabs non-effective at all, why?, because it took me out 
of society, I felt so good where I was, I felt confident, I felt that." 
He found that the past five years going in and getting out of rehabilitation centres and 
the inability to get hold of heroin in prison he did want to remain abstinent. However he 
noticed that ever time that he felt the need to remain abstinent it was due to the reason that he 
was isolated from society and all the high-risk situations to relapsing were taken away due to 
this isolation from society. This made him feel overconfident in remaining abstinent by the 
elimination or minimising of high-risk situations in an isolated environment. A basic 
assumption as mentioned by Marlatt and Gordon (1985) is that relapse events are 
immediately preceded by a high-risk situation, broadly defined, as any context that confers 
vulnerability for engaging in the target behaviour. This process of going in and out of 
rehabilitations without any success of remaining abstinent can also be found in Participant 3’s 
case: 
P3: "So every six months or so or a year, I would restart my life. Get a good job and start off, 
have two months of clean. Like if one stupid thing would happen in my life and I would blame 
the drugs for it or blame myself and I would go back to the drugs." 
Participant 3 mentioned that he would attempt to remain abstinent and after six 
months of remaining abstinent he would find himself making use of heroin after a particular 
negative incident that had occurred. This can also be explained by the high-risk situations that 
individuals are faced with when they are not isolated from society such as outpatient 
rehabilitation programmes.  
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4.7.1.7 Tempted to use after being released from rehab 
 The following subordinate theme refers to the temptation of using substances shortly 
after a dependent individual is released back into society. Rehabilitation centers tend to 
segregate individuals from society so as limit them from getting hold of substances. It is an 
enclosed environment that has very strict rules and time schedules that need to be followed 
where the individuals are expected to participate in certain sessions that might include 
individual therapy, group therapy, team-building activities. This schedule allows for control 
and routine to be implemented into the individual’s life. The enclosed environment results in 
assisting the individual from remaining abstinent from substance use and dependency due to 
the limitation of exposure to high-risk situations and the inability to make use of substances 
when faced with high-risk situations (Hendershot et al., 2011). However, when individuals 
are discharged from closed institutions it breaks the barriers and limitations to the use of 
illicit substances, the individual are then tempted to make use of illicit substances due to 
being faced with real-life stressors. Due to the absence of a forced routine and the previously 
unavailable substances now being available when the individual is situated in the 
environment that they were when they were dependent to the substance increases the 
exposure to high-risk situations. This in return makes it very tempting for the individual to 
make use of the substance that they once were dependent on due to a lack of an effective 
coping response that is now stripped from them when discharged from the rehabilitation 
centre (Hendershot et al., 2011). Participant 1 recalled one particular incident regarding the 
temptation to use shortly after being released from rehabilitation: 
P1: "I remember I went to one rehab in Oxwalk for nine months and I think two days after I 
got out I was back on the stuff. Because life hit me again, all the temptations hit me, for nine 
months I was prevented from all of this, ok." 
 He remembered that after being admitted to a rehabilitation programme that required 
him to be isolated from society for nine months in order to succeed in the rehabilitation 
programme. Even being abstinent from the use of heroin for a long-term period of nine 
months that incorporated psychological intervention strategies he found that he relapsed two 
days after being released. He recalled that real life hit him again as soon as he was released 
from the isolation from society. This was due to the isolation from high-risk situations in real 
life outside from the isolation of rehabilitation centres where he felt safe to roam without 
having to make use of heroin. Participant 1 referred to the temptations that hit him again once 
he was released from this particular rehabilitation centres of which he was prevented from for 
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the last nine months. This refers back to the theoretical concept suggested by Dimeff and 
Marlatt (1998) regarding high-risk situations, whereby the probability for an individual to 
relapse would increase if they are not equipped with effective coping responses, a decrease of 
self-efficacy together with positive outcome expectancy would progress in an initial use of a 
substance. This would then be followed by an abstinence violation effect and would then 
ultimately result in the person relapsing from the abstinence of heroin. A similar case can be 
found in Participant 2: 
P2: "When I was in rehabs I was out of society and when I got back into society I was, ‘Wow, 
I am back,’ you know. Like, ah, yes, now I can go and do this and I am going to do that." 
 Participant 2 also experienced the same effect regarding rehabilitation centres and 
their programmes to recovery whereby every time she was released from rehabilitation 
programmes she was using again. She also recalled that she felt that she was isolated from 
society and also the burden of dependency when at a rehabilitation centre, but as soon as she 
was released she gave in to the temptations of society where the options of using seemed 
endless due to various high-risk situations that she was faced with. A more detailed 
description of this experience was indicated by her through the following: 
P2: "I was in Noupoort rehab for about a year and a half. Came back about seven months 
ago, the first day that I came back I relapsed. They found heroin in my car that was 
confiscated… and, well, basically I was just down in the dumps." 
Shortly after being released from a longitudinal rehabilitation programme as indicated 
by Participant 2, where she spent a year and a half in a rehabilitation facility, she was using 
again and felt that she was depressed, this can relate to the abstinence violation effect that she 
has experienced once she noticed that her commitment to remain abstinent has now been 
violated. It is considered more likely when one holds a dichotomous view of relapse and/or 
neglects to consider situational explanations for lapsing. In sum, the relapse prevention 
framework emphasises high-risk contexts, coping responses, self-efficacy, affect, 
expectancies and the abstinence violation effect as primary relapse antecedents (Witkiewitz 
& Marlatt, 2004). 
4.7.1.8 Used prescribed agonist medication to get high 
 The following subordinate theme needs to be understood in the context of the 
standard medicating procedure currently being used for heroin dependent individuals. Heroin 
dependent individuals are prescribed an agonist treatment that may include substances such 
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as methadone, suboxone and subutex together with psychological treatments in order to 
sustain abstinence from the use of heroin. What these medications do is mimic the effects of 
heroin, they also contain an opioid which causes the individual to not withdraw from their 
normal heroin habitual nature. 
Agonist therapy is the administration of long-acting opioid receptor agonists with the 
aim of reducing or eliminating illicit drug use. This therapeutic technique is controlled by 
means of supervision when the substance is administered, the aim is to increase retention rate 
in treatment and to help reduce many of the risk factors that are associated with illicit drug 
use which may include factors such as crime and infections that are related to the use of illicit 
substances (Soyka et al., 2011). What some of the participants tended to do with this 
medication is to inject this form of medication to get high, because some of the agonistic 
medications induce a similar experience as the euphoric effects as heroin. Therefore, it does 
not block these opioid receptors such as naltrexone does and the individual tends to remain 
dependent on some sort of opioid. Rather than trying to remain abstinent from an opioid these 
substances merely replicate the effects of heroin. This then results in the cycle of lapsing and 
relapsing because the individual is never opioid-free but rather this method pursues a 
weening process from reducing the milligrams of the agonist periodically. For some of these 
dependent individuals it can be seen as a way to make use of a prescribed opioid to consume 
for recreational and dependent purposes such as Participant 1: 
P1: "… well, for me, before the naltrexone… okay. There was methadone, suboxone, and, 
first of all, subutex, but, then I used to crush it and spike it and all of that, okay. I then went to 
suboxone, so, it was basically methadone and suboxone, and the problem is that suboxone 
and methadone are synthetic forms of heroin. So, it is basically exactly the same it just 
nowhere near as intense, okay, and you don’t get the high. All that those things did for me 
was to stop the withdrawal… that’s it." 
 Particularly for Participant 1, before the use of an antagonist such as naltrexone he 
went through the general procedure that would be prescribed for heroin-dependent 
individuals which was that of an agonist treatment. He indicated that he made use of various 
agonist medications in order to be treated for heroin dependency which consisted of 
methadone, suboxone and subutex, which are all synthetic and legally prescribed medication 
used in the recovery process of heroin-dependent individuals. For him it was also a way to 
get high in which he indicated that he used to crush and inject his medication in order to 
achieve a similar effect as heroin. He, however, indicated that it does not give the same 
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euphoric effect that heroin gave him, and yet, it stopped the withdrawals from occurring. 
These medications tend to prolong the dependent factor to substances due to the reason that it 
mimics the effects of heroin. This could be one of the reasons that Participant 1 did not find 
this form of therapy very useful in an attempt to remain abstinent from opioids. A similar 
experience can be found in Participant 4: 
P4: "I went onto, what’s it called, suboxone, for a little while. I carried on using while I was 
on suboxone. Subutex as well, I carried on using while I was on subutex and then also 
eventually, I got onto methadone, then I carried on using while I was on methadone, then I 
shot up the methadone and they took that away from me. They stopped me from being 
allowed to use methadone, so I went back to suboxone." 
 Even when Participant 4 was on the usual prescribed medicated treatment for heroin-
dependent individuals, he continued to make use of heroin whilst on these medications and a 
prescribed programme for psychological treatment. He also indicated that he made use of 
suboxone and subutex and later moved onto making use of methadone whereby he started to 
inject the methadone in order to get high. He was later then taking off of methadone and was 
prescribed suboxone once again. This did in fact not stop him from making use of heroin as 
well as making use of the prescribed medication in order to attempt remaining abstinent from 
the use of opioids. He further elaborated on his experience with the prescribed agonist 
medications: 
P4: "But, it just, it didn’t, it never really worked and it never really blocked the heroin either, 
so I got to a point on suboxone where I could just use and I was still getting the full effect of 
it." 
 Participant 4 indicated that the use of agonist medication has never worked for him 
due to it not blocking the euphoric effect of an opioid. He recalled that he had reached the 
point where he used suboxone to such an extent that he was experiencing the full effect that 
he experienced when he was making use of heroin. This in return does not solve the problem 
of attempting to remain abstinent. These agonistic medications seems to replicate the use of 
heroin even when the individual attempts to remain opioid-free, as individuals report 
experiencing the same effect as when they were on heroin. Surely this could be seen as a safe 
method in order to avoid them from making use of an illicit heroin that is bought off the street 
thereby questioning the safety and legitimacy of the substance. However this does not solve 
the problem of remaining opioid free and living an abstinent lifestyle.  
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4.7.2 Giving the naltrexone pellet implant a chance 
 The superordinate theme that was developed for this section was derived from five of 
the subordinate themes listed in table 4.1 above. This particular theme concerns the 
introductory period of the participants’ experiences of seeking an alternative method of 
recovery and abstinence related to heroin dependency which the participants followed prior to 
being introduced to the naltrexone pellet implant. This includes their initial thoughts 
regarding the naltrexone pellet implant itself and the decision to make use of this form of 
treatment. In itself, this theme discusses the process of deciding to make use of naltrexone 
and all the factors related to this procedure experienced by the participants. Furthermore, this 
theme explored and interpreted the experiences and perceptions of the individuals regarding 
the decision to give the naltrexone pellet implant a chance in order to attempt to remain 
abstinent from the use and dependency to heroin.  
4.7.2.1 The will to remain abstinent 
This particular subordinate theme discusses the period where the individual had made 
the decision - from their own free will - that they wanted to remain abstinent from the use of 
heroin and the lifestyle that was associated with their use and dependency on heroin. This 
consisted of the period where they had decided that it was time to make a change regarding 
their lifestyle due to various reasons that include a decision to rid themselves of a lifestyle 
that they were no longer willing to maintain, a sense of self-actualisation that their drugging 
lifestyle was not worthwhile anymore. This particular instance occurred after various 
attempts of remaining abstinent including various lapses and relapses that form part of the 
recovering process.  
P1: "Then I decided let me actually give this a go, I may as well just give this a go because I 
can’t use. So, I’ve got nothing to lose. It lasted for three months and I made myself a promise 
that I was going to give myself everything I’ve got for three months because I can’t use 
anyway. And, because of not being able to use it was an easier decision to make, put it that 
way" 
 This particular interpretation made by Participant 1 indicated that he had made the 
decision to attempt sobriety through means of remaining abstinent from the use of heroin. His 
decision was influenced after the naltrexone pellet implant was inserted. He was informed by 
his physician that he would not be able to use when on the naltrexone pellet implant. 
Regardless of what his physician indicated of abstaining from the use of heroin while on this 
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particular treatment, Participant 1 did however try to use heroin when on the naltrexone pellet 
implant. To his surprise he found that there was no euphoric effect when he made use of 
heroin due to the biological nature of the naltrexone pellet implant blocking the opioid 
receptor cells, therefore having no effect when the individual tries to make use of an opioid 
such as heroin (Kjome & Moeller, 2011). Furthermore, due to the inability for heroin to have 
any effect on him, he decided to make the choice of remaining abstinent from the use of this 
illicit substance. This was the moment that he decided that he will give naltrexone a chance in 
attempting to remain abstinent for the duration of three months, which is also the duration 
that the naltrexone pellet implant lasts within the human body. He further indicated that it 
was an easier decision to make because of the inability to feel the euphoric effect of heroin. 
This realisation encouraged Participant 1 to remain abstinent and give the naltrexone pellet 
implants a chance in aiding him through his recovery process. In some sense, this realisation 
relates to the contextual theory of this particular study whereby the positive outcome 
expectancies of the use of heroin has been eliminated and in some sense has increased 
participant’s self-efficacy by means of being more motivated to remain abstinence. This 
indicates that the probability of a relapse occurring is therefore decreased (Witkiewitz & 
Marlatt, 2004). A similar instance occurred with Participant 2, whereby she indicated the 
following: 
P2: "But, in a point in time you get tired of being sick and tired. Okay, and, I realised that I 
don’t want to live this live anymore, but that is still not enough for you to actually remain 
clean. You want to change your live, because you don’t just want to stay clean, you want to 
change your lifestyle." 
 She indicated that she reached a point where she became fed up wither use. Here, 
Participant 2 experienced a sense of self-actualisation in terms of the life of substance use 
was not a life worth living anymore and she wanted a change. This relates back to the 
decision of remaining abstinent from the use of heroin in the sense that she indicated that she 
wanted to change her life. She, furthermore, indicated that the decision in itself to remain 
abstinent is still insufficient to actually remain abstinent from the use of heroin. She indicated 
that a lifestyle change needed to be adhered to in order to actually remain abstinent whereby 
she indicated that she did not want to merely remain clean but rather change her lifestyle. 
This relates to dealing with not only the physiological factors related to substance 
dependence but rather approaching this problem of dependency from a holistic perspective 
through means of changing one’s lifestyle which also incorporates the psychological and 
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environmental/social factors in remaining abstinent. This can be found in the next section she 
indicated within the interviewing process: 
P2: "You know what, of all the rehabs that I have been to and of all the crap that I have tried, 
for the first time in my life I actually feel like I got this, you know. But, you are going to have 
to feel… like any addict, I speak for addicts because we all are the same, you have to want it. 
You have to change your mindset and your thinking pattern you have to want to" 
 This refers to the previously mentioned holistic approach to remaining abstinent in a 
sense that she indicated that she had to change her cognitive schemas in order to truly want to 
remain abstinent. She also seemed to relate with various substance dependent individuals in 
that you really have to want to remain abstinent. Participant 2 further elaborated that she 
finally felt that she has the sense of self-efficacy in order to remain abstinent from the use of 
heroin. After many attempts of remaining abstinent, the use of the naltrexone pellet implant 
made her feel that she would be able to succeed in finally ridding herself of the grip of 
dependency. A very similar case was found within Participant 3 in terms of the decision to 
remain abstinent from the use of heroin, shortly, after the implant was inserted: 
P3: "Five minutes later I have made the decision that I will not use again. This was now a 
drastic measure, so, in itself it was like a big gesture to me and I would like to have to honour 
it in a way, but, I consciously decided that this was the last time that I was ever doing 
anything to myself that would result in using or the prevention of using." 
 Participant 3 indicated that five minutes after the implant was inserted, he had made 
the decision to remain abstinent from the use of heroin. For him this was a drastic measure in 
that he now went to an extreme in order to remain abstinent. As discussed earlier, for 
Participant 3, the decision to make use of the naltrexone implant was quite a shocking reality 
due to the fear of an unfamiliar implant being inserted in his body. Because of this, 
Participant 3’s decision to remain abstinent after the implant was inserted was something that 
he now needed to honour. He had made a promise to himself that this would be the last 
attempt in making use of certain medication in order to remain abstinent from the use of any 
illicit substance. For Participant 3 this was in a sense his last stand to remaining abstinent 
which was his realisation to remaining abstinent. This can be found evident in most of the 
participants in this particular study, whereby, they had come to a decision to remain abstinent 
when they realised the lengths that they had to go to in order to remain abstinent, which was 
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the thought of making use of an implant. After various attempts of remaining abstinent, this 
was seen as a last resort to remain abstinent from the use of heroin. 
4.7.2.2 Initial thoughts about the naltrexone implant 
 This subordinate theme refers to the initial information regarding naltrexone implant 
therapy with pellet implantation that the participants were faced with. This incorporates the 
first time that they heard about naltrexone through a friend, family member, other dependent 
individuals and the media. This also incorporates what they thought naltrexone was, the 
stories they heard about naltrexone and their thoughts around making use of naltrexone and 
what their personal thoughts were regarding using it themselves. The following was 
Participant 1’s initial thoughts regarding the naltrexone pellet implant: 
P1: "Okay, I had a friend that heard about a doctor in Pretoria that started the naltrexone 
implant. Wasn’t known at all at that time, but anyway, I thought that this guy was lying to me 
about this and he spoke to a friend that got the number. Dr X had only just started doing it. 
And, I phoned, I didn’t even believe it from the beginning… I didn’t, I thought that it was a 
hoax. I thought that it was a load of crap." 
 The first time that Participant 1 heard about the naltrexone pellet implant was through 
a friend of his that also had a problem with the use and dependency of heroin. At that time 
this friend approached Participant 1 in order to tell him about this particular alternative 
format of medication in order to aid one in the recovery process. At the time that he heard 
about the naltrexone pellet implant and what this friend was telling him, the naltrexone pellet 
implant was not well known within South Africa, actually very few people knew about the 
naltrexone pellet implant and the function of this particular alternative aid to recovery. 
Initially, Participant 1 thought that this friend was lying about this particular aid to recovery, 
this was due to the reason that Participant 1 had made use of so many recovery processes 
throughout his lifetime that he did not believe that there would be an aid in assisting him to 
remain abstinent from the use of heroin.  
When Participant 1 contacted the physician that inserted the implant at that time he 
was thinking that this is just another hoax or some sort of money-making scheme that would 
take advantage of substance dependent individuals in order to make money. For him this was 
“a load of crap” as he believed that this particular physician was possibly taking a chance 
with a vulnerable population of individuals. There were some similarities in Participant 2’s 
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experiences in terms of their initial thoughts regarding the naltrexone pellet implant, although 
there were some differences: 
P2: " Okay, I knew about it for a long time, like I had a lot of addict friends and they went for 
the naltrexone implant and things like that. And, my mom and them wanted me to go for it 
and I just never did… years ago, and I was like, pfffttt, I am not going for an implant, what 
the fuck? But this time it was my sister’s husband and he is also struggling with like CAT use 
and stuff. The last time that I got arrested my mom said, it is just… or Noupoort or 
naltrexone, just give it a try or no… do it. " 
 Similar to Participant 1’s experiences, Participant 2 also heard about the naltrexone 
pellet implant through friends that also struggled with substance dependence that made use of 
the implant. However, what was different for her was that her parents wanted her to go for 
the implant. She did not want to go for the implant at the time that her parents told her to try 
and make use of this particular aid to recovery. For her, at that time, she did not want to have 
any implant inserted in order to aid her in the recovery process. She found that she was not 
ready to seek an alternative method to recovery due to not being committed to remain 
abstinent from the use of heroin.  
For Participant 2, it took someone close to her, “But this time it was my sister’s 
husband” to realise that she noticed first hand, that this form of therapy seemed to work for 
her sister’s husband. So, the last time that she got arrested for the possession of heroin, her 
mother gave her a choice between a long-term recovery programme – which she dreaded – or 
stay home and make use of the naltrexone pellet implant. Although she was pressured to 
some extent in making a choice between these two options, she had made the decision to 
rather give the naltrexone pellet implant a chance. The feeling that one is being taken for a 
fool in agreeing to utilise this form of treatment in aiding with remaining abstinent from the 
use of heroin seemed to be evident within the next participant: 
P3: "I thought to myself… this guy could be putting a fucking marble…just a plain old goon 
up my ass and I wouldn’t know the difference." 
Participant 3 was also quite reluctant to believe what the people around him were 
telling him about the use of the naltrexone implant. He did not really trust the fact that this 
aid to recovery could be that effective. For him, he reported that it felt that the person doing 
the implant was planning to insert an ineffective object into his body, whereby, he will be 
fooled to believe that the aid that has been inserted has some miracle effect on the body 
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whilst in the meantime they would have inserted some form of placebo. He, furthermore, 
elaborated: 
P3: "So, from then on she researched about it, and, I don’t know how she found out, she 
found out about Participant 1. She paid for the first implant and she paid for the first two 
months of counselling. I think somebody in her work told her about it. Since then, I found out 
it is a lot more well-known than what I thought." 
 His aunt went to do some more research regarding the naltrexone pellet implant and 
it’s assistance in the recovery process. This was the time that his aunt found Participant 1 as 
he acts as the lay counsellor for the naltrexone support group. This was the time that his aunt 
spoke to him in order to guide them through the process of having the implant inserted. 
Initially, his aunt was the one that told him about the use of the naltrexone implant as this was 
the initial information that he got hold of regarding the naltrexone pellet implant. After this 
initial interaction with his aunt, Participant 3 went onto doing his own research regarding the 
naltrexone pellet implant, it was at this stage that he realised that the use of the naltrexone 
pellet implant was more well-known that he initially thought. This was the moment that 
Participant 3 felt more confident in making use of this form of medication in order to aid him 
in the recovery process of heroin dependence. A similar instance that occurred in P1, 2 and 3 
also occurred with Participant 4: 
P4: "And, then the overdoses started and it started to get bad, and then my mom found 
Participant 1 over the internet, and then he introduced us to the Naltrexone. I’d heard about 
it probably about four years ago, but there was something about it not being legal in the 
country, or… I don’t know what that was, so I left it and then one of my friends got an 
implant and I thought okay, well, let me, let me try that out." 
 Participant 4 had also been informed about the naltrexone pellet implant through 
friends, although at the initial interaction regarding being informed about this form of 
therapy, he had decided not to make use of it due to him recalling that the naltrexone pellet 
implant was not a registered form of medication within South Africa, in which it is still not a 
registered medication within South Africa (Weich et al., 2013). This caused him to decide 
against the use of this particular form of treatment. However when he was faced with 
multiple overdoses four years after his initial encounter with being informed about this 
treatment he considered. This led to his mother making contact with Participant 1 in order to 
guide them through the process of making use of this form of treatment. Participant 4 also felt 
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a bit more comfortable in making use of this treatment method when one of his friends, who 
at that time, also made use of the naltrexone pellet implant for the treatment of the same illicit 
substance dependency that Participant 4 suffered from. It was after these encounters that 
Participant 4 had made the decision to give the naltrexone pellet implant a chance. 
4.7.2.3 The decision to make use of the naltrexone implant 
 This particular subordinate theme refers to the initial decision that the participants 
went through in making use of the naltrexone implant. It incorporated the reasons why these 
individuals decided to make use of the naltrexone pellet implant despite whatever information 
they have gained about this form of therapy from relatives, friends or the media. Here, the 
decision of making use of the naltrexone implant was explored and what led to the decision to 
make use of this form of therapy. Furthermore, this theme incorporates their decision to 
remain abstinent from the use of heroin with an unfamiliar form of aid or rather an alternative 
form from the general practices of attempting to remain abstinent such as being segregated 
from society by means of being admitted to a recovery centre. Participant 1 had made the 
following statement regarding his personal decision to make use of the naltrexone pellet 
implant in attempting to remain abstinent from the use of heroin: 
P1: "But, you know what, I decided I have nothing left to lose ok. Rehabs was not an option 
for me anymore, I thought let me just go and see what this is about. If it was a hoax then, 
whatever, okay." 
 After various attempts of remaining abstinent and the continuous relapse processes 
that Participant 1 had experienced in his lifetime, he decided that this was an alternative 
method to the usual practise of being admitted to rehabilitation centres. He indicated that he 
had nothing left to lose due to having made use of so many recovery programmes – 29 to be 
exact- and failing to remain abstinent. Relapse can be viewed as a modal outcome for 
individuals who receive substance abuse treatment. In a study of relapse among heroin users 
after residential treatment Gossop et al. (2002) found that one third (34%) of the sample used 
heroin within three days of leaving treatment, 24% used within seven days of treatment and 
50% used within 14 days after leaving treatment. After just 30 days after leaving treatment 
57% of the sample of 145 individuals had used again. So, it seems that relapse from opioid 
such as heroin is quite common when individuals return to society from treatment centres. 
For Participant 1, the option to go back to a rehabilitation centre was out of the equation, he 
had failed too many times in attempting to remain abstinent that he felt that he had nothing 
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left to lose in making use of the naltrexone pellet implant. It was at that moment that he had 
decided that he would like to go and find out what the naltrexone pellet implant was about 
and whether this would be his way of finally getting a grip on his heroin dependency. Even if 
it was a “hoax”, he was so desperate in finding a way out that he would make use of an 
unknown substance in order to rid him from the claws of dependency. Quite a similar 
instance occurred with Participant 2, whereby she discussed the following: 
P2: "And, I was tired of being sick and tired, before I even got the implant…let me be 
perfectly honest with you…this is not a cure, this is if you decide if it is going to work for you. 
And, I said, ‘Well I tried everything already, this is the last resort okay’. And, I heard about 
naltrexone and people said it is wonderful…and I went for it." 
Participant 2 voiced, “I was tired of being sick and tired, before I even got the 
implant…”, which indicated that she was tired of attempting to remain abstinent from the use 
of heroin. She has been through the same process as Participant 1 of being admitted to 
rehabilitation centres and following their programmes in which the result of relapsing as soon 
as she got released from the rehabilitation centres was a reality. She, furthermore, elaborated 
that for her the use of the naltrexone pellet implant is not a cure or a silver bullet in order to 
rid oneself from the dependency of heroin. 
Participant 2 indicated that it would be able to work once an individual has made the 
decision to remain abstinent from the use of an illicit substance such as heroin. Once an 
individual has decided to remain abstinent and has the will to remain abstinent, the naltrexone 
pellet implant will be an affective aid in the recovery process of heroin dependency. 
Similarly, with Participant 1, she shared that she had run out of options of finding a 
programme or centre that would enable her to remain abstinent. This is where she had 
realised that due to constant relapse soon after the release from rehabilitation centres, that she 
had no option but to try and make use of the naltrexone pellet implant. Moreover, this related 
to her direct quote: “this is the last resort okay”, whereby she had decided that nothing else 
had worked so far and that she has been given the choice to make use of an alternative form 
of recovery, and for her the use of the naltrexone pellet implant was seen as the last resort in 
order to remain abstinent from the use of heroin. As with Participant 1, Participant 2 had also 
been made aware of the naltrexone pellet implant through family and friends, this is where 
she was informed of this alternative form of therapy, and, that it has worked for someone in 
her own family. This encouraged her to give this alternative form of therapy a chance in 
attempting to remain abstinent. She, furthermore, discussed the following: 
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P2: "Like I said, you have to want it, people that haven’t had, like, I have had so many times 
where I have been so ashamed and disappointed in myself… you know, I felt so disappointed, 
I felt such shame, I felt hatred for myself, I lost myself, I felt just… I was sick and tired of 
being sick and tired of just seeking fixes, of just being that person of having no meaning in 
life. You know what I just wanted it to be fucking over, I just wanted it to be over. I felt just 
that this is the time for me to just… if this doesn’t work, then I don’t know what will. I 
decided that I will give this a chance, because I don’t want to live this life anymore… that is 
what I felt." 
 She felt an accumulated amount of disappointment, shame and hatred towards herself 
as well as a sense of hopelessness for not being able to remain abstinent from the use of 
heroin after being admitted to various rehabilitation centres, whereby, she lapsed and 
eventually relapsed shortly after. She felt that this occurrence had made her feel that there is 
no meaning in her life and that the constant disappointment in herself and her family made 
her feel that she just wanted this lifestyle to be over. This particular feeling of 
disappointment, shame and hatred can be seen as an experience of what is called the 
abstinence violation affect as indicated by Marlatt and Gordon (1985b), whereby, if this 
individual breaks this ‘rule’ (lapse), the way they think about this situation of ‘breaking the 
rule’ would have an influence on whether or not they will continue the use of the substance in 
an uncontrollable manner and would lead to the abandonment of the abstinence ‘rule’. This 
creates what is called the abstinence violation effect, which may influence whether an initial 
lapse may lead to a relapse. This reaction focuses on the individual’s emotional response 
towards an initial lapse and the causes to which the individual attributes the lapse. Individuals 
who tend to attribute the lapse to their own personal failure are most likely to experience 
negative emotions and guilt which may then lead to the increase of substance use as an 
attempt to escape the feelings of guilt and failure. Individuals that attribute lapses to stable, 
global and internal factors beyond their control are most likely to abandon the abstinence 
attempt which may result in a full-blown relapse. Individuals who are more likely to attribute 
their lapse to the inability to cope effectively with a high-risk situation are more likely to 
recover or prolapse than the former. This could possibly explain why Participant 2 had felt 
this immense disappointment in herself due to “breaking the rule” of remaining abstinent 
from the use of heroin. This then in return, may have caused her constant relapse from heroin 
when she returned shortly to her being discharged from rehabilitation centres. 
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In Participant 3’s case, it was quite a different experience in that he did not really 
want to remain abstinent from the use of heroin, however, he still ended up giving the implant 
a chance:  
P4: "I would say my family and Participant 1…It didn’t come from me at all, I didn’t want it, 
and I didn’t want to stop using. So, it was purely just my family saying, listen, try it out. 
Participant 1 was like saying give it three months, get the implant, give it three months and if 
you want to go back to using after that, you can. Then I thought, “Okay, well, I’ve given 
myself so many years to use I may as well try and get clean." 
 Participant 3 shared that he did not want to stop using heroin as he had an extremely 
close attachment with heroin. As mentioned previously within Participant 4’s narrative, he 
indicated that he had such an attachment to heroin in that he finds it extremely difficult to let 
go of this illicit substance. He was approached by his parents and Participant 1 in order to 
convince him to attempt the use of the naltrexone pellet implant. After having a discussion 
with Participant 1 he indicated that “Participant 1 was like saying give it three months, get 
the implant, give it three months, and, if you want to go back to using after that, you can”, 
where this for him was an indication that he might as well give the naltrexone pellet implant a 
chance. Participant 4 indicated that he had been using heroin for such a long time that he 
might as well just give sobriety a chance. This instance was also found evident in Participant 
1, 2 and , whereby, they thought that they have nothing left to lose and might as well just give 
this alternative form of treatment a chance. For these individuals it was found that giving the 
naltrexone pellet implant a chance was seen as the last resort in that they had previously 
attempted to remain abstinent from the use of heroin on a number of occasions that they 
would try any alternative form of treatment just to help them break the grip of dependency. 
4.7.2.4 Fear of receiving the naltrexone implant 
 This subordinate theme refers to the participants’ fear or hesitancy towards receiving 
the implant, this is because of the naltrexone pellet implant being an unfamiliar form of 
treatment that that have not yet made use of. This, furthermore, includes the fear of being cut, 
fear of an unknown substance being inserted into your body, fear of the implant itself being 
present in the participant’s body. Moreover, it includes the fear of letting go of the dependent 
lifestyle, wherein the individual has to make a choice of remaining abstinent after making use 
of illicit substances for year. It also involved the fear of letting go of a lifestyle that the 
individual was comfortable with. Participant 2 indicated the following: 
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P2: "I didn’t want to go because I hate people cutting on me, okay, first I never had stitches 
in my life. I had needles and shit…” 
 She indicated that she did not want to go for the implant for the fear of being cut, the 
fear for the actual procedure of getting the implant inserted. This particular procedure of the 
insertion of the naltrexone pellet implant starts off with an application of an antiseptic in 
order to clean the area of insertion, this is followed with the administration of a local 
anaesthetic, whereby, a wound needs to be made for the implant to be inserted. The wound 
would then be sutured and dressed. A follow-up session is required in order to avoid infection 
and to remove the sutures (de Wet, 2015). This particular procedure was explained to her 
when the appointment for the insertion of the naltrexone pellet implant was made. She 
indicated that she did not even have stitches before and therefore feared the surgical 
procedure even more. Furthermore, she indicated that she did in fact experience the insertion 
of needles due to her administration of heroin via injection. For her this procedure seemed 
significantly worse than the injection of heroin. 
The fear that Participant 3 had experienced in terms of receiving the naltrexone pellet 
implant was quite different: 
P3: "So, I thought like, fuck that is the last thing, I don’t want to be shitting on the doctor’s 
table.” 
 Participant 3 had a great fear of defecating as soon as the naltrexone pellet implant 
was inserted. This also involved the fear of attendant embarrassment in front of the doctor 
and his own family. This is related to the acute withdrawal that is experienced once an 
individual received the naltrexone pellet implant. This acute withdrawal would usually occur 
if an individual would have used a few days prior to receiving the naltrexone pellet implant, 
this is why the physician recommends to the patient that they should try and remain abstinent 
from the use of heroin as long as they can. This is to avoid these acute withdrawal periods 
from occurring (Julien et al., 2011). For Participant 3, he believed that he would defecate 
himself when he experienced the acute withdrawal symptoms and had the fear of 
embarrassing himself in front of the physician. Participant 3 further indicated that: 
P3: "… they told me it’s a chip, where they put a chip in my ass… I thought like a chip, no, 
no, no, no here are some hidden plans here. The moment that I walk out of the gate I will get 
shocked, I was like no, I don’t want anything put in me."  
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 He was quiet hesitant to receive the implant due to a story that he had heard from 
friends of his that have heroin dependency. He was told that it would be a chip that would be 
inserted and that when he makes use of an illicit substance such as heroin that he would be 
shocked and monitored when using. For him this was the fear of being tracked when using 
the substances in that he did not want to be controlled by a “chip” when making use of 
substances. He feared that there was a hidden agenda with the use of the naltrexone pellet 
implant and that he would be part of a great hoax. He was also quite reluctant for an unknown 
object to be inserted underneath his skin, thus he indicated: “I don’t want anything put in 
me." 
The fear that Participant 4 experienced was related to separation from heroin use: 
P4: "A guy named X did it, the implant. I knew the implant would cut me off from heroin so I 
was so scared of that-, that I tried to kill myself before I got the implant.” 
For Participant 4 the fear was related to him being separated from the use of heroin, 
that he would have to break this bond that he had with the use of heroin was one of the 
greatest fears that he experienced. The fear was so great that he attempted suicide before he 
went for the naltrexone pellet implant. For him, the bond with the use of heroin was so strong 
that he was willing to take his own life rather than letting go of this great bond he had with 
the use of heroin. 
The fear experienced by the participants in the current study indicated that there 
seemed to be a form of miscommunication regarding the naltrexone pellet implant, a form of 
being uninformed regarding the actual function of the naltrexone pellet implant. These 
misperceptions regarding the naltrexone pellet implant was influenced by false and inaccurate 
information given by friends, family and the media. However in retrospect, the use of the 
naltrexone pellet implant when seen as an aid by the participants in assisting them with the 
recovery process from their dependency on heroin. 
4.7.3 Physical experiences of the use of the naltrexone pellet implant 
 Due to the reason that individuals do experience different physical responses to 
different forms of medications, this superordinate theme was developed from the four 
subordinate themes, found in table 4.1 above, which explored and interpreted the various 
physical symptoms that were experienced by the participants during the process of making 
use of the naltrexone pellet implant. These physical experiences that participants were 
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exposed to include the process they had to endure shortly before as well as during the process 
of making use of the naltrexone pellet implant for the aid of recovery, abstinence and relapse 
prevention. The participants, of the current study, shared different physical reactions related 
to the use of this form of treatment that will be discussed in these particular subordinate 
themes, which had a major impact in the process of the recovery process and the will to 
remain abstinent from the use of heroin. 
4.7.3.1 Detox and withdrawal before receiving the naltrexone pellet implant 
 This particular subordinate theme refers to the period of detoxing and withdrawing 
that the participants had to endure before they went for the actual surgical insertion of the 
naltrexone pellet implant due to the advice given by the health care practitioners or the 
counsellor. The usual procedure that needs to be followed by the patients before they receive 
the naltrexone pellet implant would be for them to be opioid-free for at least 5-10 days, this is 
also known as the detoxification period. However this period can be reduced in selected cases 
for up to 72 hours.  
According to de Wet (2015) practitioners need to inform their patients regarding the 
opioid-free period due to the risk of rapid opiate detoxification where patients should attempt 
to remain clean from the use of heroin before the surgical procedure occurs. Reason for being 
clean before the implant is inserted is due to the effects that naltrexone implant has on the 
body when inserted, as individuals are likely to experience acute withdrawals when they 
receive the naltrexone implant if they have not refrained from the use of heroin (de Wet, 
2015). During this period the individual might experience some form of withdrawal 
depending on their severity of heroin use, this is also related to the tolerance that they have 
built to the use of heroin, whereby, this will depend on the severity of the withdrawal from 
heroin. The long-term use of opioids results in changes in the number of sensitivity of opioid 
receptor cells, which tend to mediate at least some of the effects of tolerance and withdrawal. 
Although long-term use is associated with the increased sensitivity of various 
neurotransmitter systems that include dopaminergic, cholinergic, and serotonergic neurons, 
the effect of opioids on the noradrenergic system is the primary mediator of the symptoms of 
opioid withdrawal (Sadock & Sadock, 2007). The concept of trying to remain clean from the 
use of heroin before receiving the naltrexone pellet implant as discussed earlier had an impact 
on Participant 1’s experience with receiving the naltrexone pellet implant: 
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P1: "Okay, when I had the implant I was one of the first clients in the country to get it. And at 
that stage no one even knew that with heroin addicts you have to try and detox first, okay, 
you’ve got to try and be at least three to four to five days clean of heroin, okay." 
 In his experience when receiving the naltrexone pellet implant Participant 1 was not 
informed about the fact that he had to remain clean from the use of heroin for at least a period 
of 72 hours as indicated previously. This lack of information was due to the reason that the 
naltrexone pellet implant was only being introduced into the South African context at that 
particular stage. As he indicated, he was one of the first individuals that had received the 
naltrexone pellet implant within South Africa. 
Participant 1, as a consequence, shared that he had experienced acute withdrawals 
shortly after the naltrexone pellet implant was inserted. During the first few days Participant 
1 did experience acute withdrawals due to the reason that he made use of heroin before he 
went in for the naltrexone pellet implant, this will be discussed later on with an interpretation 
from his side. 
As for Participant 2, she had adhered to remaining clean before the implant was 
inserted as she indicated: 
P2: "So, I got there with my mom and I was just like… I really, I haven’t used for like a day 
and a half and I am struggling, hey. I am just sitting in the car and I am like…I can’t get any 
[heroin] and I am tripping and I am freaking out and I am sweating and I am withdrawing 
hectically." 
 She had experienced withdrawal symptoms due to the recommendations made by the 
physician that administered the procedure of inserting the naltrexone pellet implant. Even 
through the withdrawal period and knowing that she would be receiving the implant, she 
shared that she still wanted to make use of heroin in order to just feel better, in order to rid 
her from the withdrawals that she was experiencing. Participant 2 indicated that she struggled 
with the withdrawal symptoms, wherein, she was “freaking out” when she was sitting in the 
car on the way to the physician’s office. She remembered that she was sweating which is 
known as one of the symptoms to opioid withdrawals. One of the main reasons that 
compulsive users of opioids such as heroin tend to continue the use of this drug is to avoid 
the unpleasant withdrawal syndrome that they experience if they discontinue the use of the 
substance. The opioid withdrawal process consists of both physical and mental components. 
The physical component has major disturbances of autonomic nervous system origin that 
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include lacrimation, rhinorrhea, perspiration, tremor, gooseflesh, dilated pupils, anorexia, 
nausea, emesis, diarrhoea, dehydration, elevated temperature and blood pressure, and 
yawning. These physical symptoms tend to accompany a negative mental state of dysphoria, 
depression, and anxiety (Iversen et al., 2009). 
4.7.3.2 Experiencing anxiety in the doctor’s office 
 This particular subordinate theme refers to the anxiety that the participants 
experienced when they were moments away from receiving the implant, this was experienced 
when they were present in the doctor’s office. The anticipation of receiving the implant can 
make individuals rather uneasy. Uneasiness can be linked to the withdrawal symptoms 
experienced due to the reason that the participants had to try and remain clean for a few days 
and therefore experienced some form of anxiety. 
P2: "And, it is warm and there are kids screaming and… because it is like a doctor’s office 
you know, there are kids screaming and there are these people looking at you… and, then 
they want to pay and I don’t know… whatever. You are so in a daze, you are not using and 
you are in this environment, and, that is why you just want to get out and you just… " 
 The day that Participant 2 had gone for her naltrexone pellet implant she has also 
begun to withdraw in order to receive the implant as mentioned earlier. She indicated that 
when she was sitting down in the physician’s waiting room she was quite annoyed and 
irritated by the screams of children that have also come to see the physician due to illness. It 
can be seen that she had experienced some sense of anxiety as she indicated that the people 
were looking at her and the fact that she indicated that she just wanted to have the procedure 
done and vacate the doctor’s office. She, furthermore, indicated that she was in a “daze” 
which indicated that she was not feeling well due to the withdrawal symptoms that she was 
experiencing. This in all made her feel very uncomfortable, whereby, she further elaborated: 
P2: "And, I am just sitting there, and, I am just like… uhmmm…okay… and, I am just tapping 
my toes and I am just freaking out and I’m like-. I am going first. Because, I know that I don’t 
want to go, you know a lot of addicts would just run out of there… bolt and would want to go 
and use, because you feel like that." 
 She indicated that she felt quite agitated with the situation of waiting for the 
procedure to take place, the  idea of knowing that she would have to stop using heroin while 
she was busy withdrawing made her want to run and make use of heroin. She felt that she did 
not want to be in the situation and that she wanted to go and use heroin in order to make 
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herself feel better. This is related to the euphoric feeling that is experienced when making use 
of heroin in that it tends to numb the individual from any emotional aspects related to life 
challenges, which is related to the short-term outcome expectancies that the individual 
experiences. 
Another important factor to the relapse prevention model would be the outcome 
expectancies that individuals experience. These are typically described as an individual’s 
notion regarding the consequences of substance use which might influence an individual’s 
ability to use a substance depending on the strength and behaviour of the expectancy which 
includes the previous effects that the substance had on the individual. These types of 
expectancies consist out of both short- and long-term expectancies with both positive and 
negative outcomes attached to them, where they may have varying levels of pertinence to the 
individual. 
Furthermore, short-term reward contingencies tend to reduce negative mood states, 
inducing the sense of euphoria from making use of the psychoactive substance, the change of 
the individual’s cognition where it tends to create a positive sense of self and then tends to 
reduce the stress whether physical or emotional. Short-term negative consequences consist of 
the loss of behavioural inhibition that may result in various social problems that consist of 
legal, financial, deficit of role function and various health risks. In contrast to short-term 
negative consequences are the long-term contingencies of abstaining from the use of illicit 
substances that will result in improved role functioning, improved interpersonal relations, 
better health and greater stability (Marlatt & Gordon, 1985b). So, for Participant 2, arguably, 
the short-term outcome expectancy is to get out of this situation and to go make use of heroin 
in order to rid her from the anxiety that she is experiencing at the moment. As such, at this 
point in time Participant 2 voiced she was not worried about the long-term effect that this will 
have on her and the decision to make use of heroin at that present moment. For her, she just 
wanted to escape in which she indicated: “I don’t want to go, you know a lot of addicts would 
just run out of there… bolt and would want to go and use, because you feel like that.", for her 
this was her mindset at that present moment, where she wanted to escape and go make use of 
heroin in order to deal with the withdrawals and the anxiety that she was experiencing at that 
moment. 
A similar instance occurred with Participant 3, whereby, he indicated that: 
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P3: "I was sitting like this- [demonstrates] I was fucking peeling back this whole thing 
[referring to his nail cuticle on his thumb] like that in the doctor’s office."  
 It was found that Participant 3 also experienced a form of anxiety as he indicated that 
sitting in the physician’s office made him feel quite anxious whereby he responded to the 
anxiety by means of peeling back the cuticle of his nail on his thumb. This was a form of 
coping in order to distract him from the anxiety of receiving the naltrexone pellet implant in 
that he had a physical response to the anxiety that he was experiencing at that moment. 
In order to conclude with this subordinate theme, the researcher noticed that these 
participants experienced great anxiety when receiving the naltrexone pellet implant in that 
they had both a physical as well as a physical response to the clinic environment where the 
implant procedure took place – for them at least- and that one particular participant even had 
the thought of abandoning this procedure just to go and have a fix of heroin in order to ease 
the anxiety that was experienced when sitting the physician’s waiting room in order to 
receive the naltrexone pellet implant. 
4.7.3.3 Getting sick after the naltrexone implant was inserted 
 This particular subordinate theme refers to a level of sickness that participants had 
experienced when they made use of the naltrexone pellet implant. This includes the stage 
where they initially had the implant inserted together with the experience of having the 
naltrexone in their bodies for the three-month duration that it was originally designed for. 
These physical experiences might vary from individual to individual ranging from 
experiences where some physical sickness or changes occur in a few minutes after the 
implant were inserted to the last day of the naltrexone pellet implant’s function having 
subsided. 
These physical symptoms were quite common in a lot of these participants which may 
be due to the nature of the effects of the implant after it was inserted which includes the rapid 
or acute withdrawal syndrome in individuals that are heroin dependent, up until some side-
effects with regards to the use of the naltrexone pellet implant. If an opioid dependent 
individual makes use of the naltrexone pellet implant it will result in an acute blockade of 
opioid receptors and will in return precipitate a rapid onset of severe opioid withdrawal 
reactions within a matter of 5 minutes and may last for up to 48 hours. So theoretically, when 
the u-opioid receptors are sufficiently occupied by naltrexone, no additional antagonist can 
stimulate them in which it has an affinity of at least 20 times that of morphine. Therefore 
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when the naltrexone pellet implant is used in an already opioid-dependent individual it can 
cause acute and severe withdrawal symptoms by a much more frequent and severe agitation 
than described in withdrawal cause by the usual detox process such as deciding to remain 
abstinent or rather going cold turkey (Hassanian-Moghaddam, Afzali, & Pooya, 2014). In this 
sense, when an individual does not go through the usual recommended process of remaining 
abstinent for at least 7 days, they will experience severe withdrawal symptoms. As with the 
case of Participant 1: 
P1: "I wasn’t aware, I wasn’t told, no one knew… I remember I shot out in the toilet before I 
went in for the implant ha, ha, ha, and I tell you this… when he put the implant in… straight 
afterwards I felt hey! No problem, but 20 minutes later I shat myself, I was puking all over 
myself before I got home, I couldn’t control anything in my body and the next two days… I 
am serious now… I actually thought that I was going to die." 
 In this indication presented by Participant 1 it was found that he was not made aware 
of the fact that he had to remain abstinent from the use of any form of opioid such as heroin 
for at least 7 days. Participant 1 indicated that he made use of heroin in the physician’s office 
bathrooms minutes before he had to go for the surgery. This lead to the acute physical 
withdrawals that he experience in that 20 minutes after the implant naltrexone pellet implant 
was inserted, he had defecated himself and was vomiting before he could arrive home. He 
indicated that he could not control any of these bodily functions when he went through this 
acute withdrawal. For him it was such a traumatic event that he was scared that he might die, 
he even indicated that he thought that he was going to die because of the severe withdrawals 
that he was experiencing. He further indicated: 
P1: "It is the worst detox that you have ever seen, but do you know what the good part about 
it? I tell you I went through so many withdrawals in my life that lasted for ten days, fifteen 
days, and twenty days. This was like three days, four days, but it was the worst ok, but it was 
all like poof, gone, gone." 
For Participant 1, the withdrawals that he had experienced during the initial use of the 
naltrexone pellet implant was the worst withdrawal that he had ever experienced. As he 
indicated that “I went through so many withdrawals in my life” indicates that he made a 
comparison of the withdrawals that he had experienced during the use of the naltrexone pellet 
implant and the usual withdrawals that he had experienced throughout his life with the use of 
the general method of detoxification from heroin. Regardless of the agony that he had 
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experienced during the withdrawal period on the naltrexone pellet implant, he indicated that 
one of the good parts of making use of the naltrexone implant was that his withdrawal period 
was shortened as compared to the usual detoxification method used in various recovery 
centres. He indicated that the usual method of detoxification would have lasted for up until 
twenty days, whereby the use of the naltrexone pellet implant and the withdrawals 
experienced during this process was way worse, however the period was shorten up until two 
days. This was one of the components to the use of the naltrexone pellet implant that 
Participant 1 really appreciated. Literature indicates that the severity and time of onset 
regarding withdrawal symptoms in individuals dependent on opioids depend on the half-life 
of the opioids used. Withdrawal symptoms starts to surface within 6-12 hours after the last 
dose, this occurs when the individual is physiologically dependent on short-acting drugs such 
as heroin. Symptoms may take 2-4 days to surface in the case of longer-acting drugs that 
were used such as methadone or LAAM (L-alpha-acetylmethadol). Acute withdrawal 
symptoms for short-acting opioids will peak within 1-3days and gradually subsides over a 
period of 5-7 day (American Psychiatric Association, 2013). Biochemical and subclinical 
differences that are usually unnoticed by the dependent individual, which lasts up to twelve 
additional months after the date of cessation (Kaplan, 1983). This brought us to what 
Participant 2 had experiences when her implant was inserted that was quite similar to what 
Participant 1 had experienced: 
P2: "Yes but its… you know, you don’t feel anything but, whatever… he immediately puts in 
the stitches, like immediately afterwards like in fifteen minutes you start feeling crap. You 
start feeling the effects… fifteen minutes I promise you. I was sick, like as soon as that pill 
started working with my endorphins and getting the opium and stuff, pushing it out of my 
system… I was… and it’s not withdrawing, it’s like a bad trip." 
 She described the process of the surgical procedure where after the physician had 
made the cut and had inserted the implant followed by the stitching of the wound. She 
indicated that shortly after the implant was inserted ”fifteen minutes I promise you”, she had 
started to experience the acute withdrawals in which she described is quite different from the 
usual withdrawals that she had experienced in previous recovery programmes and trying to 
remain abstinent from the use of heroin through a detoxification process. For her it was not 
the same as experiencing withdrawal symptoms but rather “a bad trip” that she had 
experienced shortly after the naltrexone pellet implant was inserted. The referred instances 
regarding the endorphins relates to the functioning of the naltrexone within the human body 
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that was explained to her by the physician before the implant procedure. For her, it felt as if 
the naltrexone was busy pushing out the heroin in her system, and for her this was the reality 
of how the naltrexone had an effect on detoxing her from heroin. She further indicated: 
P2: "But at this stage you know, I was so sick, but I didn’t want to use. I was like so, it was 
weird like the sense of… it was so bad that I felt it was leaving my system you know. I wasn’t 
like a withdrawal where it was painful, like those painful feelings that I got. It was more 
about, it was going to be over soon and I felt like it was getting out of my system, but I was 
sick and I was puking." 
 She indicated that she was feeling so sick at that moment that she did not think about 
using heroin in order to ease the withdrawal symptoms. For her it was an unfamiliar sickness 
that she had not experienced before when withdrawing from heroin. She indicated that she 
did not feel the pain when withdrawing as before, but rather she felt that she could actually 
feel how the heroin was leaving her system at that moment. This could be found in literature 
whereby antagonists such as naltrexone tend to also have an affinity to the mu receptor sites, 
however, after attaching to the receptor sites they tend to elicit no change in cellular 
functioning due to the reason for lacking intrinsic activity. This means that they compete with 
the mu agonist for the receptor which hastens withdrawal in an opioid-dependent individual 
and reverse the analgesic response that would originally be caused by the agonist. The one 
example of such a substance would be the use of naltrexone that is clinically used for the 
treatment of heroin dependency, this causes the individuals to experience no analgesic effects 
of heroin after the administration of the antagonist (Julien et al., 2011). This was also found 
evident in what she indicted by the following: 
P2: "Say about three days, it’s like it depends on how many substances you had in your 
system, like they ask you at the doctor’s office when last you used. If it was two hours earlier, 
I mean you are going to be really sick. Rather than say three days or two days or ten hours, 
obviously it had some time to release a little bit out of your system. But the more you have in 
your system the harder that pill works to push it out." 
 She indicated that it depended on the amount of heroin that she had in her system at 
that moment that would have the effect of the severity of the withdrawal symptoms that she 
experienced. She was quite aware that she would experience a severe form of sickness when 
using heroin before the naltrexone pellet implant was inserted. This was why she stayed with 
the recommendations that were made by the physician in order to stay abstinent as long as 
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possible before the implant was inserted. However, she did in fact experience sickness due to 
the rapid withdrawals produced by the naltrexone pellet implant as she indicated that she did 
however vomit when she got home after the implant was inserted. Participant 3 also 
experienced some form of sickness, however it was quite different from the severity of 
withdrawals experienced by Participant 1 and 2 in that: 
P3: "Then I left and I did feel a little sick when I got home, but that was also I think in my 
head, because Participant 1 said to me like ‘if you going to use, you going to feel it’ and you 
have an hour max and then you better find the toilet so, but it could’ve been my head because 
I didn’t use for about four days before." 
 Here Participant 3 indicated that he did in fact experience some form of being sick but 
he was not sure if it was due to the reason that Participant 1 told him that he would 
experience acute withdrawals if he used heroin shortly before he had to go for the naltrexone 
pellet implant. He was aware that if he would make use of heroin shortly before he had to go 
for the naltrexone pellet implant, which is why he decided that it would be wise to rather 
remain abstinent from the use of heroin before he went for the naltrexone pellet implant. This 
would be the reason that he had not experienced any severe withdrawals symptoms as he 
indicated that he was clean from the use of heroin for at least four days before the went for 
the naltrexone pellet implant. When comparing the level of severity of withdrawal symptoms 
between the participants at hand it can be seen that the participants (1 and 2) that made use of 
heroin shortly before the naltrexone pellet implant was inserted experienced more severe 
withdrawal symptoms as compared to Participant 3’s experience of withdrawal. This is 
because he had decided to remain abstinent form the use of heroin before the naltrexone 
pellet implant was inserted. A similar experience was found with Participant 4 when he 
initially received the naltrexone implant: 
P4: "Well I felt a little bit sick when I got it because I’d used three days before, but it, it’s 
probably the best clean time I’ve had…I felt a little bit nauseous and a little bit of 
withdrawals because I didn’t detox properly before I got the implant, but it wasn’t, it wasn’t 
bad at all, it was manageable." 
 Similarly, Participant 4 had also experienced a very little sickness when it came to 
experiencing withdrawal symptoms after the naltrexone pellet implant was inserted. This was 
due to the reason for remaining abstinent from the use of heroin for a total of three days. 
Therefore most of the detoxification was completed three days prior to the naltrexone implant 
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insertion process, which made him experience minimal nausea. For him it was manageable to 
handle the withdrawal symptoms in which he was able to function properly after the insertion 
of the naltrexone pellet implant. In concluding this particular superordinate theme, it can be 
seen that these participants’ severity of withdrawal symptoms depended on the amount as 
well as the time that they made use of heroin prior to the process of receiving the naltrexone 
pellet implant. As seen by Participant 1 and 2, they had experienced acute withdrawals due to 
using heroin shortly after receiving the naltrexone implant which created the naltrexone to act 
quite strongly against the opioids within their system. For Participant 3 and 4, the sickness of 
the withdrawals was not that big of a problem due to being aware that they needed to remain 
abstinent from the use of heroin prior to the naltrexone implant. This in return made them 
experience fewer withdrawal symptoms in which they were able to manage after the 
naltrexone pellet implant was inserted. 
4.7.4 Naltrexone pellet implant as an aid for relapse prevention 
 This particular superordinate theme is to some extend the crux to this study, seen as 
the aim to this study was to explore the subjective experiences of the use of the naltrexone 
pellet implant as an aid for relapse prevention from heroin dependency. This superordinate 
theme was developed from the seven subordinate themes that can be found in table 4.1 above, 
these subordinate themes holistically created the subjective experiences and perceptions of 
the use of the naltrexone pellet implant as an aid for relapse prevention to the use and 
dependency to heroin. Most of these subordinate themes that are present in this superordinate 
theme are linked to the contextual theory known as the Relapse Prevention Theory (Marlatt & 
Gordon, 1985b). This particular theme will be discussed throughout the write-up process of 
this particular superordinate theme which was integrated throughout the research process. 
This particular contextual theory to this study was fully discussed in Chapter 2, however a 
summary of this particular theory will be discussed throughout. To summarise, the relapse 
prevention model proposed by Marlatt and Gordon (1985b), consist of a cognitive-
behavioural approach to the relapse process that centres around the high-risk situation and 
how the individual tends to respond to the high-risk situation when they decide to remain 
abstinent from the use of an illicit substance such as heroin. If the individual does not have an 
effective coping response or some form of confidence in order to deal with the high-risk 
situation, the probability for them to give in to temptation would be high. The individual’s 
decision to make use of a substance or stay abstinent is then mediated by their outcome 
expectancies for the effect of the use of the substance. Individuals that tend to make use of a 
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substance may be susceptible to the abstinence violation effect which causes self-blame and 
the sense of loss of control over the use of a substance. This may then result in the increased 
probability to make use of a substance and therefore increase the probability of a full-blown 
relapse. On the other side, if the individual posits an effective coping response towards high-
risk situations through means of an increased or higher self-efficacy, the probability of the 
occurrence of a full-blown relapse is then decreased. 
4.7.4.1 Naltrexone as an aid and not a miracle cure 
 This particular subordinate theme refers to the belief that naltrexone is seen as an aid 
and not a miracle cure. The particularity to the use of the words “miracle cure” refers to a 
form of medication that has some form of biological entities that will cure the individual from 
the use and dependency to heroin. That it is viewed as a silver bullet to curing individuals 
from the claws of heroin dependency in some sense. Various websites such as naltrexone 
saves lives (Lubbe, 2012) and magazines articles (Carstens, 2012) described naltrexone 
implants as a cure for substance abuse especially acting as a miracle cure for heroin 
dependency. Which in retrospect, it was found that it is an aid to the recovering process 
whereby the participants indicated that the use of naltrexone pellet implant alone would not 
be sufficient in remaining abstinent from the use of heroin and various other illicit 
substances, but rather the combination of naltrexone pellet implant and some form of therapy 
would be required to assist in the process of relapse prevention and remaining abstinent from 
the use of heroin. When referring to the naltrexone pellet implant as an aid it is understood 
through the interaction with the participants that it aids with the physiological symptoms 
related to post-use of heroin. By this the researcher refers to decreasing the amount of days it 
takes to withdrawal from heroin when making use of the naltrexone pellet implant, also 
referring to the decrease of cravings, obsessions and effects of the heroin due to the nature of 
the effects that the naltrexone pellet implant had on the participant biologically. Furthermore, 
there is also a psychological component that is linked to the use of the naltrexone pellet 
implant in order to assist the individual to remain abstinent from the use of illicit substances 
such as heroin. Participant 1 indicated the following: 
P1: "Eventually you have to save your own life. That is why I said that it is not a cure, it is an 
aid. But without it [naltrexone pellet implant]…heroin addicts will not get through it ok. That 
is my believe today, because you saw when I was a heroin addict and all that ok, it’s just… 
all my friend were dying… all my friend from twelve, thirteen years ago… every single one of 
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them are dead, every single one. My girlfriend is dead, all of them, I was the only survivor ok, 
and I believe if it wasn’t for the naltrexone I wouldn’t be here, I would be back in prison for 
the rest of my life and I believe if the naltrexone was here earlier, all my friends would have 
been here today. I really believe it." 
 As indicated earlier, for Participant 1 the use of the naltrexone pellet implant was not 
a cure but rather an aid to the recovery process in maintaining abstinence from the use of 
heroin. However, he indicated that it was up to him to save his own life, by this he meant that 
although he was making use of the naltrexone pellet implant to aid him in the recovery 
process, it was his own responsibility to deal with the psychological component to remain 
abstinent from the use of heroin. Here he was indicating the importance of making the 
decision to remain abstinent and holding true to that decision. Sure enough the naltrexone 
pellet implant aided him in shortening the withdrawal period as well as aiding him in 
preventing obsessions and craving for the use of heroin, however the responsibility to deal 
with the psychological and habitual was up to him. He believed that heroin dependent 
individuals will not be able to remain abstinent from the use of heroin if they do not make use 
of the naltrexone pellet implant. For him this belief originates from his experience with the 
use and dependency to heroin whereby some of his friends and partner had passed away due 
to overdose from heroin. Now that he was the only survivor, he believes that if it was not for 
the use of the naltrexone pellet implant he would most probably faced the same fate as his 
friends. He believed that if they were introduced to the naltrexone pellet implant that they 
would most probably be here with him today. For him, the naltrexone pellet implant was a 
life saver and in some sense the cure to his dependency was that he was able to change as a 
human being, to change his behavioural aspects to dependency in which he indicated: 
P1: "That was my cure, the naltrexone helped me to be able to change, but change is the 
cure, but without the naltrexone… the truth is that I couldn’t put the drugs down no matter 
what, ok. So it helped me to stay abstinent from the drugs, but change helped me to live 
without the drugs. That is how I see it. " 
 Here he indicated that the so called “cure” was his ability to change his behaviour to 
the use of heroin. Participant 1 indicated that it was quite easy to stop making use of heroin, 
however he found it quite difficult to cease the use of heroin which is linked to the decision to 
remain abstinent. In this sense, he had to work on remaining abstinent which is linked to the 
psychological aspect to remaining abstinent. This can be found evident in the Relapse 
Prevention Theory in that when an individual is faced with high-risk situations to the use of 
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an illicit substance in that when an individual is faced with a high-risk situation they should 
be able to have an affective coping response in order to increase their own self-efficacy in 
order to decrease the probability for a relapse from occurring (Marlatt & Gordon, 1985b). In 
this sense, the naltrexone pellet implant aided Participant 1 in not using heroin and ceasing 
obsession as well as cravings to the use of heroin, even if he wanted to make use of heroin, 
the naltrexone pellet implant would have ceased the euphoric effect created by heroin in the 
body. Therefore, leaving Participant 1 to focus on working on affective coping responses to 
remaining abstinent when faced with high-risk situations. The psychological component in 
this situation would also be linked to the increase of Participant 1’s self-efficacy in that 
literature indicated that when an individual who has initiated a behavioural change should 
start to gradually experience a growing sense of personal control and self-efficacy in order to 
master his or her behaviour in a high-risk situation. With this in mind, one of the key factors 
to the relapse prevention model is how an individual is then able to respond to this high-risk 
situation. An effective coping response defined as a cognitive or behavioural compensatory 
strategy that reduces the likelihood of lapsing- would be able to culminate a high-risk 
situation in a lapse and therefore eliminate the tendency to give in to the temptation of 
substance use and decreasing the probability of a relapse. In turn, an ineffective coping 
response might decrease self-efficacy and a return to target behaviour will increase the 
probability for future lapses (Hendershot et al., 2011; Larimer et al., 1999; Witkiewitz & 
Marlatt, 2004). This further supported his following indication: 
P1: "Because you have got to change. Putting down the drugs is the easy part, but keeping 
them down is the hard part, ask any addict. Change will help you keep it down, because you 
become a different person now, the new person you become doesn’t have that need to use 
every day like the old person. And that is what it is about." 
 Basically Participant 1 had an effective coping response to the high-risk situations that 
he faced during his lifetime which in return increased his sense of self-efficacy. This made 
him feel that he was not the same old dependent individual that had to make use of heroin in 
order to function. Therefore decreasing the probability for a relapse occurring. In this sense 
the naltrexone pellet implant aided him in remaining abstinent from the use of heroin and that 
it was up to him to create an effective coping response to the high-risk situations in order to 
remain abstinent from the use of heroin. This particular instance was also found within 
Participant 2 in that: 
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P2: "This is not a cure, you will feel better psychologically. I just wanted to get this through 
and I believed that I can do this you know, because there was someone with me. There was 
someone telling me ok well this is what you will feel, so I was through it. At the beginning I 
was feeling like depressed like is what I have to go through, is this what I have to go through 
now? Is this really my life? And soon you get to make peace with it, that you have to make 
peace with the fact that you have to get over your shame and your hatred for yourself. You 
have to forgive yourself in order for this naltrexone to do its work." 
 She also believed that the use of the naltrexone pellet implant is not a cure but rather 
an aid to the recovery process from heroin dependence. Participant 2 believed that she would 
be able to get through the hard process of remaining abstinent from the use of heroin in that 
she indicated that that Participant 1 helped her by means of guiding her through the recovery 
process. Furthermore she indicated that the use of the naltrexone pellet implant helped her to 
feel better psychologically. In this sense she believed that the commitment to the use of the 
naltrexone pellet implant helped her to be able to work on the psychological aspects to 
remaining abstinent from the use of heroin, in that it created a sense of self-efficacy in order 
“to get this through” which indicates that she was committed to remain abstinent for the 
duration of the 3 months that the naltrexone pellet implant was active in her body. However, 
one of the most important aspects to her abstinence was that there was someone with her 
guiding her through the process to recovery and abstinence. She further indicated that in 
order for the naltrexone pellet implant to aid her in the recovery process and remaining 
abstinent from the use of heroin, she had to deal with the self-hatred, depression and the guilt 
that she was experiencing due to constant failure to remain abstinent from the use of heroin. 
This in a sense speaks to the ability to be able to focus on the psychological aspects to the 
recovery process from heroin abuse in that naltrexone allows the individual to be able to get 
through the physical symptoms related to heroin dependency that includes obsessions and 
cravings. This then allows for the focus to be placed on the psychological components to the 
recovery process which is one of the most important factors to focus on when in the process 
of remaining abstinent. She further indicated:  
P2: "Some people use it as a cure and it is not, because then you would have to be on the 
implant for the rest of your life." 
 Her indication here refers to the fallacy that the naltrexone pellet implant would be a 
cure to heroin dependency as indicated previously, in that for her the important aspect was 
dealing with the psychological components related to heroin dependency rather that making 
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use of a substance for the rest of her life- almost a scapegoat in some sense- in order to 
receive a silver bullet for freeing oneself from the claws of dependency. This is when she 
indicated that if that is the matter at hand, that an individual would have to then make use of 
the naltrexone pellet implant for the rest of their lives, which indicates that the individual 
would only keep remaining abstinent from the use of heroin when on the naltrexone pellet 
implant in that it would then be seen as a form of maintenance treatment rather than an aid to 
dealing with the wholistic aspect to heroin dependency which includes both the physical and 
psychological aspects to remaining abstinent. A similar experience was found within 
Participant 3 in that: 
P3: "And unfortunately that is where the pill has its downfall, it can’t change who you are. It 
just helps you not use because unfortunately I have seen the effects, if you do use on that 
shit… " 
 He indicates that there is however a downfall for him regarding the naltrexone pellet 
implant in that it does not change the person who you are, but rather keeps you from making 
use of heroin. Therefore, it would be up to the individual to work on the psychological 
aspects related to heroin dependency in that they have to be willing to focus on psychological 
modalities such as counselling in order to deal with the dependency in a wholistic manner 
rather than focusing on only the physiological aspect related to dependency. This relates back 
to what Marlatt and Gordon indicated (1985b) indicated by an effective coping response in 
that the naltrexone pellet implant does in some sense act as an physiological coping response 
to the decreasing period of withdrawals and the elimination or rather decreasing of the 
obsessions and the craving. Through this, it allows the individual to be able to cope with the 
physiological aspects related to heroin-dependency, however, for Participant 3 he needed to 
change who he was through attending some form of therapy in order to work on the 
psychological components related to remaining abstinent from the use of heroin. Participant 4 
made use of a very interesting analogy in that the indicated that: 
P4: "Because the naltrexone isn’t a cure, it’s like a, it’s the crutches, if I can make an 
analogy out of it, your legs aren’t going to get stronger if you sit in a wheel chair, you need 
to use the crutches and actually use your legs." 
 As with most of the participants, the naltrexone pellet implant is not a cure but rather 
an aid for the recovery process that Participant 4 also experienced in his process of making 
use of the naltrexone pellet implant. For his the naltrexone pellet implant was the crutches in 
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order to make his legs stringer to be able to walk again, in this sense, he referred to his legs as 
the ability to walk again in that being able to walk free from the dependency of heroin. As he 
indicated that the wheelchair being the heroin abuse and dependency that he had to get out of 
in order to walk again, and for him he had to make use of the crutches in order to walk again. 
However, for him to be able to walk again with the use of the crutches he had to be able to 
stand up from the wheelchair which is related to the previous discussion in that one has the 
aid of the naltrexone pellet implant, but for an individual to be able to remain abstinent one 
has to work on the psychological component related to heroin dependency. It was found that 
all the participants agreed that the naltrexone pellet implant is not a cure to heroin 
dependency but rather an aid to relapse prevention in that it would be the responsibility of the 
heroin abuser to be willing to work on the psychological components related to heroin 
dependency.  
4.7.4.2 People, places and things as a trigger 
 This code refers to the high-risk situations that the participants were faced with in 
society which acted as triggers to make use of an illicit substance such as heroin. As indicated 
by Marlatt and Gordon (1985b), one of the central components to the relapse prevention 
theory is that a high-risk situation frequently serves as the immediate precipitator of the use 
of an illicit substance such as heroin. According to this model, when an individual has 
decided to remain abstinent from the use of an illicit substance due to the willingness to 
pursue in an act of behavioural change that they will start to experience some sense of 
increased self-efficacy or mastery over their behaviours which will grow as they maintain the 
change. Certain situations, events, emotions or people can pose a threat to the person’s sense 
of control and, consequently may precipitate a relapse crisis. These situations may include 
emotional or cognitive states such as diminished self-efficacy and negative emotions such as 
anger, depression or anxiety. It might also include environmental contingencies such as being 
conditioned to illicit substance cues such as certain spaces, objects and people. Furthermore, 
physiological states such as withdrawals, cravings and urges might also be a form of trigger 
for the use of substances. These individuals were exposed to these situations through their 
everyday lives and would have had to be equipped with the necessary effective coping 
responses in order to deal with these high-risk situations or triggers. These triggers or high-
risk situations were experienced before, during and after the treatment method of naltrexone. 
For Participant 1 these high risk situations that he experienced during the process of 
attempting to remain abstinent where: 
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P1: "Ok, a lot of people ask me, especially family members of addicts. Ok, the truth is, in the 
beginning it was the high that was the trigger, graving the next high." 
 He experienced high-risk situations during the process of recovery in that he indicated 
that in the beginning, before the use of naltrexone, it was the actual craving for the use of 
heroin that trigger the constant use for heroin in which the developed a dependency to heroin. 
He indicated that a lot of family members asked him what the reason was to him constantly 
using and not ceasing the use of heroin. He indicated that this is what most heroin dependent 
individuals experience in that it was always craving the next high of heroin which caused the 
vicious circle of heroin dependency. However he indicated that when he received the 
naltrexone pellet implant he had experienced the following: 
P1: "For the first nine months to a year people, places and things, any people that used, any 
people that drank I didn’t associate with and I didn’t have contact with. Any place that sold 
alcohol, anything like that, I wasn’t around, I didn’t go to a restaurant for the first nine 
months, why? Because I would see people drinking, other things… I said people, places and 
things. Things like gambling going into other things, porn, sex are big triggers. Because you 
know what I say? Anything that ups me, that make me… hey! That just takes me above the 
normal state of mind… I want to add the drugs." 
 For him, the first nine months of making use of the naltrexone pellet implant where he 
received 3 consecutive implants, he avoided “people, places and things” that would have an 
effect on him to make use of heroin. He further indicated that he avoided any form of 
situation that was linked to something that would enable him to develop some form of 
dependency in which he indicated that he avoided people that drank alcohol, parties where 
alcohol would be made available for people, casino’s where people gambled. He even went 
so far as to try and avoid going to a restaurant due to the reason that alcohol would be sold 
there. This for him was a way of coping with his heroin dependency in that he avoided any 
high-risk situation that might allow him to make us of an illicit substance. Thinks was due to 
the fear that he would not be able to cope with the temptations of the environment in that he 
might experience a lapse or relapse which might cause a sense of abstinence violation effect. 
This would have resulted in perceiving a short term positive effect of the use of a substance 
in that it might violate his commitment in remaining abstinent and eventually followed by a 
relapse process. He did this due to his indication of that “Anything that ups me, that make 
me… hey! That just takes me above the normal state of mind… I want to add the drugs.", 
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therefore explaining why he wanted to avoid certain environmental high-risk situations 
(Dimeff & Marlatt, 1998). Moreover, he continued with the statement of: 
P1: "So I have got to stay away from anything that ups me… people, places and things, ok. I 
couldn’t go to a place that had a vibe, because you know what? I am at that vibe and what I 
need is the drugs, so that is what I did. And I still today, six years later, people places and 
things play a huge part of my life today." 
 As indicated previously, he avoided these high-risk situations, even when he was on 
the naltrexone pellet implant. He indicated that when he would be exposed to these situations 
he would want to make use of an illicit substance in order to amplify the feeling that he 
experienced during that particular moment in the environment. Furthermore, he indicated that 
he still avoided these situations as this helps him to not make use of illicit substances such as 
heroin. For him this is one of the coping responses that he personally makes use of, it might 
not be a psychologically recommended way of doing so as this might create avoidant 
behaviour in him which might cause problems of social functioning. However, this was a 
mechanism that he was more than happy to use as compared to being dependent to heroin. A 
similar experience was found with Participant 2 in that what she experienced was: 
P2: "Everything is a trigger at the end of the day, like anything that reminds you of where 
you have been… uhm… whether it has been hearing a song that was at that stage popular on 
the radio and you would use drugs, in your car and that song would be playing, that is a 
trigger you know." 
 For her many situations acted as a high-risk situation in that she indicated that 
"Everything is a trigger at the end of the day, like anything that reminds you of where you 
have been…” even after the use of the naltrexone pellet implant that she had to still deal with 
the high-risk situation in the sense that everything that reminded her of her previous life as a 
heroin dependent individual was a form of a trigger to make use of heroin again. She further 
indicated that it could be anything from a song that she use to listen to that was associated 
with the heroin use, and whenever she was exposed to this high-risk situation that this would 
act as a trigger. She further elaborated on: 
P2: "I mean my worst social environments were like boyfriends, and old friends, people that I 
used to know in school and people that I used to know before using. And then you start using 
together and you think that it is not that bad because you know each other for so long.” 
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 Participant 2 indicated that one of her worst high-risk situations would have been old 
boyfriends and friends that she use to interact with when she was still a heroin dependent 
individual, she further mentioned that even people that she knew before becoming heroin 
dependent was a trigger to her making use of heroin again. These particular individuals was a 
high-risk situation for her in the sense that she indicated that when she met up with them pre-
recovery, that they would start using together, and for her the use with old friends was 
justified by the reason that they knew each other for a long time and that it would be om to 
use with these individuals. This was her high-risk situation to the use of heroin in that during 
that time she did not have an effective coping response whereby her self-efficacy was 
decreased due to the constant feelings of self-hatred, depression and disappointment as 
mentioned earlier on which caused her to experience the positive short term outcome 
expectancy to the use of heroin. This furthermore caused the abstinence violation effect to 
occur and led to a full blown relapse. In Participant 3’s case, it was quite a different 
experience to what he experienced as high-risk situations to the use of heroin in that: 
P3: "Myself, if I was having free time where nobody had control over me or nobody can have 
an eye on me for a certain amount of time. Honestly if someone had said to me like you are 
on your own now. Whether it was at my girlfriend’s house or if I was here [at home]. If ever 
there was a time where I had no supervision for more than a day and a half, it was either 
weed, cocaine, CAT, heroin on the odd occasion, but something would be saying in my head 
that nobody is watching me." 
 For Participant 3, the high-risk situation to the use of heroin was that when he had 
time by himself, whether it was at home or whether it was at his girlfriend’s house, he would 
have the urge to start using. In this sense he indicated that his high-risk situation would be 
being alone without any supervision, if he knew that his parents would not be home for a long 
time, he would then have the urge to start using heroin. He indicated that he would make use 
of various substances when being alone at home, even if someone indicated to him that he 
would be left alone somewhere, he would see this as an opportunity to make use of an illicit 
substance. It was as if he thrived on the fact that being left alone would have allowed him to 
use and he would be able to use without being caught. With Participant 4, it was quite a 
similar experience as seen in Participant 2 and Participant 1 whereby: 
P4: "Yes, absolutely. I mean, like, at first everything was a trigger, I mean money, the big 
ones are like money, the car, friends, certain places, but I mean for me a trigger would be 
waking up in the morning and just like, that would be the trigger, I would wake up and I 
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would just want to use. So the triggers became pretty much everything in my life. You know I 
had a good day I’m going to go and use, I had a bad day, I’m going to go and use. It just 
became everything." 
 For Participant 4, the high-risk situations were when he had money with him that 
would have enabled him to afford the use of heroin, also the fact that he had a car in order to 
go drive to a dealer without the supervision of a parent or friend and lastly the friends and 
places which related to what Participant 1 and 2 indicated by “People, places and things” in 
that with the situation of Participant 4. For him all of these three factors played a role in 
acting as a trigger to make use of heroin again, which he indicated that these triggers or high-
risk situations became everything in his life. In this sense, eventually he ended up waking up 
in the mornings and then would just crave the next fix of heroin, where the urge to make use 
of heroin had become the high-risk situation for him to make use of heroin. For Participant 4, 
his whole life experience became a reason to make use of heroin in the sense that if he had 
difficulty with emotions he would use heroin, even if he had a good day he would go make 
use of heroin. It started to become a part of Participant 4’s everyday life which is evident in 
his narrative, whereby he indicated that he has an emotional attachment to the use of heroin 
and therefore making it so much more difficult for him to remain abstinent from the use of 
heroin before making use of the naltrexone pellet implant. Before the use of the naltrexone 
pellet implant, Participant 4 indicated that he had an emotional attachment with the use of 
heroin which referred to the use of heroin assisting him in dealing with emotional difficulties 
such as the elimination of panic attacks. This caused him to be more attached to the use of 
heroin as this was seen as a method of getting rid of his emotional difficulties. It was found 
that for these participants various aspects in their life acted as a high-risk situation in that 
these various aspects became a trigger to make use of heroin which ranged from 
environmental, physical, emotional and relational situations.  
4.7.4.3 Naltrexone increases self-efficacy 
 This particular subordinate theme referred to the experience that these participants 
went through when they made the decision to remain abstinent from the use of heroin and to 
maintaining this change in their life, they might be faced with high-risk situations throughout 
their recovery process, however the use of the naltrexone pellet implant aided them to go that 
extra mile in remaining abstinent. However this spoke to the physiological component to 
remaining abstinent from the use of heroin, therefore these participants were left to deal with 
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the psychological component related to remaining abstinent from the use of heroin which 
speaks of one of the important components to the relapse prevention model known as self-
efficacy. The concept of self-efficacy introduced by Bandura (1977) was found to be a final 
common pathway that mediates behavioural change which can be linked to relapse in 
dependant behaviour. Self-efficacy can be defined as the degree to which an individual feels 
confident and capable of performing certain behaviours in a specific situational context. It 
regards the belief that one is capable to cause some effect on one’s environment-that one is 
effective. According to the cognitive behavioural model of relapse, a higher level of self-
efficacy is a predictor of improved treatment outcomes across various types of dependent 
behaviours, where as in this case the dependency to heroin and with it the ability to remain 
abstinent from its use. Accordingly, the self-efficacy theory verified that behavioural changes 
produced by different types of treatment are mediated by a common cognitive mechanism 
called efficacy expectancy. The expectancy of being able to cope with successive high-risk 
situations as they develop is closely associated with the idea of self-efficacy. So when an 
individual feels confident to cope effectively with a high-risk situation, they would then 
indirectly influence the perception of self-efficacy. Moreover, this referred to the individual 
that was able to make a change in his/her life structure for the better good of remaining 
abstinent from the use of heroin through the aid of the naltrexone pellet implant. This caused 
them to be more motivated in remaining abstinent from the use of heroin.  
P1: "by knowing that I have got the implant, yes was a big part of it ok. So it was a barrier, 
but the second big part was that I felt good, I felt great, I felt alive for the first time in twenty 
years. I could smile properly," 
 Participant 1 indicted that the mere fact that he was aware that there was a naltrexone 
pellet implant in his body in order to aid him in his recovery process made him feel more 
confident and willing to remain abstinent from the use of heroin. This was linked to the 
awareness of being informed by the physician that he should deviate from making use of 
heroin as this might have health implications if he decided to make use of heroin. 
Furthermore, he indicated that it acted as a barrier to the use of heroin in that he would not be 
able to experience the euphoric effect that is created by the use of heroin due to the effect that 
the naltrexone pellet implant has on the neurobiological system of the human body. He 
further elaborated on how good the naltrexone pellet implant made him feel in terms of being 
more motivated to function without the use of an illicit substance such as heroin. For twenty 
years he had to make use of heroin just to function properly in order to avoid withdrawing 
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from heroin. As indicated previously, he would wake up each morning and use heroin in 
order to function, and now that he has been released from the claws of heroin cravings and 
obsessions he now feels that he is actually alive for the first time in twenty years. This relates 
to the sense of self-efficacy that he now has the ability to take lead of his own life and that he 
was now able to have some control over the use of heroin as compared to before the use of 
the naltrexone pellet implant. A similar indication was expressed by Participant 2: 
P2: "Sometimes I wake up and I feel crap and I feel so sick today and I don’t know why and I 
got a little flu and I would be like, I would want to use today. And I would just go and drive 
and go use, and I think to myself, but why? Why would I want to? I feel so good and I look 
better, I feel better, I exercise, I actually have structure, I actually… you know I am actually 
becoming normal." 
 Here she indicated that before the naltrexone pellet implant she use to find any excuse 
to drive and go buy the next fix, whether it was because she felt a bit depressed or sick, she 
would drive and buy heroin in order to release her from both physical and emotions pain. 
This in return created a sense of uncontrolled decisions, in that she had to make use of heroin 
in order to feel better. She further indicated that there was a time where she had some 
introspection in that she was now talking to herself in order to think why she wanted to make 
use of heroin. This was the moment when she weighed the options of the decision to remain 
abstinent from the use of heroin, in that she indicated that because she had made use of the 
naltrexone pellet implant that she had now gain more control over her life. She had indicated 
that she started to develop structure in her life through means of feeling better, looking better 
and being involved in physical exercise which is a form of healthy living. Furthermore she 
indicated that she had now become normal in the sense that she did not have to make use of 
heroin in terms of worrying about the next fix, having to use in order to feel better about 
herself and that she had developed structure due to the naltrexone pellet implant. This 
indicated that the use of the naltrexone pellet implant aids the individual to work on other 
aspects of their life in terms of taking their lives back. This also speaks to self-efficacy in 
terms of Participant 2 having the ability to control her situation. In that with the help of the 
naltrexone pellet implant, she was able to start changing her life in order to live without the 
dependency to heroin. Participant 3 indicated a similar experience: 
P3: "You are in a better mind frame to think twice. You are not in that ‘I have to get now’, 
you are sitting there, your withdrawals are alleviated at least and your mind goes to drugs 
136 
 
immediately but then you think no, this… then you think of taking it out and then you think 
no…it is in and I will probably still get sick because it is in my bloodstream… nah…" 
 For him the mere mind-set of thinking to make use of heroin was the key to remaining 
abstinent in that he indicated a better mind-frame was the difference for him in order to 
remain abstinent. Due to the functionality of the naltrexone pellet implant in terms of 
eliminating obsessions and craving to illicit substances such as heroin, it aided this participant 
in eliminating the thinking pattern of “I have to get now” which is linked to the obsession of 
making use of heroin. Thus, through his indication of the elimination of the constant 
obsession with the use of heroin he was able to change his mind-set with regards to being 
dependent to heroin use. He further indicated that his withdrawals were alleviated due to the 
use of the naltrexone pellet implant which made him think about making use of heroin, 
however, he did think about the long term effect that this decision would have on him 
remaining abstinent from the use of heroin. He also thought about taking out the naltrexone 
pellet implant so that he would be able to make use of heroin, following that thought was his 
awareness that he might get sick when he was on the naltrexone pellet implant. This whole 
thinking process led to his decision to rather remain abstinent from the use of heroin and keep 
to his decision to leave the implant in and stick to remaining abstinent. Therefore his decision 
to remain abstinent was influenced by the actual implant that was in his body, which in some 
sense allowed him to take control in making a decision of remaining abstinent, thus leading to 
the discussion of the naltrexone pellet implant having an influence in the individual’s self-
efficacy. A similar instance occurred with Participant 4: 
P4: "So the naltrexone was that brick wall that stood between me and the drug. So that I 
could experience life and start doing the program and see what sober life was about." 
 Participant 4 indicated that the naltrexone pellet implant aided him in terms of 
creating a barrier or rather “a brick wall” between him and the use of heroin, thus indicating 
that he was no longer able to make use of heroin in order to feel the euphoric effect that he 
experienced when making use of heroin. This allowed him to remain abstinent from the use 
of heroin where he was able to experience a life without the use or dependency to heroin. 
This furthermore allowed him to make use of a recovering programme with a clearer mind-
set due to the absence of obsessions and cravings that allowed him to focus on the 
psychological aspects to an abstinent lifestyle. In this sense it allowed him to experience an 
increased sense of self-efficacy that allowed him to focus on remaining abstinent from the use 
of heroin. It was indicated by these participants mentioned above that they all have 
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experienced some sense of increased self-efficacy due to the use of the naltrexone pellet 
implant acting as an aid to their recovery process. They indicated that they experienced a 
sense of control over their lifestyle and that they felt that they were able to function and have 
structure without making use of an illicit substance such as heroin. Furthermore, these 
participants were able to work on psychological aspects pertaining to heroin dependency in 
order to remaining abstinent from the use of heroin. 
4.7.4.4 Naltrexone decreases cravings and obsessions 
 This particular subordinate theme referred to the decrease of cravings and obsessions 
to the use of heroin when they made use of the naltrexone pellet implant. A considerable 
amount of research has focused on identifying the predictors of the causes of relapse in order 
to develop treatment strategies for the prevention thereof. It was found that one of the 
strongest predictors of the causes of relapse in substance dependence is cravings (Breese et 
al., 2011; Shadel et al., 2011). The tolerance in the act of the desire of the use of a substance 
may be expressed as urges or cravings which are hypothesized to be mediated by the positive 
outcome expectancies of engaging in the prohibited behaviour. Cravings can be defined as an 
individual’s subjective experience of an urge or desire to make use of a substance. Numerous 
models to craving have consistently acknowledged that it can be experienced as intrusive 
thoughts and their elaboration, an impulse drive or motivation, a stress response, an 
emotional state, a physical sensation, substance wanting or any other manifestation that is 
relevant for an individual who endorses experiencing a craving or urge to make use of a 
substance (Cox & Klinger, 2002; Kavanagh et al., 2006; Paulus, 2007; Robinson & Berridge, 
1993; Sinha & O’Malley, 1999; Tiffany & Wray, 2009). The roots to craving can be 
attributed to biological, affective, or cognitive motivators. In the biological models of 
craving, the dependent behaviour of individuals can be seen as a brain disease whereby the 
causes of such cravings and use of the substance are born from neurobiological and 
physiological states (Witkiewitz et al., 2013). Cravings can be reflected in neural states where 
neurotransmitters such as dopamine, serotonin and gamma-aminobutyric acid (GABA) can 
be linked to drug use. It is evident that dopamine in the dorsal striatum has been associated 
with reported cravings and that GABA dysregulation has been associated with a craving drive 
that has been described as a relief of tension. From a cognitive perspective of craving, it is 
suggested that craving originates in cognitive processes such as memory, that reflect higher 
order information processing that evolved into automatic processes of use. Marlatt and 
Gordon (1985a) suggest that cravings are a result of cognitive expectancies for drug use as 
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mentioned previously. Research has indicated that naltrexone has an anti-craving effect in 
individuals who experience difficulty in remaining abstinent from the use of heroin. This 
means that naltrexone tends to eliminate the cravings caused by obsessions and compulsive 
thoughts of the illicit substance once individuals have ceased the use of opioids. The precise 
mechanism for craving reduction has not quite been determined, however, it is most likely 
linked to the antagonistic mechanism of the opioid pathways to the nucleus accumbens, 
which in return reduces the total amount of dopamine being released (Kunøe et al., 2012). 
The rationale behind the use of naltrexone for opioid use disorder as a treatment method lies 
behind the idea that it tends to motivate the reduction of the use of opioids such as heroin 
when the individual is unable to experience the pleasurable ‘euphoric’ effects of the illicit 
substance (Larney et al., 2014). In Participant 1’s experience with dealing with obsessions 
and craving when he made use of the naltrexone pellet implant was as follow: 
P2: "Structured lifestyle, yes to just not obsess about one thing anymore you know, I started 
just keeping myself busy with different parts of my life and things I still liked and… but you 
have to work with it… so… " 
 The elimination of the obsessions and cravings to heroin use allowed him to 
restructure his lifestyle in that the use of the naltrexone pellet implant assisted him to be more 
focused on much more important aspects in his life which assisted him in the recovery 
process, as well maintaining abstinence. The naltrexone pellet implant did assist him in not 
obsessing about the use of heroin, however he indicated that he still attempted to keep 
himself busy with other important aspects of his life in order to work on eliminating the 
obsessions of heroin use. For him, he still had to focus on keeping himself busy for the 
naltrexone pellet implant to have the total effect on him that he required in order to remain 
abstinent. That is why he indicated that “but you have to work with it” in that it is still up to 
the individual to have the responsibility to work on their psychological components in 
remaining abstinent whether it would be through therapy or some form of psychological 
introspection in order to deal with these psychological component to the use and dependency 
to heroin. 
P3: "Like now I don’t, like when I am alone I will sit and watch tv. I don’t think about getting 
up and going somewhere just in case someone doesn’t know where I am, and my girlfriend 
doesn’t know… don’t be naughty, stay at home and watch tv and be a good boy like that is 
something that I want, it is not hard work to be able to do that now." 
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 As discussed previously, Participant 3’s high-risk situation related to the use of heroin 
was when he was left alone at home or whenever he felt that he was not being supervised by 
a family member or a loved one. After he had received the naltrexone pellet implant he could 
sit alone at home without being supervised by his parents for the fear of using, rather he 
indicated that he now did not use because he did not feel that he wanted to use and that he 
was now able to be alone at home without obsessing to make use of heroin. The use of the 
naltrexone pellet implant has made it easier for him to be able to remain abstinent due to the 
lack of cravings and the obsession to go and buy heroin in order to get high. Therefore it was 
found that for Participant 3, the cravings and obsessions to the use of heroin had dissipated 
due to the use of the naltrexone pellet implant. Participant 4 indicated the following: 
P4: "I mean it’s just three months straight of no cravings and the triggers and when I got out 
of the rehab I went straight into, back into life, and it was almost like I was never on drugs at 
all." 
 Participant 4 indicated that for three months (duration of the naltrexone pellet implant 
being active in the body) he did not experience any cravings or obsessions to the use of 
heroin. He received the implant shortly before going to rehab whereby he indicated that his 
experience was quite different from all the other occasions of visiting a rehabilitation centre. 
The difference for him was that when he went to rehab while making use of the naltrexone 
pellet implant, it was easier for him to be able to focus on other important psychological 
factors of remaining abstinent, this refers to the development of effective coping responses in 
order to decrease his probability of a relapse when faced with a high-risk situation. He further 
indicated that he was able to get back to living in society with a more confident attitude of 
remaining abstinent from the use of heroin. This was a very important factor to Participant 4 
as he had various attempts to remaining abstinent which involved continuous failed attempts 
at remaining abstinent from the use of heroin. These failed attempts occurred shortly after 
being discharged from rehabilitation centres. The naltrexone pellet implant enabled him to 
experience a sober sense of self in which he indicated that when he was released from rehab 
that he felt that he had never made use of an illicit substance. Overall, it was found that these 
participants experienced less to none obsessions and cravings to the use of heroin when they 
made use of the naltrexone pellet implant  in order to remain abstinent from heroin use. 
This was due to the neurobiological effects that the naltrexone pellet implant had on these 
participants which encouraged them to focus on their sobriety and the psychological aspects 
related to that rather than obsessing about the use of heroin.  
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4.7.4.5 Using or thinking of using while on the naltrexone pellet implant 
 This particular subordinate theme referred to the participant making use or thinking of 
making use of heroin while on the naltrexone implant. This referred to the lapsing factor 
when on the implant despite the fact that they were told that it would be life threatening when 
making use of heroin while on the implant due to the risk for overdose. Here the researcher 
explored the reasons for them making use of heroin while they had made a decision to remain 
abstinent. Furthermore, the researcher was interested in exploring the various reasons for 
these participants making use of the heroin when they decided to remain abstinent and the 
different reasons why this decision was made. Moreover, this subordinated theme refers to 
the effects that they have experienced when making use of heroin while on the naltrexone 
implant which ranged from physiological to psychological effects to the use of heroin while 
on the naltrexone implant. The association to the individual thinking of making use of heroin 
when on the naltrexone implant has a connection with the outcome expectancies related to 
what they will feel when making use of heroin and the effect such euphoria that is 
experienced by the individual which might lead to a lapse or progress to a full-blown relapse 
(Dimeff & Marlatt, 1998). Participant 1 was asked whether he made use or thought about 
making use of heroin when on the naltrexone pellet implant by which his response was: 
P1: "I’ll tell you now, in the beginning, yes, I did try and use on the implant once I will tell 
you it was a week later. I might as well have shot water into my veins, it was a freaking 
joke.” 
 Participant 1 did in fact try to make use of heroin when the naltrexone pellet implant 
was still active in his body, to be exact he indicated that he had attempted to make use of 
heroin a week after he had received the naltrexone pellet implant. He expressed his 
experience of the use of heroin as a joke as he indicated that he did not experience any 
euphoric effect to the use of heroin. He indicated that he might as well have injected water 
into his veins and that it was a joke to him as he could not believe that the heroin had no 
effect on him at all. This eliminated the euphoric effect of the heroin for him was now 
eliminated so to make use of heroin was totally useless for him. He further indicated why he 
had attempted to make use of heroin by the following: 
P1: "Habit. Habit, I wasn’t craving, obsessing, nothing it was habit. I found that with a lot of 
my clients. It was just habit, it was what I did, every single day of my life and I will give you 
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another reason, us addicts don’t listen, we don’t believe ok, we are stubborn sons of bitches 
ok." 
 He indicated the reason for making use of heroin although he was aware that he had 
the naltrexone pellet implant still active in his system that it was habit. He indicated that it 
was more the habit of using heroin that led to his decision to use again. Participant 1 
indicated that this was something that he did every day of his life and that the use of heroin 
was a form of habit, he did not experience cravings or obsession of the use of heroin but 
rather the habit of using heroin led to his decision to make use of heroin. He further indicated 
that the other reason that he had attempted to make use of heroin was due to his stubbornness. 
By this he indicated that although he was told not to make use of heroin when on the implant 
that he would still have tested the effects of heroin use when on the naltrexone pellet implant. 
To his surprise the heroin did not have an effect by which he indicated the following: 
P1: "Ok, I only really became committed after I tried to use, ok that’s my truth. I got this and 
I have been told that when you use you are not going to get the effect and all that, and I 
thought that it was all bullshit. That’s the truth ok, so I was still very sceptical alright, then 
when I did… it was about a week later and I swear there was no… I actually became angry 
ha ha ha ha, ok. After I got angry ok, but at the same time there was anger and relieve at the 
same time, because I knew now that I can’t use." 
 As indicated, Participant 1 only became committed to remain abstinent from the use 
of heroin after he had tried to use when on the naltrexone pellet implant. He had to see for 
himself whether or not the naltrexone pellet implant was as effective as the physician had told 
him, and only through testing this by means of making use of heroin did he believe that this 
was not the hoax that he first thought it would be. He further indicated that he experienced a 
sense of anger towards the use of the naltrexone pellet implant in that he was no longer able 
to experience the euphoric effect of the use of heroin. He furthermore indicated that he had 
also experienced a sense of relieve in that this could be a form of therapy that might actually 
aid him in remaining abstinent from the use of heroin. For him this enabled him to give the 
naltrexone pellet implant a chance in attempting to remain abstinent from the use of heroin. 
Participant 3 had quite a different experience in that: 
P3: "I didn’t use but I thought about it. In the beginning you still crave a little, but the 
naltrexone helps with this. It is not as bad as needing to phone somebody now.” 
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 Participant 3 did however not attempt to make use of heroin when on the naltrexone 
pellet implant although he did think about making use of heroin in that he indicated that he 
did crave the use of heroin in some extend. For him the craving was not to a great extent in 
that he would go as far as phoning his heroin dealer and purchasing heroin in order to use. 
Rather, he indicated that the naltrexone helped dissipate the cravings to the use of heroin after 
it was fully active in his body. This experience of making use of heroin was quite different 
for Participant 4 in that he in fact did experience some sort of effect to the use of heroin in 
which he indicated the following: 
P4: "The effects of the heroin was very minimal, I didn’t really feel anything. It just, you 
don’t really get that kick, that like rush, you know. When you shoot up, you can feel the 
heroin like crawling through your veins as it spreads through your body and I couldn’t feel 
that at all." 
 When Participant 4 made use of heroin whilst on the naltrexone pellet implant, he did 
in fact experience some effects of the heroin in that he indicated that it was minimal and not 
the same as when he was not on the naltrexone pellet implant. For him, the use of heroin was 
not the same that it gave him the same “kick” that it usually gives him. Furthermore, he 
indicated that the rush that heroin gave him was abstinent and that when one makes use of 
heroin in that it feels as if the heroin crawls through one’s veins. These sensations that were 
experienced before when the individual was making use of heroin were abstinent with the use 
of the naltrexone pellet implant. Thus, indicating that the naltrexone pellet implant had quite 
an effect on Participant 4. Participant 4 was still able to experience some effect of the use of 
heroin. For him, the reasons for using were also a matter of habit,  he indicated previously 
that he had quite an emotional relationship with heroin and that a bond was formed between 
him and this illicit substance, thus referring to the habitual nature of his heroin dependency. 
Overall, it was found that these participants did experience some sense of thinking to make 
use of heroin while on the naltrexone pellet implant, whereby most of them did in fact 
attempt to make use of heroin. This was due to their curiosity as to the effects that the heroin 
would have on them when they were on the naltrexone pellet implant. Some were even 
sceptical to what they were told about the naltrexone pellet implant and how it will benefit 
them and had attempted to push the boundaries and experiment with this in order to test its 
reliability.  
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4.7.4.6 Ceasing the use of naltrexone 
 This particular subordinate theme referred to the process of ceasing the use of 
naltrexone after a period of abstinence, in that the individual would not want to remain on the 
naltrexone pellet implant in order to function without the use of heroin. Naltrexone is quite 
different from other pharmacological treatment modalities such as the use of opioid agonist 
such as methadone and suboxone which replicates heroin in some sense. Linked to this is the 
weaning off modalities of the use of opioid agonists in that evidence suggests that various 
other factors have an influence in making use of agonist therapies which include the fear of 
withdrawal from the agonist treatment, beliefs that making use of methadone is far worse 
than the consumption of heroin. There was also an indication that the use of methadone can 
also be seen as a form of self-medication due to its similarity of effect that are related to the 
use of heroin (Mathers et al., 2010; Peterson et al., 2010). This makes it far more difficult for 
the individual to remain abstinent from the use of opioids. Therefore, the alternative method 
of aiding the individual in remaining abstinent would be the use of the naltrexone pellet 
implant. Moreover, the use of the naltrexone pellet implant does seem to create some form of 
safety in that it helps eliminate cravings and obsessions to the use of heroin. So in this sense 
the use of the naltrexone pellet implant might become problematic in that the individual 
would be too afraid to cease the use of the naltrexone pellet implant. The required period of 
making use of naltrexone would be 9 months. It is up to the individual to decide how many 
implants they would want to make use of. This differs from person to person as to when they 
feel that they would want to stop the use of naltrexone. Ceasing the use of naltrexone is a big 
step as this might bring back some cravings and urges to make use of heroin again. This is 
encouraged by either being exposed to high-risk situations or the physiological effects that 
the naltrexone has on the opioid receptors cites. Thus, the opioid receptor cites are no longer 
blocked and the dopamine receptor cells will continue the regular process. This in return 
might cause a risk to the person going through the process of recovery, this might cause a 
lapse or even a full blown relapse when the naltrexone is no longer present in the body. The 
individual should learn to live without the naltrexone as it is both costly as well as only being 
an aid to the recovery process, it is the person’s own responsibility to deal with the 
psychological aspects related to heroin dependency. Heroin dependency is both a 
physiological process as it is a psychological process, therefore the naltrexone only supports 
the individual by means of working on the physiological responses experienced by heroin 
dependent individuals. Therefore psychological therapeutic modalities need to be 
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implemented in order for the individuals to remain totally independent of any substances for 
both legal and illicit substances. Participant 1 indicated the following: 
P1: "I didn’t need to wean of it, it is not addictive at all. It is not mind altering, I didn’t need 
to ween of it. " 
 For Participant 1 one of the benefits of making use of the naltrexone pellet implant 
was due to the exclusion of the weaning process of pharmacological modalities of an aid to 
relapse prevention. He indicated that he did not have to wean of the naltrexone pellet implant 
due to it not being a mind altering substance such as methadone and suboxone. This made it 
easier for him to be completely opioid free. By knowing that he was completely opioid free, 
he was aware that he did not have to endure a process of withdrawals when attempting the 
weaning process of agonistic substances. This encouraged him even more in attempting to 
remain abstinent from the use of any opioid. Although he did indicate that there was a sense 
of fear when he had to cease the use of the naltrexone pellet implant whereby he indicated: 
P1: "I felt scared, make no mistake, I did have fear, but because of the therapy that I went 
through I changed so much that I was confident enough to do it.” 
 Participant 1 did experience a sense of fear when he had to make the decision to stop 
the use of the naltrexone pellet implant, although he mentioned that he was confident enough 
to make that step due to the therapy that he received during the process of making use of the 
naltrexone pellet implant. This brings us back to the importance of the therapeutic process 
whereby an individual needs to seek some form of therapy in order for the naltrexone pellet 
implant to aid them in the will to remain abstinent and maintaining the abstinence from the 
use of heroin. This is related to the development of effective coping responses in that the 
naltrexone pellet implant enables the individual to focus on the psychological aspects rather 
that attempting to be obsessed and crave the use of heroin (Dimeff & Marlatt, 1998). 
Participant 3 experienced great progress with the attempt to remain abstinent in that he 
indicated the following: 
P3: "I don’t even know that this one is in. This is not a conscious thing, I am passing that 
stage so for me… I never want to have to ever be told ‘I think you should go for another 
pellet’." 
 He indicated that the implant did not even bother him in the sense that he didn’t 
obsess about this implant inside his body, but rather he was more focused on working with 
the psychological components in remaining abstinent. He indicated that “I am passing that 
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stage” he had passed the stage where he was aware of the naltrexone pellet implant being 
active in his body and that he now focused on remaining abstinent. Furthermore, he indicated 
that he would never want to go back to insert another pellet implant in that he now feels quite 
competent to cease the use of the naltrexone pellet implant in that he would not be going for a 
follow up implant in future. This was his own decision to remain abstinent without the use of 
a follow-up implant whereby he felt that he has reached a higher level of coping and that his 
self-efficacy is to a level where he would be able to cope with high-risk situations in 
remaining abstinent from the use of heroin. Participant 4 indicated that he also did not want 
to be on the naltrexone pellet implant for the rest of his life in which he indicated the 
following: 
P4: "The Naltrexone, we can’t be on naltrexone for the rest of our lives, you know there is a 
time where I’m going to have to go off it and basically the recovery is preparing to live 
without the naltrexone now. It’s you know, first it’s without out the drugs, but you know I 
don’t want to be on Naltrexone for the rest of my life." 
 He indicated that he is quite aware that he would not be able to make use of the 
naltrexone pellet implant for the rest of his life and that there will be a time that he would 
have to function without the use of the naltrexone pellet implant. For him, it was of great 
importance to be able to face sobriety without the use of the a follow-up implant in that he 
indicated that he had to work on remaining abstinent from the use of heroin without the use 
of naltrexone. He indicated that he already defeated the process of remaining abstinent from 
the use of heroin and that the next step would be to remaining abstinent from the use of 
heroin when ceasing the use of the naltrexone pellet implant. The cessation of the use of the 
naltrexone pellet implant was seen as the nest step in the recovery process for these 
participant in that they have already defeated the use of heroin with the aid of the naltrexone 
pellet implant, however the next step for them was that they had to now cease the use of the 
naltrexone pellet implant. It was found that many of them felt that they would want to cease 
the use of the naltrexone pellet implant in order to feel that they could now function without 
the aid of a pharmacological modality and that it would be their responsibility to ensure that 
they have an effective coping response to high risk situations before they attempt to cease the 
use of the naltrexone pellet implant.  
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4.7.5 Psychological aspects related to the use of the naltrexone pellet implant 
Due to the reason that human behaviour can be seen as a wholistic entity when being 
examined, on cannot separate the psychological from the physical. This particular 
superordinate theme was concerned with the psychological aspects that are evident in the 
subjective experiences and perceptions of the participants involved in this particular study, 
these four subordinate themes that can be found in table 4.1 above are furthermore concerned 
with the counselling aspect that is associated with the use of the naltrexone pellet implant in 
the recovery and abstinent process of the use of this particular form of treatment to relapse 
prevention. Moreover, this superordinate theme is concerned with certain cognitive processes 
and thinking patterns that are linked to the use of this particular form of therapy and these 
participants’ thinking pattern associated with the use of the naltrexone pellet implant therapy. 
4.7.5.1 Recovery with naltrexone in society 
 This particular subordinate theme referred to the participants being able to recover 
whilst in society when making use of naltrexone. With traditional modalities related to the 
recovery process of heroin dependency consisting of dependent individuals following a 
certain process in order to remain abstinent from the use of heroin which includes 
detoxification, rehabilitation in an enclosed environment it creates a temporary safe haven. 
Furthermore, this allows for an environment where the individuals will be segregated from 
society when they are admitted to a recovery center. This in itself creates a supporting, drug-
free environment where the individual can have time to recovery. However, when these 
individuals are then released from the recovery center they are then released into society 
where they should be able to face these high-risk situations once again. In this sense, given 
the high relapse rates soon after being released from rehab becomes of concern, these 
individuals are now tempted by these high risk situations when they are released from their 
safe haven whereby their probability for relapse increases. With the use of the naltrexone 
pellet implant they were able to be faced with the high-risk situations head-on when in 
society rather than being segregated from society and all the temptations while in rehab they 
feel that this is more effective. Being segregated from society seems to tempt the individuals 
in a sense that they already plan to relapse after being released from the rehabilitation center. 
Therefore, when they were faced with their usual environment in society they are able to 
recover while faced with high-risk situation which in a sense is more effective than being 
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segregated from society. For Participant 1 the use of the naltrexone pellet implant in society 
acted as a protective barrier in which he indicated: 
P1: "Because it gives you… see what happens is that it gives you a protective barrier, even if 
you are in society ok, it gives you a protective barrier that you can’t use ok. So you… that 
gives you say… let say three implants gives you nine months ok, because they are three 
month implants. For those nine months you have a chance to find out if you really enjoy life 
or not without it." 
 For him the naltrexone pellet implant acted as a protective barrier to the use of heroin 
in that the protective barrier for him was the inability to experience the euphoric effects of 
heroin. Due to the neurobiological aspects of the use of the naltrexone pellet implant (Kunøe 
et al., 2012), he did not see the use of heroin as very beneficial. For the nine months that he 
had made use of the naltrexone pellet implant, it was a barrier to the use of heroin in society 
in that no matter if he made use of heroin it had no effect on him, therefore the use of the 
naltrexone pellet implant in society encouraged him to remain abstinent from the use of 
heroin even though he was faced with high-risk situations. This led to his decision to remain 
abstinent from the use of heroin whilst in society due to not being able to experience the 
euphoria that heroin created when he made use of it. Participant 2 experiences a similar 
instance in that she indicated the following: 
P2: "But with the naltrexone, I was still in society but I was sober which was so helpful to be 
able to control myself while I am in the environment that I was in when I was using. And it is 
encouraging for me to be able to control myself you know what I am saying? Obviously it 
helped me, the naltrexone, but like I say, because you are faced… you can still work and be 
in recovery, rather than being way where you have rules and restrictions… you are still… 
and addicts hate being controlled." 
 She indicated that she even though she was in society and facing high-risk situations, 
she was still able to remain abstinent from the use of heroin in that she was able to control 
herself. She was not obsessed with the use of heroin and experienced no cravings which 
allowed her to rather focus on controlling her psychological aspects related to heroin 
dependency. She was faced with the same environment when she was making use of heroin 
before she had decided to remain abstinent. For her it was the ability to remain abstinent in 
the same environment when she was making use of heroin and taking control of these 
situations in facing her sobriety. This encouraged her to remain abstinent in a sense that she 
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felt more confident to be able to face these high-risk situations without making use of heroin. 
For her, the ability to face her high-risk situations while in society was more effective in that 
she felt that she was no longer confined by the space of a rehabilitation centre where there 
were rules and restrictions in order to recover from the use of heroin. She felt that 
rehabilitation centres was not effective due to being controlled by confined space that 
segregated her from society. Participant 3 had a similar experience in that: 
P3: "But when I got the naltrexone I immediately felt that I fought for nothing because this is 
the way and that it is… It is not like rehab where they go and sit you down and sedate you 
feel more fucked and you hope that they come with the horse tranquilizers and hope to get 
even higher." 
 He indicated that he noticed immediately after making use of the naltrexone pellet 
implant that he had found a way to function without the use of heroin and that the naltrexone 
pellet implant was a form of recovery that he was quite comfortable with. It was different to 
the experiences that he went through when making use of rehabilitation centres in that he 
indicated rehabilitation centres administered medications that made him feel high. For him, 
rehabilitation centres were a place where he could make use of other substances that would 
have tranquilised him, thus reinforcing the sedative aspects related to the use of illicit 
substances in society. For these participants, the use of the naltrexone pellet implant in 
society enabled them to face their high-risk situation head-on which was a form of working 
on their sobriety whilst being exposed to the same environments they were in when they 
made use of heroin.  
4.7.5.2 Counselling is necessary when on naltrexone 
 This particular subordinate theme referred to the psychological treatment modality 
associated with the naltrexone maintenance therapy with pellet implantation. It is believed 
that naltrexone is a miracle cure for some in the general public as well as people making use 
of the naltrexone pellet implant, this might be due to various misinterpretations through the 
media where naltrexone is seen as a miracle cure to heroin dependency (Carstens, 2012). This 
however, in retrospect, is not a cure but rather an aid to the physiological response of the 
body when an individual has decided to remain abstinent. Therefore some form of 
psychological intervention is required in order to work on the individual’s psychological 
conditioning response to the use of illicit substances such as heroin. Counselling is 
recommended during the naltrexone maintenance therapy with pellet implantation in order to 
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deal with underlying psychological issues associated with the dependent behaviour. It can be 
seen as a holistic approach to the treatment of substance dependence. Yes, as a matter of fact, 
naltrexone does have some sort of effect on the human body that not many other substances 
have when it comes to assisting individuals in the recovery process of attempting to remain 
abstinent. Therefore it might be misinterpreted as a miracle cure rather than an aid to the 
recovery process of illicit substances. Therefore counselling is needed to have a successful 
recovery process as indicated by Participant 1: 
P1: "Well, I tell you now, it was more therapy that helped me with that ok, but during the 
therapy I always felt confident. I felt that I had the naltrexone ok, I felt good all the time, the 
naltrexone made me feel so good ok, I was never down, I never had mood swings. I used to 
suffer from hectic depression, my depression was hardly there, you know what I am saying? 
My mood fluctuations… I was either like a passive baby or an aggressive tyrant you know. 
Now I was just in the middle, I was calm, I was able to sleep at night, I was getting sleep, I 
was able to concentrate for further periods. It just made it easier for me.” 
 Participant 1 indicated that the therapy that he had acquired when he made use of the 
naltrexone pellet implant was one of the key components to his recovery. However, he further 
indicated that the use of the naltrexone pellet implant helped him in feeling more confident to 
be able to work on the therapeutic modalities related to the recovery process from heroin 
dependency. Through this he indicated that the use of the naltrexone pellet implant dissipated 
his mood fluctuations, made him feel less depressed, eased his anger and allowed him to 
focus on the psychological aspects to remaining abstinent. He recalls that he could not focus 
on these aspects as the emotional aspects related to heroin dependency was standing in his 
way to focus on the psychological aspects such as following a therapeutic process in 
remaining abstinent from the use of heroin. His decision to seek psychological treatment was 
linked to the inability to make use of heroin due to the naltrexone pellet implant being active 
in his body in which he indicated the following: 
P1: "That I knew now that I had to change ok, that I can’t use, I can’t do what I used to do 
because I am not using. So now I have to try and live life without it, and that is when I 
realised that I need help." 
 Due to the neurobiological aspects related to the use of the naltrexone pellet implant, 
Participant 1 realised that he would not be able to experience the same effects that the use of 
heroin was producing in the past. Therefore he decided that it was time to seek psychological 
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treatment which is linked to his will to make a change and remain abstinent from the use of 
heroin. This was the time that Participant 1 realised that he needed to seek some sort of 
psychological treatment in order to develop an effective coping response to the high-risk 
situations that he might face in his decision to remain abstinent from the use of heroin. For 
him living without the use of heroin was a difficult task as he indicated that he now had to 
learn how to live life without the use of heroin due to years of habitual use of heroin as 
indicated earlier. Participant 2 indicated a similar situation: 
P2: "I am very obsessive compulsive, which is why drugs were very hectically to me. Because 
I will be obsessed about something and I will keep it that way. But what I realised is that you 
have to go for counselling, you have to work with the system, you cannot do it alone." 
 Participant 2 indicated that she was always quite “obsessive compulsive” in that she 
referred to the use of heroin as an obsessive component in her life, that it was as much a 
psychological component to her making use of heroin as it was a physical component. In this 
she interpreted that once she gets obsessed with something that she will stick to that 
obsession, which explains some part of why she had been obsessed with the use of heroin and 
eventually became dependent. She had come to the self-actualisation that counselling would 
in fact be necessary in order to deal with this particular obsession with the use and 
dependency to heroin. For her, the use of the naltrexone pellet implant was a major step 
towards the road to recovery, however she felt that she had to work with the system of 
seeking psychological therapy in order to change her life by means of living a life of 
abstinence. She realised that she had to seek professional guidance in remaining abstinent 
from the use of heroin. This is related to the development of an effective coping response in 
that Participant 2 started to realise that she would in fact have to start working on an effective 
coping response in order to increase her self-efficacy, thus decreasing her chance for a full-
blown relapse to occur (Marlatt & Gordon, 1985b). She furthermore elaborated on the 
psychological aspects of remaining abstinent in the following: 
P2: "That is why counselling is so important. You have to gain self-empowerment again and 
things like that. Like I said if I come to the end of my naltrexone where it starts wearing off 
and I start thinking about it and I feel that I start obsessing again… then maybe or maybe 
not, but like I feel two is maybe enough for me. But you can never say, you have to get your 
life straight. I have to have my life worked out now.” 
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 She referred to the importance of counselling in order to “gain self-empowerment” 
over her life where she would be able to face the high-risk situations in order to remain 
abstinent from the use of heroin. This again refers back to what was discussed in her previous 
quote in that it is of great importance that she would be able to develop an effective coping 
response to facing high-risk situations. This made her feel that she would be able to control 
these obsessions that she had difficulty with when making use of heroin. One particular 
aspect that encouraged her to seek psychological treatment in order to remain abstinent was 
the reality that she will eventually have to cease the use of naltrexone. She was particularly 
concerned with the obsessions and craving for heroin use returning after ceasing the use of 
the naltrexone pellet implant. She indicated that she might need to make use of two 
naltrexone pellet implants in order to focus on the psychological aspects whereby she would 
be able to empower herself with an effective coping response as to feel confident enough to 
cease the use of the naltrexone pellet implant and continue remaining abstinent without the 
help of the naltrexone pellet implant. Participant 4 went through quite a different experience 
which could support both Participant 1 and 2’s statements that counselling is necessary when 
on the naltrexone pellet implant: 
P4: "Well I tried, I tried, just using naltrexone at first and when the naltrexone wore off I 
would keep relapsing. So my first implant was a three month implant and that, that I didn’t 
do any program at all, I just spoke to Participant 1 on the phone. You know just chatted and 
then when that implant wore off I started using again." 
 Participant 4 indicated that he did make use of the naltrexone pellet implant without 
seeking proper psychological treatment for heroin use and dependency. He believed that the 
use of the naltrexone pellet implant would have been enough for him to remain abstinent 
from the use of heroin. In his experience, after the first naltrexone pellet implant started to 
wear off he did in fact start to experience some obsessions and cravings to the use of heroin 
and according to his interpretation this was the reason that he relapsed after making use of the 
initial naltrexone pellet implant. Participant 4 indicated that he did not get enough 
psychological support in that he only spoke with the counsellor over the phone and did not 
focus on the psychological aspects related to remaining abstinent such as the development of 
an effective coping response to high risk situations after the use of the naltrexone pellet 
implant. It was found that these participants realised the importance of the psychological 
aspects to remaining abstinent in that they had to work on developing an effective coping 
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response in order to remain abstinent from the use of heroin when they decide to cease the 
use of the naltrexone pellet implant. 
4.7.5.3 Dealing with high-risk situations when on the naltrexone pellet implant 
 This particular subordinate theme referred to situations that the individual was faced 
with when they have made the decision to remain abstinent from the use of substances such 
as heroin with the aid of the naltrexone pellet implant. A central aspect to the outline of the 
cognitive-behavioural model to relapse prevention as proposed by Marlatt and Gordon ( 
(1985a), is the detailed classification of certain factors or situations that can trigger potential 
relapse episodes know as high-risk situations. High-risk situations can be defined as any 
context in which an individual’s attempt to refrain from the use of a substance is threatened 
and might trigger the individual’s vulnerability for reengaging in substance use. These 
situations might include emotional or cognitive states (for example, negative affect such as 
anger and anxiety or diminished self-efficacy), environmental contingencies (for example, 
interpersonal conflict, conditioned drug cues, exposure to drug related stimuli, social 
pressure) and physiological states (for example, acute withdrawal, chronic pain). So in short, 
high-risk situations can consist of people, places and things that could greatly hinder one’s 
recovery process due to its ability to remind one of substance use. According to this model, 
an individual who has initiated a behavioural change should start to gradually experience a 
growing sense of personal control and self-efficacy in order to master his or her behaviour in 
a high-risk situation. With this in mind, one of the key factors to the relapse prevention model 
is how an individual is then able to respond to this high-risk situation. An effective coping 
response- defined as a cognitive or behavioural compensatory strategy that reduces the 
likelihood of lapsing- would be able to culminate a high-risk situation in a lapse and therefore 
eliminate the tendency to give in to the temptation of substance use and decreasing the 
probability of a relapse. In turn, an ineffective coping response might decrease self-efficacy 
and a return to target behaviour will increase the probability for future lapses (Hendershot et 
al., 2011; Larimer et al., 1999; Witkiewitz & Marlatt, 2004). These participants were faced 
with temptation in society such as social gatherings where people consume alcohol in order to 
have a good time and a mere memory of their past experiences when they made use of heroin. 
These participants were faced with these situations and attempted to remain abstinent while 
others individuals seemed to enjoy themselves by consuming substances such as alcohol, 
drugs. This made them feel vulnerable or excluded from the group due to their history of 
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substance dependency and the decision to remain abstinent and therefore they did not partake 
in the consumption of substances. Participant 1 indicated the following: 
P1: "Now I had to cope with all the shit around me, like people looking down on me, people 
picking on me you know, people telling me how shit I was my whole life and not having a way 
out." 
 For Participant 1 it was a constant struggle to be dealing with individuals who looked 
down on him for what he did in his previous lifetime of heroin use in that he had to partake in 
criminal activities that included stealing and housebreaking in order to feed his dependency 
to heroin. They resented him for not being able to control his dependency and remain 
abstinent from the use of heroin, and now that he had decided to remain abstinent to the use 
of heroin with the aid of the naltrexone pellet implant he had to face these high-risk situations 
of resentment from other individuals. This indicates the importance for the individual to be 
able to develop an effective coping response in order to deal with these high-risk situations 
that they might deal with in their everyday life. He indicated that “Now I had to cope with all 
the shit around me” in that he had to deal with the resentment of his family members which 
was one of the most difficult situations that he had to deal with. This in itself was one of 
Participant 1’s high-risk situations in that he had to develop an effective coping response to 
situations as these for the purpose of remaining abstinent and decreasing the probability to 
relapse. Participant 2 had a different perspective to one of the high risk situations that she had 
to deal with: 
P2: "Ok let me tell you this… on new year’s, sorry, on new year’s… I wouldn’t drink ok, I 
wouldn’t even take a sip of alcohol. Everyone, I was at a new year’s party and everyone there 
was drunk. Everyone there was partying and I felt like an outsider, really badly and this 
would probably answer it… I felt like such an outsider because everyone was drinking and 
having a good time, cheering and having shots. And I would sit there and like lose it you 
know, like drinking my Tropica [juice] and whatever. You feel like shit, you feel sad, you feel 
excluded. " 
 Participant 2 relayed that she had to deal with a very difficult high-risk situation when 
she had made the decision to remain abstinent from the use of illicit substances such as 
heroin. She indicated that she was present at a New Year’s Eve party where other individuals 
were making use of alcohol in order to have a good time. Seen as this particular time in the 
year was seen as a festive occasion that included the consumption of alcohol, Participant 2 
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was quite aware that she could not partake in the consumption of any illicit substance in order 
to remain abstinent from the use of heroin as she was dedicated to remaining abstinent from 
any illicit substance. She was aware that everyone else was having a good time by consuming 
alcohol, whereas, she had to avoid the consumption of alcohol and decided to rather consume 
juice. She indicated that she felt quite left out due to not consuming alcohol which made her 
feel like an outsider. Now this was quite a difficult situation for Participant 2 as she reported 
that due to her feeling of being segregated from the group due to refraining from consuming 
alcohol she could have given in and made use of alcohol in order to not feel excluded from 
the group. This would have led to her overstepping her boundaries of deciding to remain 
abstinent. In retrospect, she did in fact have the effective coping response to decline the use 
of alcohol which indicated that she had developed an effective coping response to what was a 
very seductive situation in consuming an illicit substance. She elaborated: 
P2: "I was paranoid of people and this time, I just realised you know that this… I am sitting 
like this and I cannot partake with this and have a good time, even though I did. You know 
you feel excluded. The reason that I am in this position is that I did make the wrong choices." 
 She reflected on the reason why she did not partake in consuming alcohol was that 
she made the wrong choices in the days that she did in fact make use of illicit substances such 
as heroin in that she would always take the consumption of illicit substances further in that it 
led to the dependency of heroin. However, she still felt excluded from the group, yet despite 
this she was able to have a good time at the end of the day without consuming any form of 
illicit substance. This also indicates that she had developed an effective coping response in 
that she deviated from making use of alcohol. A similar situation was experienced by 
Participant 4 in that he indicated the following: 
P4: "I had a good December and Christmas and everything, not because of the pill, but, 
because I felt the whole time that… even in shit situations, where I was sitting around the 
braai and my family was having a fight, I was still like happy." 
 Participant 4 had gone away with his family where the consumption of alcohol 
occurred. He indicated that his family would have a fight and that usually he would use this 
as an excuse to make use of heroin. After the aid of the naltrexone pellet implant and 
undergoing psychological support he was able to deal with this particular high-risk situation 
in that he indicated that even though his family was having a fight he was still able to sit there 
and be happy regardless of the situation around him. This indicated that Participant 3 had 
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developed an effective coping response to his high-risk situations which then increased his 
self-efficacy and, eventually, led to the decreased probability of a relapse occurring. 
In the current study, the participants verbalised that they had faced various high-risk 
situations during the process of making use of the naltrexone pellet implant in that it 
supported them in being able to work on psychological aspects related to heroin dependency. 
Through the development of an effective coping response and the ability to face a high-risk 
situation, these individuals felt more confident in themselves which speaks to their increased 
self-efficacy in which they were able to have control over their environments and maintain 
their decision to remain abstinent from the use of heroin.  
4.8 Conclusion 
 This particular study provides information from four heroin dependent individuals 
that made use of the naltrexone pellet implant, within the South African context. The 
researcher identified five superordinate themes relating to these participants’ subjective 
experiences with regards to the use of the naltrexone pellet implant as an aid for relapse 
prevention from heroin use. These Superordinate themes consisted of life before the use of 
the naltrexone pellet implant, giving naltrexone pellet implant a chance, physical experiences 
of the use of the naltrexone pellet implant, naltrexone pellet implant as an aid for relapse 
prevention and psychological aspects related to the use of the naltrexone pellet implant. The 
researcher made use of interpersonal communication with the participants in this particular 
study, including dialoguing with these particular participants together with member checking 
in order to interpret the double hermeneutic perspective to the specific paradigmatic 
perspective of interpretative phenomenology used in this study. This allowed for clarification 
on certain quotes made by participants in order to interpret the experiences that these 
participants lived through when making use of the naltrexone pellet implant as an aid to 
remaining abstinent from the use of heroin.  
The researcher collaborated with various professionals in the field of research 
methodology, specifically those that specialised in the field of phenomenological analysis in 
order to design the analytical framework for this specific study. Through an iterative process 
of interpretative phenomenological analysis and brainstorming the researcher was able to 
create an integrated process of clustering a vast amount of information to developing an 
analysis that would be readily available to an audience to follow the process of analysis in 
making sense of the study at hand. The researcher ensured to follow all the necessary steps 
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involved in interpretative phenomenological analysis in constantly being aware of the 
research question, paradigmatic approach as well as the contextual theory at hand when the 
analysis was conducted, this allowed for the researcher to be confident enough in answering 
the research question at hand. In order to maintain the authenticity of the participants’ 
accounts of the topic at hand, the researcher decided to use narrative which was personally 
extracted from the transcripts and integrated the findings as well as the discussion sections by 
way of academic justification emanating from this study to form one coherent chapter. The 
chapter following will discuss the conclusion made from the current study conducted which 
will be followed by the limitations in the current study together with some of the 
recommendations made by the researcher. 
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CHAPTER 5: CONCLUSION, LIMITATIONS AND RECOMMENDATIONS 
5.1 Introduction 
 This chapter highlights some of the important findings related to the subjective 
experiences and perceptions of heroin dependent individuals that made use of the naltrexone 
pellet implant as an aid for relapse prevention. This chapter will present the conclusion, 
limitations of the current study and recommendations for the treatment and further research 
studies within the field of heroin dependency. 
5.2 Summary and Conclusion of Study 
 Heroin use and dependency continues to be a growing problem within South Africa 
across many sites, associated with this are the problematic health consequences related to the 
use of this particular illicit substance and the administration thereof (Plüddemann et al., 
2013). These consequences ranges from dealing with infectious diseases due to the unhealthy 
sharing of needles when heroin is administered to the vast psychological modalities linked to 
the use and dependency to heroin that is inclusive but not limited to the vicious cycle of illicit 
substance use, abuse and dependency, not to mention the high mortality rates due to heroin 
use, abuse and dependency (Darke, 2011; Gorman, 2007; Plüddemann et al., 2013).  
It cannot be ignored that there are in fact various treatment facilities available to assist 
individuals who are finding it difficult to remain abstinent from the use, abuse and 
dependency to heroin, however, these facilities mainly adhere to customary practices in the 
treatment process of heroin dependency. These customary practices are limited to three main 
alternatives that include detoxification that would be followed with long-term residential 
treatment and opioid maintenance treatments such as the use of methadone, suboxone and 
subutex just to mention as few (Kunøe et al., 2012). 
Opioid maintenance treatments are agonist medications or medically dispensed heroin 
that are administered under controlled supervision and is seen as substituting or maintaining 
dependence on heroin. The opioid maintenance treatment has been found successful in 
reducing mortality, morbidity and drug-related criminal activity, however, there are concerns 
around the dropout rate during the initial months of treatment and that only a minority of 
these patients are able to achieve normal vocational and social functioning (Verthein et al., 
2008). Therefore, constant dropout and failure to remain abstinent from the use of heroin 
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creates great concern regarding relapse rates of individuals attempting to remain abstinent 
from the use of heroin. 
 Relapse tends to be one of the most problematic areas to the recovery process of 
abstinence to Opioid Use Disorder. As a fundamental feature of the dependence to illicit 
substances after short or even prolonged periods of abstinence, it still remains as problematic 
as the idea of addiction and dependence (Giuliano et al., 2013). It has been determined that 
approximately 40% to 60% of individuals that suffer from some sort of substance use 
disorder tend to return to substance use within one year of treatment. In a study of relapse 
among heroin users after residential treatment Gossop (2002) et al. found that one third 
(34%) of the sample used heroin within 3 days of leaving treatment, 24% used within 7 days 
of treatment and 50% used within 14 days after leaving treatment. After just 30 days after 
leaving treatment 57% of the sample of 145 individuals had used again. Understanding the 
process of relapse is central to treatment of addictive disorders and can help clinicians and 
their clients to intervene in the process to guard against relapse or to reduce the severity or 
length of relapse (Brownell et al., 1986). 
One particular theory and also one of the most prominent among psychological 
models is the cognitive behavioural approach that looks at relapse and addictive behaviour 
from a contemporary basis, including factors such as high-risk situations that may have an 
influence on the relapse process as a whole (Marlatt & Gordon, 1985b). 
 The relapse prevention model proposed by Marlatt and Gordon (1985b) formed the 
basis of the contextual theory that was used in this particular study. This particular theoretical 
framework consists of a cognitive-behavioural approach to the relapse process that focus on 
the high-risk situation and how the individual recovering from substance use tends to respond 
to the high-risk situation. If the individual does not have an effective coping response or some 
form of confidence in order to deal with the high-risk situation, the probability for them to 
give in to temptation would be high. The individual’s decision to make use of a substance or 
stay abstinent is then mediated by their outcome expectancies for the effect of the use of the 
substance. Individuals that tend to make use of a substance may be susceptible to the 
abstinence violation effect which causes self-blame and the sense of loss of control over the 
use of a substance. This may then result in the increased probability to make use of a 
substance and therefore increase the probability of a full-blown relapse. However, if the 
individual posits an effective coping response towards high-risk situations through means of 
an increased or higher self-efficacy, the probability of the occurrence of a full-blown relapse 
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is lessened. A more comprehensive description of this particular theoretical concept was 
discussed in Chapter 2. 
 Due to the limitations of alternative treatment modalities, high relapse rates and poor 
social readjustment possibilities when it comes to the use, abuse and dependency of heroin, 
these individuals may go to many lengths in order to deal with their dependent lifestyle. For 
these individuals to be able to deal with the psychological factors related to heroin 
dependency, they should be able to find a way to deal with the physical factors related to 
heroin dependency (Dos Santos et al., 2010). Due to the limitations of valid information 
regarding alternative forms of treatment for heroin dependency the researcher decided to 
investigate this alternative form of treatment to the use, abuse and dependency to heroin 
through focusing on the aspect of relapse prevention and the use of the naltrexone pellet 
implant as an aid to remaining abstinent within the south African context. 
Naltrexone, also known as naltrexone hydrochloride is sold under the trade names 
Revia, Depade or Vivitrol is a highly specific, non-addictive µ -opioid receptor antagonist 
which has a high attraction and combines to all opiate receptor sites. These receptor sites are 
involved with the development of opioid addiction, so the naltrexone will be the mechanism 
of action for the management of opioid addiction (Ling et al., 2011). This implies that it tends 
to attenuate or completely block the effects of exogenous opioids such as heroin, which 
causes the blocking of the euphoric and physiological effects of opioids which in return 
displace the euphoric effect of opioids when ingested by the human body (Kjome & Moeller, 
2011; Tucker & Ritter, 2000). This potent antagonist has shown to have valuable properties 
for the effective treatment of the addiction to opioids such as heroin and agonist medications 
such as methadone. Naltrexone was originally developed and distributed in tablet format, 
however, due to low-compliance of the oral naltrexone tablets that are taken daily or bi-daily 
it has failed to show pre-eminence over its placebo, which was evident in rapid dropout and 
low retention rate in the active naltrexone group (Minozzi et al., 2011). This non-compliance 
is often associated with individuals that withdrew from the treatment process and returned to 
the use of heroin. Even  individuals who have made progress with the oral format tend to 
relapse periodically (Hulse et al., 2004). Due to the lack of success with compliance and 
discontinuation typical of oral naltrexone format, research efforts were employed in order to 
develop a Sustained Release Naltrexone formulation (SRX) which will enabled the 
decreasing the problem of compliance that would essentially reduce the amount of dropout 
opportunities in human subjects. This removed the onus from patients to use daily oral 
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naltrexone (Kjome & Moeller, 2011). The oral format of naltrexone have shown great 
success in the treatment of heroin dependency in aiding with relapse prevention from heroin 
use (Hulse et al., 2004; Kjome & Moeller, 2011; Kunøe et al., 2012; Larney et al., 2014; 
Tiihonen et al., 2012). Due to the limitation of availability of the naltrexone pellet implant 
within the South African context, the researcher was quite interested to explore this particular 
topic in order to determine the individuals’ subjective experiences and perceptions of the use 
of the naltrexone pellet implant in aiding them with the relapse prevention process in order to 
remain abstinent to the use of heroin (Weich, 2010). 
This study adopted the Interpretative Phenomenological Analysis (IPA) paradigmatic 
approach that is deeply rooted in phenomenology and the hermeneutic school of thought 
(Smith et al., 2009). IPA allows for the interpretations of the research participants’ subjective 
experiences by the researcher that can be viewed as a key strength of the approach, in that it 
facilitates an understanding of the participants’ life worlds. One of the flaws in this regard 
would be the misinterpretation of the participants’ world perspective. Therefore the 
researcher ensured to establish rapport with the participants within this particular study by 
means of member checking as to ensure trustworthiness of this particular study. After the 
analysis was complete, the researcher ensured to return to the participants in order to ensure 
that the themes that were extrapolated from the interviews were a reasonable reflection of 
their responses (Goldblatt, Karnieli-Miller, & Neumann, 2011). It was found that there was a 
general agreement among the participants that the themes that arose from this particular study 
represented a true reflection of their experiences of the use of the naltrexone pellet implant as 
an aid for relapse prevention from heroin use and dependency.  
This particular study was conducted in order to answer the overall research question: 
‘What are the subjective experiences and perceptions of individuals who made use of the 
naltrexone maintenance therapy with pellet implantations as an aid for relapse prevention 
from heroin use and dependency?’ The aim concerned with this particular research question 
was to gain a better understanding of these participants’ subjective experiences and 
perceptions with the use of this particular alternative form of treatment in order to remain 
abstinent from the use of heroin. This was explored in order to form a platform of 
understanding the experiences that people go through when making use of the naltrexone 
pellet implant as an alternative form of recovery. The findings within this particular study 
was determined through a collation of keeping in mind some of the key components related 
to conducting a research study which included keeping in mind the contextual theory, 
161 
 
paradigmatic approach, research aim, research question and purpose of this particular study in 
mind when the analysis, findings and discussion process occurred in this particular study. 
The analysis process of this particular study presented five superordinate themes 
together with twenty four subordinate themes. This analytical process made use of the IPA 
method in order to present the subjective worldview of the participants in this particular 
study. The first theme in this study found that the participants indicated that there was a life 
before the use of the naltrexone pellet implant. It indicated that none of these participants 
started off making use of heroin and that they had experimented with various other 
substances before they became dependent to heroin. These participants found themselves 
involved with criminal activities in that they had to steal, lie and cheat in order to buy or get 
hold of their next fix. Numerous failed attempts in remaining abstinent from the use of heroin 
were experienced by these participants in that none of the general treatment modalities such 
as detoxification, rehabilitation and opioid maintenance assisted them in remaining abstinent 
from the use of heroin. Shortly, after being discharged from rehabilitation centres, the 
participants found that they were even more tempted to make use of heroin than before they 
were admitted for treatment. Some of the participants in this study made use of agonist 
medications for the treatment of heroin dependency such as methadone to get high, thus 
creating a vicious cycle of opioid use. It was found that heroin use became part of their daily 
functioning. 
Due to a strong will to remain abstinent to the use of heroin, the participants shared 
that they had made the decision to giving the naltrexone pellet implant a chance seen as this 
was their last resort to remaining abstinent. Their initial thoughts regarding the naltrexone 
pellet implant included that this particular aid was part of a hoax and that it seemed quite 
impossible to believe that this could act as a ‘silver bullet’ in order to rid them from their 
dependency to the use of heroin. However, these participants feared the use of the naltrexone 
pellet implant due to being informed that about the dangers of overdose when making use of 
heroin after the implant was inserted. Furthermore, they experienced some fear with regards 
of being able to stop making use of heroin in that they might not experience the euphoric 
effect they were so use to during their dependence. 
Furthermore, participants experienced a vast amount of physical symptoms once the 
naltrexone pellet implant was inserted. One particular experience that stood out for these 
participants was the memory of the detoxification process that they had to endure before the 
naltrexone pellet implant was to be inserted in order to avoid severe withdrawals. Following 
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the detoxification, the participants recalled the memory of them experiencing some anxiety 
and nervousness in the physician’s office minutes before the naltrexone pellet implant had to 
be inserted. This anxiety was mainly the fear of making use of an unknown aid in the attempt 
to remain abstinent from the use of heroin together with the inability to make use of heroin 
once the implant was inserted. Moreover, one of the most recalled memories regarding the 
experiences shortly after the insertion of the naltrexone pellet implant was the ‘sickness’ that 
these individuals experienced due to severe withdrawals. These severe withdrawals were 
experienced, mainly, by participants that made use of heroin, shortly before receiving the 
naltrexone pellet implant. 
One of the core superordinate themes to this study is the use of the naltrexone pellet 
implant as an aid for relapse prevention in that participants indicated that the use of the 
naltrexone pellet implant was not a cure but rather an aid to the recovery process of heroin 
dependency. This was due to them indicating that one needed to make use of psychological 
intervention modalities together with the use of the naltrexone pellet implant in order to 
approach the problem of heroin dependency in a holistic manner.  
The use of the naltrexone pellet implant acted as an aid to the recovery process in that 
its use decreased cravings and obsessions to heroin use due to the nature of the 
pharmacological modalities of the naltrexone pellet implant. The naltrexone pellet implant 
works specifically on blocking the opioid receptor sites which has an impact on the 
dopaminergic neurotransmitter system in that it has a direct effect on the cravings and 
obsessions regarding heroin use (Kjome & Moeller, 2011). This led the participants to focus 
on dealing with the psychological aspects of heroin dependency in that the cravings and 
constant obsessions gave way to focusing on counselling modalities in order to rid them of 
their dependent behaviour. Furthermore, it was indicated that these individuals experienced a 
sense of increased self-efficacy when they made use of the naltrexone pellet implant due to 
being able to take control of their emotional and environmental conditions in the abstinence 
of heroin use. This is interlinked with the relapse prevention model presented by Witkiewitz 
and Marlatt (2004), in that the probability of a relapse occurring will decrease once the 
individual has developed an effective coping response together with an increased sense of 
self-efficacy. 
It was evident in these individuals’ experience that the use of the naltrexone pellet 
implant did in fact aid them in remaining abstinent from the use of heroin in that once they 
were faced with a high risk situation, that they were able to remain abstinent due to the aid of 
163 
 
the naltrexone pellet implant that eliminated the craving and obsessions together with the 
development of effective coping responses and an increased sense of self-efficacy even 
though they were still very aware of their personal high-risk situations.  
These participants indicated that various high-risk situations were evident during the 
use of the naltrexone pellet implant as an aid for relapse prevention of heroin use, however 
they were able to control these situations. There were some indications from these 
participants regarding making use or thinking of making use of heroin whilst making use of 
the naltrexone pellet implant. Some participants did indicate that they had attempted to make 
use of heroin while on the naltrexone pellet implant in which they indicated that the heroin 
had no euphoric effect on them. Thus, the use of the naltrexone pellet implant assisted them 
by means of not being able to experience the euphoria created by heroin use in that there was 
no more short-term outcome expectancies, therefore they experienced no value of making use 
of heroin whilst on the naltrexone pellet implant. Moreover, these participants indicated that 
there would be a time that they would have to cease the use of the naltrexone pellet implant 
seen as they would not like to be using the naltrexone pellet implant for the rest of their 
abstinent lifetime. This indicated that they felt confident enough to remain clean from any aid 
with regards to sustaining their abstinence from heroin use. 
Furthermore, it was found that there was a psychological component to the findings of 
making use of the naltrexone pellet implant as an aid to relapse prevention from heroin use. 
The use of the naltrexone pellet implant enabled the participants to face their high-risk 
situations whilst in society, they recalled that the naltrexone pellet implant was more effective 
due to the ability to recovery whilst in society when facing their high-risk situations. This was 
due to many failed attempts in making use of the general treatment modalities made available 
for them in the current South African context such as detoxification, admission to 
rehabilitation centres and opioid maintenance. In this, they indicated that relapse occurred 
shortly after being released from the rehabilitation centres. They indicated that this is due to 
the rehabilitation facilities creating a safe haven with strict rules, emotional support, 
supervision and the lack of illicit substances made available due to the enclosed space of a 
rehabilitation centre. This highlights the necessity of counselling modalities to the recovery 
process when making use of the naltrexone pellet implant even when recovering within 
society. 
In order to conclude, it was found that the use of the naltrexone pellet implant as an 
aid for relapse prevention to heroin use and dependency had various positive components 
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related to remaining abstinent. It was found that the naltrexone pellet implant as a particular 
aid or treatment method was experienced positively in a sense that these individuals found it 
beneficial to make use of the naltrexone pellet implant in remaining abstinent from the use of 
heroin. 
In perspective to the contextual theory of relapse prevention the use of the naltrexone 
pellet implant as an aid to relapse prevention from heroin use for these participants indicated 
an increase of self-efficacy through the development of effective coping responses to high-
risk situations (Marlatt & Gordon, 1985b). Therefore the use of the naltrexone pellet implant 
as an aid to the recovery process of heroin use and dependency and indicating the decreasing 
probability of a relapse from occurring when these participants are faced with high-risk 
situations whilst recovering in society, is confirmed. This brought the researcher to consider 
various limitations regarding this particular study which will be discussed. 
5.3 Limitations of the Study 
The purpose of this study was to explore the subjective experiences and perceptions 
of heroin dependent individuals making use of the naltrexone pellet implant as an aid to 
relapse prevention from heroin use. The researcher is aware that the participants did in fact 
discuss their experiences with follow-up implants and the process of remaining abstinent 
during this period. This section describes the limitations associated with the study at hand. 
One of the limitations regarding this study is that of the recruitment of participants. 
The researcher did in fact experience difficulty in recruiting participants in Gauteng due to 
the limitations of the availability of the naltrexone implant and the process that needs to be 
followed in order for the individual that needs to receive the implant such as the Section 120 
of the MCC. Furthermore, this study found that the participants were quite hesitant to speak 
about their experiences with the use of the naltrexone pellet implant as an aid for relapse 
prevention. It was found that these potential participants were not psychologically ready to 
speak about their experiences in that they were in a process of recovery and would not want 
to reflect on past experiences with the use and dependency to heroin. 
The costliness of the naltrexone implant may also be a factor to explain the limited 
number of individuals making use of this form of treatment. Therefore the sample size of this 
particular study poses limitations in terms of representivity as the researcher recruited four 
participants. However, Smith et al (2009) indicates that even a small sample size of three 
participants could be sufficient for a qualitative study. 
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The majority of the sample selected for the participation of the study seemed to be 
more dependent on illicit substances that are not related to this study - such as cocaine, 
methamphetamine, ecstasy, CAT and so forth. And this study specifically aimed to explore 
individuals that’s main substance in abuse is heroin. It was noted that the participant in this 
study did however have a polydrug use nature where they did not just make use of heroin but 
also tended to make use of other substances with the use of heroin. The limitation related to 
this is due to the assumption that naltrexone was most effective for the treatment of heroin 
dependency due to its neurobiological properties and its effect of blocking the opioid receptor 
cites. However, it should be noted that the researcher did in fact adjust and adapt the 
interview schedule before conducting the interviews with the participants in this study in 
order to focus on the use of heroin specifically. 
Although the researcher initially proposed to interview various professionals in the 
field of naltrexone maintenance therapy with pellet implantation, it was decided that due to 
the nature of this study, the researcher is interested in what the individual’s subjective 
experiences were with regards to making use of naltrexone maintenance therapy with pellet 
implantation as an aid for relapse prevention from heroin use. Therefore, interviewing the 
professionals in this particular setting would not deem appropriate as they might not have 
lived this experience themselves. The researcher is aware that these professionals might have 
vast knowledge in this particular field and that they might have contributed in this study. 
However, due to the nature of enquiry it is not deemed necessary. 
5.4 Recommendations for Future Research 
 As much as this study produced an exploration of the use of the naltrexone pellet 
implant as an aid for relapse prevention from heroin, the researcher have a few 
recommendations for future research related to this field of study. 
It would be worthwhile to investigate these individuals’ experience regarding ceasing 
the use of the naltrexone once they have gone through the therapeutic process in more detail. 
This is to elaborate or to explore the process in order to indicate if these participants will be 
willing to let go of the use of naltrexone and not going for additional implants from the 
standard three implants recommended by healthcare professionals. Exploring this component 
may open up the subsequent factors related to ceasing the use of naltrexone. It was found in 
this study that the participants feared being off the naltrexone pellet implant because they 
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feared relapsing again. It might also be that these individuals felt the naltrexone pellet 
implant was a safe haven for them in remaining abstinent.  
 The development of an adjunct naltrexone implant therapeutic process (counselling 
aspect) should be implemented and measured, this will aid the psychological aspect to 
remaining abstinent from illicit substances. Due to the nature of how naltrexone is available 
in the South African context, including the limited availability of naltrexone, it can be seen as 
an outpatient treatment method. Therefore, a step-by-step guide to the recovery process with 
the use of the naltrexone pellet implantation should be investigated and developed for these 
particular individuals making use of this alternative treatment modality. Furthermore, this 
will encourage the ceasing process of naltrexone implant therapy as to including a section 
whereby the individual should go through a process of ‘letting go’ of the naltrexone implant 
that may be a difficult task to accomplish due to the evidence found in the participants within 
this particular study. 
 Furthermore, an investigation of the counselling programme followed by the 
naltrexone support group should be conducted in order to determine its effectiveness with the 
support of the naltrexone pellet implant that was created by Participant 1. Seen as the 
counselling aspect to the recovery process was regarded as key by participants to remaining 
abstinent the researcher felt that this in itself could be a very important aspect to investigate. 
Lastly, the researcher felt that the exploration of the naltrexone pellet implant should 
be investigated by a sample of participants that made use of various other substances besides 
heroin, in that the main illicit substance of abuse and dependence should be of another group 
of illicit substances besides that of the opioid group. This is to determine whether or not 
participants will have a similar experience as this particular study. If not, what would be 
some of the similarities and differences to this particular study? Finally, the researcher 
recommends that a similar study should be conducted on a larger representative sample, 
across the country or different contexts, in order to determine their lived experiences with the 
use of the naltrexone pellet implant as an aid for relapse prevention from heroin dependency. 
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APPENDICES 
Appendix A: Consent Form 
 
INFORMED CONSENT FORM FOR PARTICIPATION IN RESEARCH STUDY 
Research topic: 
 
Naltrexone maintenance therapy with pellet implantation as an aid for relapse prevention of 
heroin dependent individuals: a South African perspective. 
 
Description of the research that you will be involved in 
You are invited to participate in a research study conducted by Hugo Denton van der Walt in 
fulfilment of a MA (psychology) in Research Consultation degree, Department of 
Psychology, University of South Africa. The focus of the study would be to explore and 
understand the subjective experiences of heroin dependent individuals regarding the 
naltrexone implants as an aid for relapse prevention from heroin use. 
Your participation will involve an interview which will be recorded. The reason for recording 
the interview is that the researcher would be able to transcribe and analyse the data in depth, 
which will result in more detailed data for the purpose of this study. 
Risks and discomforts 
There are no physical risks involved in conducting the research. Although there might be 
some topics that will be discussed during the interview that might be sensitive to the 
participant or that may cause emotional discomfort. This will be noted by the researcher and 
the necessary precautions will be applied in order to avoid any harm. 
Potential benefits 
Your participation in this research study would contribute towards understanding and helping 
other individuals struggling with the use of certain substances. Your participation may 
contribute towards the use of naltrexone as a viable aid in the treatment process for substance 
use disorders. Note that this study does not involve monetary compensation for participating.  
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Protection of confidentiality 
Your name and personal details will not be mentioned within this study, you will be referred 
to by a pseudonym in order to protect personal information about yourself. The audio 
recording of the interview will be transcribed and stored in a safe place so that no one outside 
of the study would have access to this recording, after three years on completion of the study, 
all raw data will be destroyed. Note: that only the researcher and his supervisor will be able to 
have access the recording and the transcripts. 
Voluntary participation 
Your participation in this research study is voluntary. This means that you have the right to 
choose whether you want to partake within this study, and that you may withdraw your 
consent to participate at any stage during the interview process. You will not be penalized in 
any way if you decide that you no longer want to participate or withdraw in the interview 
process. 
Contact information 
If you have any questions or concerns regarding the interview process and the study or if any 
problems arise from this study- please feel free to contact the researcher, Hugo van der Walt 
at 072 958 6383, or study supervisor, Prof. Monika dos Santos, Psychology Department, 
University of South Africa, Email: dsantmml@unisa.ac.za. Tel: 012 429 8577.  
 
I, (name and surname) __________________________________________ have read this 
consent form and have been given the opportunity to ask questions. I give my consent to 
participate in this study. 
 
Participant’s signature: _____________________             Date: _______________ 
 
Witness: _____________________        Date: _______________ 
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Appendix B: Interview Schedule 
INTERVIEW SCHEDULE 
 
Topic: Naltrexone maintenance therapy with pellet implantation as an aid for relapse 
prevention of heroin dependent individuals: a South African perspective. 
 
You are hereby requested to partake in the proposed study mentioned above, in fulfilment of 
a MA Psychology (Research consultation) degree, Department of Applied Psychology, 
University of South Africa. This study aims to explore the use of naltrexone maintenance 
therapy with pellet implantations as a suitable option in aiding individuals who suffer from 
heroin addiction. To gain a better understanding of the subjective experiences of individuals 
who receive naltrexone  maintenance therapy with pellet implantation in preventing relapse 
and maintaining abstinence from the abuse of heroin. 
The interviews that will be conducted in this proposed study will be audio-recorded in order 
to be analysed and reviewed. All the information that you will contribute towards this 
interview will be kept confidential. You will be identified by a pseudonym or another name 
of your choice in order to stay anonymous. The duration of the interview would not exceed 
one hour. 
The participant has the right to ask for a copy of the result of the final study, or a copy of the 
research proposal. This should be requested by the researcher, Hugo van der Walt, which can 
be contacted on 072 958 6383, or e-mail the researcher at: hugovanderwalt@yahoo.coom 
If you have any questions or concerns about this study, or should any problem arise as a 
result of the study, please feel free to contact the researcher. 
Also feel free to contact the supervisor: 
Prof. Monika dos Santos, Psychology Department, University of South Africa, Email: 
dsantmml@unisa.ac.za. Tel: 012 429 8577.  
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Research topic Naltrexone maintenance therapy with pellet 
implantation as an aid for relapse prevention 
of heroin dependent individuals: a South 
African perspective 
Course Masters in Research Consultation 2014 
Student name Hugo van der Walt 
Student number 44715927 
Student contact details 072 958 6383 
hugovanderwalt@yahoo.com 
Supervisor name Prof. Monika dos Santos 
Supervisor contact details Tel: 012 429 8577 
 
dsantmml@unisa.ac.za.  
 
Department Psychology Dept. Human Sciences 
Institution UNISA 
Research participant  
Date of interview  
Time of interview  
Location of interview  
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Participant contact details  
 
Introduction 
 
Hello, my name is Hugo van der Walt, thanks you for agreeing to participate in the study.  As 
previously mentioned, I am conducting an academic study in order to complete my Master’s 
degree in Research Consultation. 
 
Please take note that your identity and the data being collected will remain anonymous at all 
times during the conduction of this study. I want you to know that this is a safe environment 
where you would not be judged about the information that is gathered. This study is about 
exploring what your experiences were, from your perspective, during the use of naltrexone as 
an aid for relapse prevention.  I want you to please be as honest as possible about the answers 
that you give me in this interview. 
 
Any questions before we start? 
 
MAIN INTERVIEW QUESTION: 
 
What are your personal experiences with the use of naltrexone maintenance therapy with the 
pellet implantation with regards to relapse prevention, and to aid you in the recovery process 
of heroin dependency? 
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A. BIOGRAPHIC INFORMATION: 
 
AGE: __________ GENDER______________ RACE______________ 
 
B. INTERVIEW QUESTIONS: 
 
This interview will start of by focusing on your experiences with the use of heroin before you 
decided to make use of naltrexone, whereby we will then be moving on to exploring your 
experience during the use of naltrexone. And we will then be ending of with what your future 
perspective would be regarding the use of naltrexone. 
 
Just to clarify, did you in fact have a problem with heroin use specifically? 
 
1. Past experiences: 
1.1 Could you tell me about your experiences of the use of heroin?  
- When did you first start using heroin? 
- How long have you used heroin? 
- Why did you use heroin? (the actual factors associated with its use)(Outcome 
expectancies) 
- Was there a time that you decided to stop using and seek help? 
- Rehabilitation centers, medication, counselling etc. 
- Why did you make use of these forms of recovery?  
- Were you then motivated to stop using heroin? And why? 
- Were there any “triggers” that caused you to make use of heroin after trying to remain 
clean? And what were they? (Physical, emotional, social) 
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- Were you able to “bounce back” from using again? And what influenced your 
decision to do so/or not being able to do so? 
2. During the use of naltrexone (We will now be discussing the process of making use of 
the naltrexone implant, so during the use of naltrexone) 
2.1 How did you find out about the naltrexone pellet implant therapy? 
- What did you think about this alternative form of recovery when you first found out 
about it? 
- What led to your decision to make use of this form of treatment? 
 
2.2 What did you experience during the first time that you received the naltrexone implant? 
- What was the procedure like? 
- Did you experience any side-effect of the use of naltrexone? If so, how did this 
influence your recovery process? 
- What were some of the physical symptoms that you experienced during the use of 
naltrexone? (loss of cravings,  
- Did you experience any withdrawal symptoms while on the naltrexone treatment? If 
so, how was it different from normal withdrawal symptoms when stopping the use of 
heroin? And did this have an impact on your road to recovery? 
- What were some of the psychological symptoms that you experienced? (Mood, 
emotions) 
- Have you made use of more than one implant since then? And why? 
 
2.3 How did the naltrexone maintenance therapy with pellet implantation help you to 
remaining clean? (Avoid relapses from occurring) 
 
- Throughout the process of making use of naltrexone implants did you experience any 
form of craving? 
- How is this different from the usual cravings without the use of naltrexone? 
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- Did you ever try to use again when on naltrexone? And what did you experience 
when you used? 
- If so, what led to your choice to use again? (High-risk situations) 
- How did “using again” make you feel after you had the initial goal of remaining 
clean? (Abstinence violation effect) 
- Did naltrexone help you “get back on the wagon” when you tried to use again? And 
how? 
- Would you say that naltrexone helped you to avoid a relapse from heroin? 
 
2.4 Did you undergo any form of counselling when you were making use of naltrexone? 
(Group meetings, personal counselling sessions etc.) (Self-efficacy) 
- Why did you go for counseling? 
- Did the use of naltrexone encourage you to seek psychological counselling? And 
Why? 
- Do you think it is important to go for counselling when making use of naltrexone? 
Why so? 
- How did the use of the naltrexone implant therapy affect your everyday life (for 
example: your emotions, thinking processes, behavior, and motivation to stay clean, 
social interactions with friend and family, relationships etc.)? 
- Were there times when a social situation might have triggered you to use again while 
on naltrexone? (any conflict, social pressures, physical symptoms etc.) 
 
2.5 How did the naltrexone therapy influence your road to recovery overall? 
 Did it benefit you? 
 Did it influence you negatively? 
 
3. Future 
3.1 Do you plan to get another implant? What are the reasons? 
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3.2 Would you recommend this treatment to other individuals that have difficulty remaining 
abstinent/clean? Why so? 
 
3.3 Is there anything else you feel you would like to add regarding this subject? 
 
End of interview 
 
We have come to the end of the interview. Thank you very much for your time and 
participation. Are there any questions or concerns you might have that you would like clarity 
on or to discuss regarding the study? 
 
Should you have any further queries regarding the study please feel free to contact me any 
time. 
 
My contact details are hugovanderwalt@yahoo.com or 072 958 6383 
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Appendix D: Confidentiality Clause of co-coder 
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